EurekaMag PDF full texts Chapter 72,079

Zhuo, Z.; Lu, H.; Zhu, J.; Hua, R.-X.; Li, Y.; Yang, Z.; Zhang, J.; Cheng, J.; Zhou, H.; Li, S.; Li, L.; Xia, H.; He, J. 2020: METTL14 Gene Polymorphisms Confer Neuroblastoma Susceptibility: An Eight-Center Case-Control Study. Molecular Therapy. Nucleic Acids 22: 17-26

Shi, Y.; Zhuang, Y.; Zhang, J.; Chen, M.; Wu, S. 2020: METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner. Cancer Management and Research 12: 13173-13184

Liu, Z.; Liu, N.; Huang, Z.; Wang, W. 2020: METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation. Cancer Management and Research 12: 12759-12767

Jian, D.; Wang, Y.; Jian, L.; Tang, H.; Rao, L.; Chen, K.; Jia, Z.; Zhang, W.; Liu, Y.; Chen, X.; Shen, X.; Gao, C.; Wang, S.; Li, M. 2020: METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics 10(20): 8939-8956

Lu, Z.; Liu, H.; Song, N.; Liang, Y.; Zhu, J.; Chen, J.; Ning, Y.; Hu, J.; Fang, Y.; Teng, J.; Zou, J.; Dai, Y.; Ding, X. 2021: METTL14 aggravates podocyte injury and glomerulopathy progression through N 6 -methyladenosine-dependent downregulating of Sirt1. Cell Death and Disease 12(10): 881

Zhou, T.; Ren, Z.; Chen, C. 2020: METTL14 as a predictor of postoperative survival outcomes of patients with hepatocellular carcinoma. Nan Fang Yi Ke da Xue Xue Bao 40(4): 567-572

Li, M.; Deng, L.; Xu, G. 2021: METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho. Molecular Medicine 27(1): 106

Zhang, X.; Li, D.; Jia, C.; Cai, H.; Lv, Z.; Wu, B. 2021: METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer. Cell Death and Disease 12(6): 617

Zhang, B.-Y.; Han, L.; Tang, Y.-F.; Zhang, G.-X.; Fan, X.-L.; Zhang, J.-J.; Xue, Q.; Xu, Z.-Y. 2020: METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion. European Review for Medical and Pharmacological Sciences 24(12): 7015-7023

Chen, X.; Xu, M.; Xu, X.; Zeng, K.; Liu, X.; Pan, B.; Li, C.; Sun, L.; Qin, J.; Xu, T.; He, B.; Pan, Y.; Sun, H.; Wang, S. 2020: METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Molecular Cancer 19(1): 106

Xu, Z.; Jia, K.; Wang, H.; Gao, F.; Zhao, S.; Li, F.; Hao, J. 2021: METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease. Cell Death and Disease 12(1): 32

Laptev, I.; Shvetsova, E.; Levitskii, S.; Serebryakova, M.; Rubtsova, M.; Zgoda, V.; Bogdanov, A.; Kamenski, P.; Sergiev, P.; Dontsova, O. 2020: METTL15 interacts with the assembly intermediate of murine mitochondrial small ribosomal subunit to form m4C840 12S rRNA residue. Nucleic Acids Research 48(14): 8022-8034

Ai, Y.; Liu, S.; Luo, H.; Wu, S.; Wei, H.; Tang, Z.; Li, X.; Lv, X.; Zou, C. 2021: METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. Journal of Immunology Research 2021: 6149558

Shi, W.; Zheng, Y.; Luo, S.; Li, X.; Zhang, Y.; Meng, X.; Huang, C.; Li, J. 2021: METTL3 Promotes Activation and Inflammation of FLSs Through the NF-κB Signaling Pathway in Rheumatoid Arthritis. Frontiers in Medicine 8: 607585

Chen, X.; Huang, L.; Yang, T.; Xu, J.; Zhang, C.; Deng, Z.; Yang, X.; Liu, N.; Chen, S.; Lin, S. 2021: METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression. Frontiers in Oncology 11: 667451

Liu, L.; Wu, Y.; Li, Q.; Liang, J.; He, Q.; Zhao, L.; Chen, J.; Cheng, M.; Huang, Z.; Ren, H.; Chen, J.; Peng, L.; Gao, F.; Chen, D.; Wang, A. 2020: METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma. Molecular Therapy: the Journal of the American Society of Gene Therapy 28(10): 2177-2190

Shi, J.; Chen, G.; Dong, X.; Li, H.; Li, S.; Cheng, S.; Li, Y.; Wang, L.; Yuan, J.; Qian, Z.; Dong, J. 2021: METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner. Frontiers in Oncology 11: 702983

Wu, Z.; Shi, Y.; Lu, M.; Song, M.; Yu, Z.; Wang, J.; Wang, S.; Ren, J.; Yang, Y.-G.; Liu, G.-H.; Zhang, W.; Ci, W.; Qu, J. 2020: METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA. Nucleic Acids Research 48(19): 11083-11096

Zhao, K.; Yang, C.; Zhang, J.; Sun, W.; Zhou, B.; Kong, X.; Shi, J. 2021: METTL3 improves cardiomyocyte proliferation upon myocardial infarction via upregulating miR-17-3p in a DGCR8-dependent manner. Cell Death Discovery 7(1): 291

Li, R.; Song, Y.; Chen, X.; Chu, M.; Wang, Z.-W.; Zhu, X. 2021: METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE. Molecular Therapy Oncolytics 22: 245-255

Lei, H.; He, M.; He, X.; Li, G.; Wang, Y.; Gao, Y.; Yan, G.; Wang, Q.; Li, T.; Liu, G.; Du, W.; Yuan, Y.; Yang, L. 2021: METTL3 induces bone marrow mesenchymal stem cells osteogenic differentiation and migration through facilitating M1 macrophage differentiation. American Journal of Translational Research 13(5): 4376-4388

Wang, Y.; Gao, M.; Zhu, F.; Li, X.; Yang, Y.; Yan, Q.; Jia, L.; Xie, L.; Chen, Z. 2020: METTL3 is essential for postnatal development of brown adipose tissue and energy expenditure in mice. Nature Communications 11(1): 1648

Li, X.; Jiang, Y.; Sun, X.; Wu, Y.; Chen, Z. 2021: METTL3 is required for maintaining β-cell function. Metabolism, Clinical and Experimental 116: 154702

Han, J.; Du, S.; Wu, C.; Qiu, M.; Su, L.; Zhao, Z.; Cheng, S.; Tao, W. 2021: METTL3 participates in glioma development by regulating the methylation level of COL4A1. Journal of Buon: Official Journal of the Balkan Union of Oncology 26(4): 1556-1562

Liu, S.; Zhuo, L.; Wang, J.; Zhang, Q.; Li, Q.; Li, G.; Yan, L.; Jin, T.; Pan, T.; Sui, X.; Lv, Q.; Xie, T. 2020: METTL3 plays multiple functions in biological processes. American Journal of Cancer Research 10(6): 1631-1646

Lin, A.; Zhou, M.; Hua, R.-X.; Zhang, J.; Zhou, H.; Li, S.; Cheng, J.; Xia, H.; Fu, W.; He, J. 2020: METTL3 polymorphisms and Wilms tumor susceptibility in Chinese children: a five-center case-control study. Journal of Gene Medicine 22(11): E3255

Wei, J.; Yin, Y.; Zhou, J.; Chen, H.; Peng, J.; Yang, J.; Tang, Y. 2020: METTL3 potentiates resistance to cisplatin through m6 a modification of TFAP2C in seminoma. Journal of Cellular and Molecular Medicine 24(19): 11366-11380

Yang, Y.; Yang, X.; Wu, Y.; Fu, M. 2021: METTL3 promotes inflammation and cell apoptosis in a pediatric pneumonia model by regulating EZH2. Allergologia et Immunopathologia 49(5): 49-56

Bi, X.; Lv, X.; Liu, D.; Guo, H.; Yao, G.; Wang, L.; Liang, X.; Yang, Y. 2021: METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246. Cell Death Discovery 7(1): 237

Hou, H.; Zhao, H.; Yu, X.; Cong, P.; Zhou, Y.; Jiang, Y.; Cheng, Y. 2020: METTL3 promotes the proliferation and invasion of esophageal cancer cells partly through AKT signaling pathway. Pathology Research and Practice 216(9): 153087

Wang, W.; Shao, F.; Yang, X.; Wang, J.; Zhu, R.; Yang, Y.; Zhao, G.; Guo, D.; Sun, Y.; Wang, J.; Xue, Q.; Gao, S.; Gao, Y.; He, J.; Lu, Z. 2021: METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N 6 -methyladenosine-dependent YTHDF binding. Nature Communications 12(1): 3803

Yuan, Q.; Zhu, H.; Liu, H.; Wang, M.; Chu, H.; Zhang, Z. 2021: METTL3 regulates PM2.5-induced cell injury by targeting OSGIN1 in human airway epithelial cells. Journal of Hazardous Materials 415: 125573

Sorci, M.; Ianniello, Z.; Cruciani, S.; Larivera, S.; Ginistrelli, L.Ceci.; Capuano, E.; Marchioni, M.; Fazi, F.; Fatica, A. 2018: METTL3 regulates WTAP protein homeostasis. Cell Death and Disease 9(8): 796

Ma, Z.; Li, Q.; Liu, P.; Dong, W.; Zuo, Y. 2020: METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Cell Biology International 44(12): 2524-2531

Diao, L.-T.; Xie, S.-J.; Lei, H.; Qiu, X.-S.; Huang, M.-C.; Tao, S.; Hou, Y.-R.; Hu, Y.-X.; Sun, Y.-J.; Zhang, Q.; Xiao, Z.-D. 2021: METTL3 regulates skeletal muscle specific mi RNAs at both transcriptional and post-transcriptional levels. Biochemical and Biophysical Research Communications 552: 52-58

Li, N.; Hui, H.; Bray, B.; Gonzalez, G.M.; Zeller, M.; Anderson, K.G.; Knight, R.; Smith, D.; Wang, Y.; Carlin, A.F.; Rana, T.M. 2021: METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection. Cell Reports 35(6): 109091

He, J.; Zhou, M.; Yin, J.; Wan, J.; Chu, J.; Jia, J.; Sheng, J.; Wang, C.; Yin, H.; He, F. 2021: METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8-mediated neutrophil infiltration. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(5): 1821-1837

Shi, W.; Yang, F.; Dai, R.; Sun, Y.; Chu, Y.; Liao, S.; Hao, B. 2021: METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in down Syndrome. Frontiers in Cell and Developmental Biology 9: 621374

Sahoo, S. 2020: METTL3-Regulated m6A Epitranscriptome Plasticity in Pathological Angiogenesis. Molecular Therapy: the Journal of the American Society of Gene Therapy 28(10): 2105-2107

Iaiza, A.; Tito, C.; Ianniello, Z.; Ganci, F.; Laquintana, V.; Gallo, E.; Sacconi, A.; Masciarelli, S.; De Angelis, L.; Aversa, S.; Diso, D.; Anile, M.; Petrozza, V.; Facciolo, F.; Melis, E.; Pescarmona, E.; Venuta, F.; Marino, M.; Blandino, G.; Fontemaggi, G.; Fatica, A.; Fazi, F. 2021: METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors. Clinical Epigenetics 13(1): 173

Wu, H.; Xu, H.; Jia, D.; Li, T.; Xia, L. 2021: METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/β-catenin pathway. Annals of Translational Medicine 9(14): 1155

Peng, Z.; Gong, Y.; Wang, X.; He, W.; Wu, L.; Zhang, L.; Xiong, L.; Huang, Y.; Su, L.; Shi, P.; Cao, X.; Liu, R.; Li, Y.; Xiao, H. 2022: METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease. Molecular Therapy: the Journal of the American Society of Gene Therapy 30(2): 932-946

Xia, C.; Wang, J.; Wu, Z.; Miao, Y.; Chen, C.; Li, R.; Li, J.; Xing, H. 2021: METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway. Toxicology 462: 152961

Zhang, Z.; Wang, M.; Xie, D.; Huang, Z.; Zhang, L.; Yang, Y.; Ma, D.; Li, W.; Zhou, Q.; Yang, Y-Gui.; Wang, X-Jie. 2018: METTL3-mediated N 6 -methyladenosine mRNA modification enhances long-term memory consolidation. Cell Research 28(11): 1050-1061

Song, H.; Song, J.; Cheng, M.; Zheng, M.; Wang, T.; Tian, S.; Flavell, R.A.; Zhu, S.; Li, H-Bing.; Ding, C.; Wei, H.; Sun, R.; Peng, H.; Tian, Z. 2021: METTL3-mediated m 6 A RNA methylation promotes the anti-tumour immunity of natural killer cells. Nature Communications 12(1): 5522

Wu, Y.; Chang, N.; Zhang, Y.; Zhang, X.; Xu, L.; Che, Y.; Qiao, T.; Wu, B.; Zhou, Y.; Jiang, J.; Xiong, J.; Zhang, J.; Zhang, J. 2021: METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 90

Han, H.; Yang, C.; Zhang, S.; Cheng, M.; Guo, S.; Zhu, Y.; Ma, J.; Liang, Y.; Wang, L.; Zheng, S.; Wang, Z.; Chen, D.; Jiang, Y.-Z.; Lin, S. 2021: METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway. Molecular Therapy. Nucleic Acids 26: 333-346

Cheng, C.; Wu, Y.; Xiao, T.; Xue, J.; Sun, J.; Xia, H.; Ma, H.; Lu, L.; Li, J.; Shi, A.; Bian, T.; Liu, Q. 2021: METTL3-mediated m6A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung. Molecular Therapy. Nucleic Acids 23: 487-500

Luo, H.; Liu, W.; Zhang, Y.; Yang, Y.; Jiang, X.; Wu, S.; Shao, L. 2021: METTL3-mediated m6A modification regulates cell cycle progression of dental pulp stem cells. Stem Cell Research and Therapy 12(1): 159

Wang, A.; Chen, X.; Li, D.; Yang, L.; Jiang, J. 2021: METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis. Journal of clinical laboratory analysis 35(9): e23931

Mu, H.; Zhang, T.; Yang, Y.; Zhang, D.; Gao, J.; Li, J.; Yue, L.; Gao, D.; Shi, B.; Han, Y.; Zhong, L.; Chen, X.; Wang, Z-Bo.; Lin, Z.; Tong, M-Han.; Sun, Q-Yuan.; Yang, Y-Gui.; Han, J. 2021: METTL3-mediated mRNA N 6 -methyladenosine is required for oocyte and follicle development in mice. Cell Death and Disease 12(11): 989

Li, R.; Qiu, X.; He, M.; Qiao, J.; He, J.; Zhong, M. 2021: METTL3-mediated mature miR-497-5p/195-5p inhibits trophoblast migration and invasion by targeting WWP1 in preeclampsia. Cell Cycle 2021: 1-16

Goh, Y.T.; Koh, C.W.Q.; Sim, D.Y.; Roca, X.; Goh, W.S.S. 2020: METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing. Nucleic Acids Research 48(16): 9250-9261

Chen, H.; Gu, L.; Orellana, E.A.; Wang, Y.; Guo, J.; Liu, Q.; Wang, L.; Shen, Z.; Wu, H.; Gregory, R.I.; Xing, Y.; Shi, Y. 2020: METTL4 is an snRNA m 6 Am methyltransferase that regulates RNA splicing. Cell Research 30(6): 544-547

Ignatova, V.V.; Kaiser, S.; Ho, J.S.Y.; Bing, X.; Stolz, P.; Tan, Y.X.; Lee, C.L.; Gay, F.P.H.; Lastres, P.R.; Gerlini, R.; Rathkolb, B.; Aguilar-Pimentel, A.; Sanz-Moreno, A.án.; Klein-Rodewald, T.; Calzada-Wack, J.; Ibragimov, E.; Valenta, M.; Lukauskas, S.; Pavesi, A.; Marschall, S.; Leuchtenberger, S.; Fuchs, H.; Gailus-Durner, V.; de Angelis, M.H.; Bultmann, S.; Rando, O.J.; Guccione, E.; Kellner, S.M.; Schneider, R. 2020: METTL6 is a tRNA m3C methyltransferase that regulates pluripotency and tumor cell growth. Science Advances 6(35): Eaaz 4551

Ali, J.; Liu, W.; Duan, W.; Liu, C.; Song, J.; Ali, S.; Li, E.; Wang, Q. 2020: METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma. Annals of Translational Medicine 8(18): 1130

Jiang, Z.; Yin, W.; Zhu, H.; Tan, J.; Guo, Y.; Xin, Z.; Zhou, Q.; Cao, Y.; Wu, Z.; Kuang, Y.; Li, C.; Xie, D.; Huang, H.; Zhao, M.; Jiang, X.; Wang, L.; Ren, C. 2021: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis. Cancer Cell International 21(1): 383

Shi, X.; Sun, Y.; Zhang, Y.; Wang, W.; Xu, J.; Guan, Y.; Ding, Y.; Yao, Y. 2021: MEX3A promotes development and progression of breast cancer through regulation of PIK3CA. Experimental Cell Research 404(1): 112580

Wei, L.; Wang, B.; Hu, L.; Xu, Y.; Li, Z.; Shen, Y.; Huang, H. 2020: MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6. Aging 12(21): 21091-21113

Zhou, X.; Li, S.; Ma, T.; Zeng, J.; Li, H.; Liu, X.; Li, F.; Jiang, B.; Zhao, M.; Liu, Z.; Qin, Y. 2021: MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression. Experimental and Therapeutic Medicine 22(5): 1343

Jiang, S.; Meng, L.; Chen, X.; Liu, H.; Zhang, J.; Chen, F.; Zheng, J.; Liu, H.; Wang, F.; Hu, J.; Li, Z. 2020: MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway. Experimental Cell Research 395(2): 112191

Xu, Y.; Pan, S.; Chen, H.; Qian, H.; Wang, Z.; Zhu, X. 2021: MEX3A suppresses proliferation and EMT via inhibiting Akt signaling pathway in cervical cancer. American Journal of Cancer Research 11(4): 1446-1462

Cao, Y.; Jiang, F.; Zhang, S.; Yang, L.; Sun, Y. 2020: MEX3C promotes osteosarcoma malignant progression through negatively regulating FGF14. Journal of Buon: Official Journal of the Balkan Union of Oncology 25(3): 1554-1561

Garcia-Silva, R.; Hernandez-Dono, S.; Mena, L.; Granados, J. 2020: Mexican Human Leukocyte Antigen Alleles Might Predict Clinical Outcome in Sars-Cov-2 Infected Patients. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 72(3): 178-179

Meng, Q.; Wang, L.; Wang, T.; Wang, M.; Zhu, W.; Shi, F.; Chen, Z.; Chen, X. 2021: MF-Net: Multi-Scale Information Fusion Network for CNV Segmentation in Retinal OCT Images. Frontiers in Neuroscience 15: 743769

O'Hagan, D.T.; Wack, A.; Podda, A. 2007: MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?. Clinical Pharmacology and Therapeutics 82(6): 740-744

Zhu, X.; Cheng, Y.; Wu, F.; Sun, H.; Zheng, W.; Jiang, W.; Shi, J.; Ma, S.; Cao, H. 2020: MFAP2 Promotes the Proliferation of Cancer Cells and Is Associated with a Poor Prognosis in Hepatocellular Carcinoma. Technology in Cancer Research and Treatment 19: 1533033820977524

Dong, S.Y.; Chen, H.; Lin, L.Z.; Jin, L.; Chen, D.X.; Wang, O.C.; Ye, Z.Q. 2020: MFAP2 is a Potential Diagnostic and Prognostic Biomarker that Correlates with the Progression of Papillary Thyroid Cancer. Cancer Management and Research 12: 12557-12567

Yao, L-Wen.; Wu, L-Lian.; Zhang, L-Hui.; Zhou, W.; Wu, L.; He, K.; Ren, J-Cai.; Deng, Y-Chao.; Yang, D-Mei.; Wang, J.; Mu, G-Gang.; Xu, M.; Zhou, J.; Xiang, G-An.; Ding, Q-Shan.; Yang, Y-Ning.; Yu, H-Gang. 2020: MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway. Oncogenesis 9(2): 17

Pan, Z.; Yang, K.; Wang, H.; Xiao, Y.; Zhang, M.; Yu, X.; Xu, T.; Bai, T.; Zhu, H. 2020: MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 34(11): 14250-14263

Wang, H.; Liu, M.; Wang, X.; Shuai, W.; Fu, H. 2022: MFAP4 deletion attenuates the progression of angiotensin II-induced atrial fibrosis and atrial fibrillation. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 24(2): 340-347

Kollakalnaduvil Raghavan, R.M.; Ali Pannippara, M.; Kesav, S.; Mathew, A.; G Bhat, S.; Hatha Aa, M.; Kk, E. 2021: MFAP9: Characterization of an extracellular thermostable antibacterial peptide from marine fungus with biofilm eradication potential. Journal of Pharmaceutical and Biomedical Analysis 194: 113808

He, Z.; Yuan, Z.; An, P.; Zhao, J.; Du, B. 2021: MFB-LANN: a lightweight and updatable myocardial infarction diagnosis system based on convolutional neural networks and active learning. Computer Methods and Programs in Biomedicine 210: 106379

Sun, J.; Li, X.; Tang, C.; Wang, S-Hua.; Zhang, Y-Dong. 2021: MFBCNNC: Momentum factor biogeography convolutional neural network for COVID-19 detection via chest X-ray images. Knowledge-BasedSystems 2021: 107494

Zhang, Y.; Peng, J.; Yuan, X.; Zhang, L.; Zhu, D.; Hong, P.; Wang, J.; Liu, Q.; Liu, W. 2021: MFCIS: an automatic leaf-based identification pipeline for plant cultivars using deep learning and persistent homology. Horticulture Research 8(1): 172

Zhao, H.; Huang, T.; Li, J.; Liu, G.; Yuan, X. 2020: MFCNV: a new Method to Detect Copy Number Variations from Next-Generation Sequencing Data. Frontiers in Genetics 11: 434

Cowpe, J.G. 2007: MFDS (2007): 'A structured and beneficial measure of achievement, underpinning progression in clinical practice'. British Dental Journal 203(7): 433-434

Lewis, T.L.; Kwon, S-Kyu.; Lee, A.; Shaw, R.; Polleux, F. 2018: MFF-dependent mitochondrial fission regulates presynaptic release and axon branching by limiting axonal mitochondria size. Nature Communications 9(1): 5008

Marazuela, P.; Solé, M.; Bonaterra-Pastra, A.; Pizarro, J.ús.; Camacho, J.; Martínez-Sáez, E.; Kuiperij, H.B.; Verbeek, M.M.; de Kort, A.M.; Schreuder, F.H.B.M.; Klijn, C.J.M.; Castillo-Ribelles, L.; Pancorbo, O.; Rodríguez-Luna, D.; Pujadas, F.; Delgado, P.; Hernández-Guillamon, M. 2021: MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy. Acta Neuropathologica Communications 9(1): 154

Chiang, H.-Y.; Chu, P.-H.; Chen, S.-C.; Lee, T.-H. 2021: MFG-E8 Regulates Vascular Smooth Muscle Cell Migration Through Dose-Dependent Mediation of Actin Polymerization. Journal of the American Heart Association 10(11): E020870

Huang, W.; Jiao, J.; Liu, J.; Huang, M.; Hu, Y.; Ran, W.; Yan, L.; Xiong, Y.; Li, M.; Quan, Z.; Rao, Y.; Chen, J.; Huang, Y.; Zhang, D. 2020: MFG-E8 accelerates wound healing in diabetes by regulating "NLRP3 inflammasome-neutrophil extracellular traps" axis. Cell Death Discovery 6: 84

Huang, W.; Jiao, J.; Liu, J.; Huang, M.; Hu, Y.; Ran, W.; Yan, L.; Xiong, Y.; Li, M.; Quan, Z.; Rao, Y.; Chen, J.; Huang, Y.; Zhang, D. 2020: MFG-E8 accelerates wound healing in diabetes by regulating "NLRP3 inflammasome-neutrophil extracellular traps" axis. Cell Death Discovery 6(1): 84

Gao, Y.-Y.; Tao, T.; Wu, D.; Zhuang, Z.; Lu, Y.; Wu, L.-Y.; Liu, G.-J.; Zhou, Y.; Zhang, D.-D.; Wang, H.; Dai, W.; Li, W.; Hang, C.-H. 2021: MFG-E8 attenuates inflammation in subarachnoid hemorrhage by driving microglial M2 polarization. Experimental Neurology 336: 113532

Yamazaki, M.; Maruyama, S.; Abé, T.; Essa, A.; Babkair, H.; Cheng, J.; Saku, T. 2014: MFG-E8 expression for progression of oral squamous cell carcinoma and for self-clearance of apoptotic cells. Laboratory Investigation; a Journal of Technical Methods and Pathology 94(11): 1260-1272

Last, J.; Brenner, M.; Yen, H.-T.; Aziz, M.; Denning, N.-L.; Wang, P. 2020: MFG-E8-derived peptide attenuates inflammation and injury after renal ischemia-reperfusion in mice. Heliyon 6(12): E05794

Carrascosa, C.; Obula, R.G.; Missiaglia, E.; Lehr, H-A.; Delorenzi, M.; Frattini, M.; Rüegg, C.; Mariotti, A. 2012: MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells. Oncogene 31(12): 1521-1532

Wang, B.; Ge, Z.; Wu, Y.; Zha, Y.; Zhang, X.; Yan, Y.; Xie, Y. 2020: MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2/3-Snail signalling pathway. Journal of Cellular and Molecular Medicine 24(21): 12799-12812

Pan, X.-Y.; Zhang, Z.-W. 2020: MFGE8, ALB, APOB, APOE, SAA1, A2M, and C3 as Novel Biomarkers for Stress Cardiomyopathy. Cardiovascular Therapeutics 2020: 1615826

Jiang, Y.; Wu, C.; Wang, G.; Yao, H.-X.; Liu, W.-H. 2021: MFI-Net: a multi-resolution fusion input network for retinal vessel segmentation. Plos one 16(7): E0253056

He, Q.-P.; Zou, Y.; Wang, P.-F.; Dou, X.-M. 2021: MFI-Type Zeolite Membranes for Pervaporation Separation of Dichlorobenzene Isomers. Acs Omega 6(12): 8456-8462

Cao, Y-Lu.; Meng, S.; Chen, Y.; Feng, J-Xiong.; Gu, D-Dong.; Yu, B.; Li, Y-Jie.; Yang, J-Yu.; Liao, S.; Chan, D.C.; Gao, S. 2017: MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion. Nature 542(7641): 372-376

Mou, Y.; Dein, J.; Chen, Z.; Jagdale, M.; Li, X.-J. 2021: MFN2 Deficiency Impairs Mitochondrial Transport and Downregulates Motor Protein Expression in Human Spinal Motor Neurons. Frontiers in Molecular Neuroscience 14: 727552

Xu, K.; Chen, G.; Li, X.; Wu, X.; Chang, Z.; Xu, J.; Zhu, Y.; Yin, P.; Liang, X.; Dong, L. 2017: MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling. Scientific Reports 7: 41718

Peng, S.; Sun, Y.; Luo, Y.; Ma, S.; Sun, W.; Tang, G.; Li, S.; Zhang, N.; Ren, J.; Xiao, Y.; Liu, X.; Zhang, J.; Gong, Y.; Xie, C. 2020: MFP-FePt-GO Nanocomposites Promote Radiosensitivity of Non-Small Cell Lung Cancer Via Activating Mitochondrial-Mediated Apoptosis and Impairing DNA Damage Repair. International Journal of Biological Sciences 16(12): 2145-2158

Meinrenken, C.J.; Rauschkolb, N.; Abrol, S.; Chakrabarty, T.; Decalf, V.C.; Hidey, C.; McKeown, K.; Mehmani, A.; Modi, V.; Culligan, P.J. 2020: MFRED, 10 second interval real and reactive power for groups of 390 US apartments of varying size and vintage. Scientific Data 7(1): 375

Marques, J.ão.P. 2021: MFRP-Related Nanophthalmos-Retinitis Pigmentosa-Foveoschisis-Optic Disc Drusen Syndrome. Ophthalmic Surgery Lasers and Imaging Retina 52(2): 110

Vela-Corcía, D.; Aditya Srivastava, D.; Dafa-Berger, A.; Rotem, N.; Barda, O.; Levy, M. 2019: MFS transporter from Botrytis cinerea provides tolerance to glucosinolate-breakdown products and is required for pathogenicity. Nature Communications 10(1): 2886

Khuller, K.; Yigit, G.ök.; Martínez Grijalva, C.; Altmüller, J.; Thiele, H.; Nürnberg, P.; Elcioglu, N.H.; Yeter, B.; Hehr, U.; Stein, A.; Della Marina, A.; Köninger, A.; Depienne, C.; Kaiser, F.J.; Wollnik, B.; Kuechler, A. 2021: MFSD2A-associated primary microcephaly - Expanding the clinical and mutational spectrum of this ultra-rare disease. European Journal of Medical Genetics 64(10): 104310

Kobayashi, N.; Kawasaki-Nishi, S.; Otsuka, M.; Hisano, Y.; Yamaguchi, A.; Nishi, T. 2018: MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells. Scientific Reports 8(1): 4969

Li, Y.; Ivica, N.A.; Dong, T.; Papageorgiou, D.P.; He, Y.; Brown, D.R.; Kleyman, M.; Hu, G.; Chen, W.W.; Sullivan, L.B.; Del Rosario, A.; Hammond, P.T.; Vander Heiden, M.G.; Chen, J. 2020: MFSD7C switches mitochondrial ATP synthesis to thermogenesis in response to heme. Nature Communications 11(1): 4837

Van den Broek, K.; Daniel, M.; Epple, M.; Hein, J.-M.; Kuhn, H.; Neumann, S.; Truszkowski, A.; Zielesny, A. 2020: MFsim-an open Java all-in-one rich-client simulation environment for mesoscopic simulation. Journal of Cheminformatics 12(1): 29

Fiorito, F.; Irace, C.; Nocera, F.P.; Piccolo, M.; Ferraro, M.G.; Ciampaglia, R.; Tenore, G.C.; Santamaria, R.; De Martino, L. 2021: MG-132 interferes with iron cellular homeostasis and alters virulence of bovine herpesvirus 1. Research in Veterinary Science 137: 1-8

Fiorito, F.; Iovane, V.; Cantiello, A.; Marullo, A.; De Martino, L.; Iovane, G. 2017: MG-132 reduces virus release in Bovine herpesvirus-1 infection. Scientific Reports 7(1): 13306

Kwak, H.; Lee, S.; Jo, S.; Kwon, Y.E.; Kang, H.; Choi, G.; Jung, M.E.; Kwak, M.-J.; Kim, S.; Oh, B.-H.; Kim, D.-S.; Hwang, S.H. 2020: MG1113, a specific anti-tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia. Research and Practice in Thrombosis and Haemostasis 4(8): 1301-1312

Chen, Y.; Fan, S.; Zhao, M.; Wu, K.; Zhu, E.; Ma, S.; He, W.; Deng, S.; Xu, H.; Zhang, J.; Ding, H.; Yi, L.; Zhao, M.; Chen, J. 2020: MG132 Attenuates the Replication of Classical Swine Fever Virus in vitro. Frontiers in Microbiology 11: 852

Ishimaru, H.; Hosokawa, K.; Sugimoto, A.; Tanaka, R.; Watanabe, T.; Fujimuro, M. 2020: MG132 exerts anti-viral activity against HSV-1 by overcoming virus-mediated suppression of the ERK signaling pathway. Scientific Reports 10(1): 6671

Mou, D.; Yang, X.; Li, S.; Zhao, W.; Li, M.; Zhao, M.; Alotaibi, N.H.; Zhang, Z.; Tang, M.; Alharbi, K.S.; Bahman, J.; Bukhari, S.N.A.; Dézlla, C. 2020: MG132 inhibits the expression of PBX3 through mi RNAs by targeting Argonaute2 in hepatoma cells. Saudi Journal of Biological Sciences 27(8): 2157-2163

Zeng, W.; Qi, W.; Mu, J.; Wei, Y.; Yang, L-Ling.; Zhang, Q.; Wu, Q.; Tang, J-Ying.; Feng, B. 2019: MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy. Scientific Reports 9(1): 2049

Yan, H.; Ma, Y-ling.; Gui, Y-zhou.; Wang, S-mei.; Wang, X-bo.; Gao, F.; Wang, Y-ping. 2014: MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression. Acta Pharmacologica Sinica 35(8): 994-1004

Liu, Y.; Du, J.; Liu, X.; Wang, L.; Han, Y.; Huang, C.; Liang, R.; Zheng, F.; Shi, G.; Li, B. 2021: MG149 inhibits histone acetyltransferase KAT8-mediated IL-33 acetylation to alleviate allergic airway inflammation and airway hyperresponsiveness. Signal Transduction and Targeted Therapy 6(1): 321

Ma, S.; Wang, Y.; Zhou, X.; Li, Z.; Zhang, Z.; Wang, Y.; Huang, T.; Zhang, Y.; Shi, J.; Guan, F. 2020: MG53 Protects hUC-MSCs against Inflammatory Damage and Synergistically Enhances their Efficacy in Neuroinflammation Injured Brain through Inhibiting NLRP3/Caspase-1/IL-1β Axis. Acs Chemical Neuroscience 11(17): 2590-2601

Whitson, B.A.; Mulier, K.; Li, H.; Zhou, X.; Cai, C.; Black, S.M.; Tan, T.; Ma, J.; Beilman, G.J. 2021: MG53 as a Novel Therapeutic Protein to Treat Acute Lung Injury. Military Medicine 186(Suppl 1): 339-345

Philouze, C.; Turban, S.; Cremers, B.; Caliez, A.; Lamarche, G.; Bernard, C.; Provost, N.; Delerive, P. 2021: MG53 is not a critical regulator of insulin signaling pathway in skeletal muscle. Plos one 16(2): E0245179

Bianchi, C.; Raggi, F.; Rossi, C.; Frontoni, S.; Bonadonna, R.C.; Del Prato, S.; Solini, A. 2022: MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance. Diabetes and Metabolism 48(2): 101292

Cai, C.; Masumiya, H.; Weisleder, N.; Matsuda, N.; Nishi, M.; Hwang, M.; Ko, J-Kyun.; Lin, P.; Thornton, A.; Zhao, X.; Pan, Z.; Komazaki, S.; Brotto, M.; Takeshima, H.; Ma, J. 2009: MG53 nucleates assembly of cell membrane repair machinery. Nature Cell Biology 11(1): 56-64

Chandler, H.L.; Tan, T.; Yang, C.; Gemensky-Metzler, A.J.; Wehrman, R.F.; Jiang, Q.; Peterson, C.M.W.; Geng, B.; Zhou, X.; Wang, Q.; Kaili, D.; Adesanya, T.M.Ayodele.; Yi, F.; Zhu, H.; Ma, J. 2019: MG53 promotes corneal wound healing and mitigates fibrotic remodeling in rodents. Communications Biology 2: 71

Liu, C.; Hu, Y-Hui.; Han, Y.; Wang, Y-Bin.; Zhang, Y.; Zhang, X-Qun.; He, D-Fen.; Ren, H-Mei.; Liu, Y-Kai.; Wang, H-Yong.; Tan, T.; Lin, P-Hui.; Li, H-Chang.; Rovin, B.H.; Ma, J-Jie.; Zeng, C-Yu. 2020: MG53 protects against contrast-induced acute kidney injury by reducing cell membrane damage and apoptosis. Acta Pharmacologica Sinica 41(11): 1457-1464

Sermersheim, M.; Kenney, A.D.; Lin, P-Hui.; McMichael, T.M.; Cai, C.; Gumpper, K.; Adesanya, T.M.Ayodele.; Li, H.; Zhou, X.; Park, K-Ho.; Yount, J.S.; Ma, J. 2020: MG53 suppresses interferon-β and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling. Nature Communications 11(1): 3624

Li, H.; Lin, P.-H.; Gupta, P.; Li, X.; Zhao, S.L.; Zhou, X.; Li, Z.; Wei, S.; Xu, L.; Han, R.; Lu, J.; Tan, T.; Yang, D.-H.; Chen, Z.-S.; Pawlik, T.M.; Merritt, R.E.; Ma, J. 2021: MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer. Molecular Cancer 20(1): 118

Yi, J-Sung.; Park, J.Sub.; Ham, Y-Mi.; Nguyen, N.; Lee, N-Rae.; Hong, J.; Kim, B-Woo.; Lee, H.; Lee, C-Seok.; Jeong, B-Cheon.; Song, H.Kyu.; Cho, H.; Kim, Y.Ki.; Lee, J-Seon.; Park, K.Soo.; Shin, H.; Choi, I.; Lee, S.Hee.; Park, W.Jin.; Park, S-Young.; Choi, C.Soo.; Lin, P.; Karunasiri, M.; Tan, T.; Duann, P.; Zhu, H.; Ma, J.; Ko, Y-Gyu. 2013: MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nature Communications 4: 2354

Zhang, M.; Wang, H.; Wang, X.; Bie, M.; Lu, K.; Xiao, H. 2020: MG53/CAV1 regulates transforming growth factor-β1 signaling-induced atrial fibrosis in atrial fibrillation. Cell Cycle 19(20): 2734-2744

Sun, L.; Li, M.; Deng, L.; Niu, Y.; Tang, Y.; Wang, Y.; Guo, L. 2021: MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer. Frontiers in Pharmacology 12: 625593

Biswas, B.; Batista, F.; Sundaram, S.; Stanley, P. 2018: MGAT1 and Complex N-Glycans Regulate ERK Signaling During Spermatogenesis. Scientific Reports 8(1): 2022

Li, J.; Xu, J.; Li, L.; Ianni, A.; Kumari, P.; Liu, S.; Sun, P.; Braun, T.; Tan, X.; Xiang, R.; Yue, S. 2020: MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway. Theranostics 10(14): 6467-6482

Xie, Y.; Zhang, Y.; Gong, M.; Tang, Z.; Han, C. 2020: MGAT: Multi-view Graph Attention Networks. Neural Networks: the Official Journal of the International Neural Network Society 132: 180-189

Nathan, K.A. 1996: MGDS-a worthwhile investment?. British Dental Journal 181(11-12): 396-397

Wu, S.L.; Bennett, J.B.; Sánchez C, H.éc.M.; Dolgert, A.J.; León, T.ás.M.; Marshall, J.M. 2021: MGDrivE 2: a simulation framework for gene drive systems incorporating seasonality and epidemiological dynamics. Plos Computational Biology 17(5): E1009030

Comtesse, N.; Niedermayer, I.; Glass, B.; Heckel, D.; Maldener, E.; Nastainczyk, W.; Feiden, W.; Meese, E. 2002: MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies. Oncogene 21(2): 239-247

Gao, F.; Deng, F.; Li, L.; Zhang, L.; Zhu, J.; Yu, C. 2021: MGG: Monocular Global Geolocation for Outdoor Long-Range Targets. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 30: 6349-6363

Kim, J.; Zhang, Y.; Day, J.; Zhou, H. 2018: MGLM: An R Package for Multivariate Categorical Data Analysis. R Journal 10(1): 73-90

Wang, Z.; Liu, Y.; Wang, Y. 2020: MGMIN: a Normalization Method for Correcting Probe Design Bias in Illumina Infinium HumanMethylation450 BeadChips. Frontiers in Genetics 11: 538492

Mikkelsen, V.E.; Dai, H.Y.; Stensjøen, A.L.; Berntsen, E.M.; Salvesen, Øy.; Solheim, O.; Torp, S.H. 2020: MGMT Promoter Methylation Status Is not Related to Histological or Radiological Features in IDH Wild-type Glioblastomas. Journal of Neuropathology and Experimental Neurology 79(8): 855-862

Shi, Y.; Wang, Y.; Qian, J.; Yan, X.; Han, Y.; Yao, N.; Ma, J. 2020: MGMT expression affects the gemcitabine resistance of pancreatic cancer cells. Life Sciences 259: 118148

Witek, P.ła.; Maksymowicz, M.; Szamotulska, K.; Piaścik, A.; Wojciechowska-Luźniak, A.; Stasiewicz, A.; Witek, J.; Zieliński, G. 2020: MGMT expression in pituitary corticotroph adenomas and its relationship to clinical, pathological, and ultrastructural parameters in patients with Cushing's disease. Folia Neuropathologica 58(4): 357-364

Hassel, J.C.; Sucker, A.; Edler, L.; Kurzen, H.; Moll, I.; Stresemann, C.; Spieth, K.; Mauch, C.; Rass, K.; Dummer, R.; Schadendorf, D. 2010: MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. British Journal of Cancer 103(6): 820-826

Hawkins, N.J.; Lee, J.H-F.; Wong, J.J-L.; Kwok, C-To.; Ward, R.L.; Hitchins, M.P. 2009: MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 22(12): 1588-1599

Nagy, E.; Gajjar, K.B.; Patel, I.I.; Taylor, S.; Martin-Hirsch, P.L.; Stringfellow, H.F.; Martin, F.L.; Phillips, D.H. 2014: MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases. British Journal of Cancer 110(12): 2874-2880

Miller, J.J.; Cahill, D.P. 2020: MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma. Neuro-Oncology 22(11): 1553-1554

Weller, M.; Stupp, R.; Reifenberger, G.; Brandes, A.A.; van den Bent, M.J.; Wick, W.; Hegi, M.E. 2010: MGMT promoter methylation in malignant gliomas: ready for personalized medicine?. Nature Reviews. Neurology 6(1): 39-51

Jank, P.; Gehlhaar, C.; Bianca, L.; Caterina, F.; Andreas, S.; Karn, T.; Marmé, F.; Sinn, H.-P.; van Mackelenbergh, M.; Sinn, B.; Zahm, D.-M.; Ingold-Heppner, B.; Schem, C.; Stickeler, E.; Fasching, P.A.; Nekljudova, V.; Taube, E.T.; Heppner, F.; Müller, V.; Denkert, C.; Loibl, S. 2020: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial. Plos one 15(8): E0238021

Brandner, S.; McAleenan, A.; Kelly, C.; Spiga, F.; Cheng, H.-Y.; Dawson, S.; Schmidt, L.; Faulkner, C.L.; Wragg, C.; Jefferies, S.; Higgins, J.P.T.; Kurian, K.M. 2021: MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. Neuro-Oncology 23(9): 1457-1469

Wick, W.; Weller, M.; van den Bent, M.; Sanson, M.; Weiler, M.; von Deimling, A.; Plass, C.; Hegi, M.; Platten, M.; Reifenberger, G. 2014: MGMT testing--the challenges for biomarker-based glioma treatment. Nature Reviews. Neurology 10(7): 372-385

Ni, Y.; Gu, J.; Wu, J.; Xu, L.; Rui, Y. 2020: MGMT-Mediated neuron Apoptosis in Injured Rat Spinal Cord. Tissue and Cell 62: 101311

Das, A.; Henderson, F.C.; Alshareef, M.; Porto, G.B.F.; Kanginakudru, I.; Infinger, L.K.; Vandergrift, W.A.; Lindhorst, S.M.; Varma, A.K.; Patel, S.J.; Cachia, D. 2021: MGMT-inhibitor in combination with TGF-βRi inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23(3): 612-619

Gerson, S.L. 2004: MGMT: its role in cancer aetiology and cancer therapeutics. Nature Reviews. Cancer 4(4): 296-307

Burak Gürbüz, M.; Rekik, I. 2021: MGN-Net: a multi-view graph normalizer for integrating heterogeneous biological network populations. Medical Image Analysis 71: 102059

Vasudevan, G.; Singh, S.; Gupta, G.; Jalajakshi, C.K. 2020: MGNREGA in the Times of COVID-19 and Beyond: can India do more with Less?. Indian Journal of Labour Economics: the Quarterly Journal of the Indian Society of Labour Economics 63(3): 799-814

Rosnati, M.; Fortuin, V. 2021: MGP-AttTCN: An interpretable machine learning model for the prediction of sepsis. Plos one 16(5): E0251248

Lai, X.; Yang, P.; Wang, K.; Yang, Q.; Yu, D. 2021: MGRNN: Structure Generation of Molecules Based on Graph Recurrent Neural Networks. Molecular Informatics 40(10): E2100091

Wang, D.; Yang, W.; Du, J.; Devalaraja, M.N.; Liang, P.; Matsumoto, K.; Tsubakimoto, K.; Endo, T.; Richmond, A. 2000: MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression. Oncogene 19(40): 4647-4659

Dodson, M.; Anandhan, A.; Zhang, D.D. 2021: MGST1, a new soldier of NRF2 in the battle against ferroptotic death. Cell Chemical Biology 28(6): 741-742

He, J.-Y.; Liang, S.-H.; Wu, X.; Zhao, B.; Zhang, L. 2021: MGSeg: Multiple Granularity-Based Real-Time Semantic Segmentation Network. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 30: 7200-7214

Kamada, M.; Nakatsui, M.; Kojima, R.; Nohara, S.; Uchino, E.; Tanishima, S.; Sugiyama, M.; Kosaki, K.; Tokunaga, K.; Mizokami, M.; Okuno, Y. 2019: MGeND: an integrated database for Japanese clinical and genomic information. Human Genome Variation 6: 53

Klotz, L.; Enz, R. 2021: MGluR7 is a presynaptic metabotropic glutamate receptor at ribbon synapses of inner hair cells. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(11): e21855

Liu, L.; Sun, L.; Wu, K.; Shi, Y.; Wang, Y.; Wang, Y.; Zhang, N.; Zhang, H.; Zhang, H. 2014: MGr1-Ag/37LRP promotes growth and proliferation of gastric cancer in vitro and in vivo. Cancer Gene Therapy 21(9): 355-363

Tao, S.; Lin, K.; Zhu, Q.; Zhang, W. 2020: MH-seq for Functional Characterization of Open Chromatin in Plants. Trends in Plant Science 25(6): 618-619

Hakkarainen, T.J.; Krams, I.; Coetzee, V.; Skrinda, I.; Kecko, S.; Krama, T.; Ilonen, J.; Rantala, M.J. 2021: MHC Class Ii Heterozygosity Associated with Attractiveness of Men and Women. Evolutionary Psychology: An International Journal of Evolutionary Approaches to Psychology and Behavior 19(1): 1474704921991994

Galperin, M.; Benati, D.; Claireaux, M.; Mukhopadhyay, M.; Chakrabarti, L.A. 2017: MHC Class II Tetramer Labeling of Human Primary CD4 + T Cells from HIV Infected Patients. Bio-Protocol 7(6):E2187

Thomas, C.; Tampé, R. 2021: MHC i assembly and peptide editing - chaperones, clients, and molecular plasticity in immunity. Current Opinion in Immunology 70: 48-56

Mahoney, K.E.; Shabanowitz, J.; Hunt, D.F. 2021: MHC Phosphopeptides: Promising Targets for Immunotherapy of Cancer and other Chronic Diseases. Molecular and Cellular Proteomics: Mcp 20: 100112

Castelli, E.C.; de Castro, M.V.; Naslavsky, M.S.; Scliar, M.O.; Silva, N.S.B.; Andrade, H.S.; Souza, A.S.; Pereira, R.N.; Castro, C.F.B.; Mendes-Junior, C.T.; Meyer, D.; Nunes, K.; Matos, L.R.B.; Silva, M.V.R.; Wang, J.Y.T.; Esposito, J.; Coria, V.R.; Bortolin, R.H.; Hirata, M.H.; Magawa, J.Y.; Cunha-Neto, E.; Coelho, V.ôn.; Santos, K.S.; Marin, M.L.C.; Kalil, J.; Mitne-Neto, M.; Maciel, R.M.B.; Passos-Bueno, M.R.; Zatz, M. 2021: MHC Variants Associated with Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals. Frontiers in Immunology 12: 742881

Streicher, H. 2021: MHC and the Power of P. Jnci Cancer Spectrum 5(1)

Baird, J.D.; Bone, A.J.; Walker, R.; Cooke, A. 1987: MHC antigen expression in the pancreas. Nature 329(6139): 493-494

Festenstein, H.; Garrido, F. 1986: MHC antigens and malignancy. Nature 322(6079): 502-503

Singh, P.B.; Brown, R.E.; Roser, B. 1987: MHC antigens in urine as olfactory recognition cues. Nature 327(6118): 161-164

Lin, K.; Bieri, G.; Gontier, G.; Müller, S.ör.; Smith, L.K.; Snethlage, C.E.; White, C.W.; Maybury-Lewis, S.Y.; Villeda, S.A. 2021: MHC class i H2-Kb negatively regulates neural progenitor cell proliferation by inhibiting FGFR signaling. Plos Biology 19(6): E3001311

Karlhofer, F.M.; Ribaudo, R.K.; Yokoyama, W.M. 1992: MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358(6381): 66-70

Esteban, F.; Redondo, M.; Delgado, M.; Garrido, F.; Ruiz-Cabello, F. 1996: MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up. British Journal of Cancer 74(11): 1801-1804

Ghadially, H.; Brown, L.; Lloyd, C.; Lewis, L.; Lewis, A.; Dillon, J.; Sainson, R.; Jovanovic, J.; Tigue, N.J.; Bannister, D.; Bamber, L.; Valge-Archer, V.; Wilkinson, R.W. 2017: MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue. British Journal of Cancer 116(9): 1208-1217

Han, Q-Hua.; Sun, R-Na.; Yang, H-Qiong.; Wang, Z-Wei.; Wan, Q-Hong.; Fang, S-Guo. 2019: MHC class I diversity predicts non-random mating in Chinese alligators (Alligator sinensis). Heredity 122(6): 809-818

Yang, W.; Li, Y.; Gao, R.; Xiu, Z.; Sun, T. 2020: MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway. Oncogene 39(5): 1098-1111

Grimholt, U.; Lukacs, M. 2021: MHC class i evolution; from Northern pike to salmonids. Bmc Ecology and Evolution 21(1): 3

Holloway, G.; Fleming, F.E.; Coulson, B.S. 2018: MHC class I expression in intestinal cells is reduced by rotavirus infection and increased in bystander cells lacking rotavirus antigen. Scientific Reports 8(1): 67

Friedman, L.A.; Bullock, T.N.; Sloan, E.A.; Ring, K.L.; Mills, A.M. 2020: MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 2020

Parham, P. 2005: MHC class I molecules and KIRs in human history, health and survival. Nature Reviews. Immunology 5(3): 201-214

Bikoff, E.K.; Jaffe, L.; Ribaudo, R.K.; Otten, G.R.; Germain, R.N.; Robertson, E.J. 1991: MHC class I surface expression in embryo-derived cell lines inducible with peptide or interferon. Nature 354(6350): 235-238

Westerdahl, H.; Wittzell, H.; von Schantz, T.; Bensch, S. 2004: MHC class I typing in a songbird with numerous loci and high polymorphism using motif-specific PCR and DGGE. Heredity 92(6): 534-542

Ji, Q.; Castelli, L.; Goverman, J.M. 2013: MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8⁺ T cells. Nature Immunology 14(3): 254-261

Ortmann, B.; Androlewicz, M.J.; Cresswell, P. 1994: MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368(6474): 864-867

Wieczorek, M.; Sticht, J.; Stolzenberg, S.; Günther, S.; Wehmeyer, C.; El Habre, Z.; Álvaro-Benito, M.; Noé, F.; Freund, C. 2016: MHC class II complexes sample intermediate states along the peptide exchange pathway. Nature Communications 7: 13224

Lau, Q.; Jaratlerdsiri, W.; Griffith, J.E.; Gongora, J.; Higgins, D.P. 2014: MHC class II diversity of koala (Phascolarctos cinereus) populations across their range. Heredity 113(4): 287-296

Sadegh-Nasseri, S.; Stern, L.J.; Wiley, D.C.; Germain, R.N. 1994: MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370(6491): 647-650

König, R.; Huang, L.Y.; Germain, R.N. 1992: MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356(6372): 796-798

Osório, J. 2013: MHC class II pathway mediates adipose inflammation. Nature Reviews. Endocrinology 9(5): 252

Jones, E.Yvonne.; Fugger, L.; Strominger, J.L.; Siebold, C. 2006: MHC class II proteins and disease: a structural perspective. Nature Reviews. Immunology 6(4): 271-282

Karakus, U.; Thamamongood, T.; Ciminski, K.; Ran, W.; Günther, S.C.; Pohl, M.O.; Eletto, D.; Jeney, C.; Hoffmann, D.; Reiche, S.; Schinköthe, J.; Ulrich, R.; Wiener, J.; Hayes, M.G.B.; Chang, M.W.; Hunziker, A.; Yángüez, E.; Aydillo, T.; Krammer, F.; Oderbolz, J.; Meier, M.; Oxenius, A.; Halenius, A.; Zimmer, G.; Benner, C.; Hale, B.G.; García-Sastre, A.; Beer, M.; Schwemmle, M.; Stertz, S. 2019: MHC class II proteins mediate cross-species entry of bat influenza viruses. Nature 567(7746): 109-112

Deverson, E.V.; Gow, I.R.; Coadwell, W.J.; Monaco, J.J.; Butcher, G.W.; Howard, J.C. 1990: MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 348(6303): 738-741

Germain, R.N.; Hendrix, L.R. 1991: MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353(6340): 134-139

Bruchez, A.; Sha, K.; Johnson, J.; Chen, L.; Stefani, C.; McConnell, H.; Gaucherand, L.; Prins, R.; Matreyek, K.A.; Hume, A.J.; Mühlberger, E.; Schmidt, E.V.; Olinger, G.G.; Stuart, L.M.; Lacy-Hulbert, A. 2020: MHC class Ii transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses. Science 370(6513): 241-247

Steidl, C.; Shah, S.P.; Woolcock, B.W.; Rui, L.; Kawahara, M.; Farinha, P.; Johnson, N.A.; Zhao, Y.; Telenius, A.; Neriah, S.Ben.; McPherson, A.; Meissner, B.; Okoye, U.C.; Diepstra, A.; van den Berg, A.; Sun, M.; Leung, G.; Jones, S.J.; Connors, J.M.; Huntsman, D.G.; Savage, K.J.; Rimsza, L.M.; Horsman, D.E.; Staudt, L.M.; Steidl, U.; Marra, M.A.; Gascoyne, R.D. 2011: MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471(7338): 377-381

Buschow, S.I.; van Balkom, B.W.M.; Aalberts, M.; Heck, A.J.R.; Wauben, M.; Stoorvogel, W. 2010: MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunology and Cell Biology 88(8): 851-856

Lee, Y.Jeong.; Jung, K.Cheon.; Park, S.Hoe. 2009: MHC class II-dependent T-T interactions create a diverse, functional and immunoregulatory reaction circle. Immunology and Cell Biology 87(1): 65-71

Perrigoue, J.G.; Saenz, S.A.; Siracusa, M.C.; Allenspach, E.J.; Taylor, B.C.; Giacomin, P.R.; Nair, M.G.; Du, Y.; Zaph, C.; van Rooijen, N.; Comeau, M.R.; Pearce, E.J.; Laufer, T.M.; Artis, D. 2009: MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nature Immunology 10(7): 697-705

Li, W.; Sofi, M.Hanief.; Wei, D.G.; Du, W.; Gervay-Hague, J.; Renukaradhya, G.J.; Brutkiewicz, R.R.; Chang, C-Hee. 2009: MHC class II-expressing thymocytes suppress invariant NKT cell development. Immunology and Cell Biology 87(2): 186-189

Anderson, G.; Jenkinson, E.J.; Moore, N.C.; Owen, J.J. 1993: MHC class II-positive epithelium and mesenchyme cells are both required for T-cell development in the thymus. Nature 362(6415): 70-73

Rodgers, J.R.; Cook, R.G. 2005: MHC class Ib molecules bridge innate and acquired immunity. Nature Reviews. Immunology 5(6): 459-471

Russell, T.; Lisovski, S.; Olsson, M.; Brown, G.; Spindler, R.; Lane, A.; Keeley, T.; Hibbard, C.; Hogg, C.J.; Thomas, Fédéric.; Belov, K.; Ujvari, B.; Madsen, T. 2018: MHC diversity and female age underpin reproductive success in an Australian icon; the Tasmanian Devil. Scientific Reports 8(1): 4175

Wiley, D. 1988: MHC gene in cytomegalovirus. Nature 331(6153): 209-210

Evans, M.L.; Neff, B.D.; Heath, D.D. 2010: MHC genetic structure and divergence across populations of Chinook salmon (Oncorhynchus tshawytscha). Heredity 104(5): 449-459

de Assunção-Franco, M.; Hoffman, J.I.; Harwood, J.; Amos, W. 2012: MHC genotype and near-deterministic mortality in grey seals. Scientific Reports 2: 659

Holmes, C.M.; Violette, N.; Miller, D.; Wagner, B.; Svansson, Válmur.; Antczak, D.F. 2019: MHC haplotype diversity in Icelandic horses determined by polymorphic microsatellites. Genes and Immunity 20(8): 660-670

Ivansson, E.L.; Magnusson, J.J.; Magnusson, P.K.E.; Erlich, H.A.; Gyllensten, U.B. 2008: MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2. Genes and Immunity 9(7): 613-623

Morizane, A.; Kikuchi, T.; Hayashi, T.; Mizuma, H.; Takara, S.; Doi, H.; Mawatari, A.; Glasser, M.F.; Shiina, T.; Ishigaki, H.; Itoh, Y.; Okita, K.; Yamasaki, E.; Doi, D.; Onoe, H.; Ogasawara, K.; Yamanaka, S.; Takahashi, J. 2017: MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nature Communications 8(1): 385

Howes, E.L.; Taylor, W.; Mitchison, N.A.; Simpson, E. 1979: MHC matching shows that at least two T-cell subsets determine resistance to HSV. Nature 277(5691): 66-68

Parham, P. 1989: MHC molecules. A profitable lesson in heresy. Nature 340(6233): 426-428

Bordon, Y. 2011: MHC molecules: Cod's wallop? It's first class!. Nature Reviews. Immunology 11(9): 570

Starling, S. 2017: MHC molecules: Immune editing shapes the cancer landscape. Nature Reviews. Immunology 17(12): 729

Klein, J.; Takahata, N.; Ayala, F.J. 1993: MHC polymorphism and human origins. Scientific American 269(6): 78-83

Figueroa, F.; Günther, E.; Klein, J. 1988: MHC polymorphism pre-dating speciation. Nature 335(6187): 265-267

Parham, P. 1989: MHC protein structure. Getting into the groove. Nature 342(6250): 617-618

Townsend, A.; McMichael, A. 1987: MHC protein structure. Those images that yet fresh images beget. Nature 329(6139): 482-483

Price, P.; Allcock, R.J.; Coombe, D.R.; Shellam, G.R.; McCluskey, J. 1995: MHC proteins and heparan sulphate proteoglycans regulate murine cytomegalovirus infection. Immunology and Cell Biology 73(4): 308-315

Howard, J. 1980: MHC restriction, self-tolerance and the thymus. Nature 286(5768): 15-16

Wilson, I.A.; Stanfield, R.L. 2005: MHC restriction: slip-sliding away. Nature Immunology 6(5): 434-435

Talarico, L.; Babik, Wław.; Marta, S.; Pietrocini, V.; Mattoccia, M. 2019: MHC structuring and divergent allele advantage in a urodele amphibian: a hierarchical multi-scale approach. Heredity 123(5): 593-607

Niskanen, A.K.; Hagström, E.; Lohi, H.; Ruokonen, M.; Esparza-Salas, R.; Aspi, J.; Savolainen, P. 2013: MHC variability supports dog domestication from a large number of wolves: high diversity in Asia. Heredity 110(1): 80-85

Kubinak, J.L.; Stephens, W.Zac.; Soto, R.; Petersen, C.; Chiaro, T.; Gogokhia, L.; Bell, R.; Ajami, N.J.; Petrosino, J.F.; Morrison, L.; Potts, W.K.; Jensen, P.E.; O'Connell, R.M.; Round, J.L. 2015: MHC variation sculpts individualized microbial communities that control susceptibility to enteric infection. Nature Communications 6: 8642

Iglesias, G.M.; Beker, M.ía.P.; Remolins, J.S.; Canet, Z.E.; Librera, J.é; Cantaro, H.; Maizon, D.O.; Fulton, J.E. 2021: MHC-B variation in maternal and paternal synthetic lines of the Argentinian Campero INTA chicken. Poultry Science 100(8): 101253

Zhang, B.-Y.; Hu, H.-Y.; Song, C.-M.; Huang, K.; Dunn, D.W.; Yang, X.; Wang, X.-W.; Zhao, H.-T.; Wang, C.-L.; Zhang, P.; Li, B.-G. 2020: MHC-Based Mate Choice in Wild Golden Snub-Nosed Monkeys. Frontiers in Genetics 11: 609414

Cebrián, C.; Zucca, F.A.; Mauri, P.; Steinbeck, J.A.; Studer, L.; Scherzer, C.R.; Kanter, E.; Budhu, S.; Mandelbaum, J.; Vonsattel, J.P.; Zecca, L.; Loike, J.D.; Sulzer, D. 2014: MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nature Communications 5: 3633

Goodman, A.M.; Castro, A.; Pyke, R.M.; Okamura, R.; Kato, S.; Riviere, P.; Frampton, G.; Sokol, E.; Zhang, X.; Ball, E.D.; Carter, H.; Kurzrock, R. 2020: MHC-i genotype and tumor mutational burden predict response to immunotherapy. Genome Medicine 12(1): 45

Castro, A.; Ozturk, K.; Zanetti, M.; Carter, H. 2020: MHC-Ii constrains the natural neutralizing antibody response to the SARS-CoV-2 spike RBM in humans. Biorxiv: the Preprint Server for Biology 2020

Alspach, E.; Lussier, D.M.; Miceli, A.P.; Kizhvatov, I.; DuPage, M.; Luoma, A.M.; Meng, W.; Lichti, C.F.; Esaulova, E.; Vomund, A.N.; Runci, D.; Ward, J.P.; Gubin, M.M.; Medrano, R.F.V.; Arthur, C.D.; White, J.Michael.; Sheehan, K.C.F.; Chen, A.; Wucherpfennig, K.W.; Jacks, T.; Unanue, E.R.; Artyomov, M.N.; Schreiber, R.D. 2019: MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature 574(7780): 696-701

Vagaska, B.; New, S.E.P.; Alvarez-Gonzalez, C.; D'Acquisto, F.; Gomez, S.G.; Bulstrode, N.W.; Madrigal, A.; Ferretti, P. 2016: MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development. Scientific Reports 6: 24251

Kieckbusch, J.; Gaynor, L.M.; Moffett, A.; Colucci, F. 2014: MHC-dependent inhibition of uterine NK cells impedes fetal growth and decidual vascular remodelling. Nature Communications 5: 3359

Santos, P.S.C.; Courtiol, A.; Heidel, A.J.; Höner, O.P.; Heckmann, I.; Nagy, M.; Mayer, F.; Platzer, M.; Voigt, C.C.; Sommer, S. 2016: MHC-dependent mate choice is linked to a trace-amine-associated receptor gene in a mammal. Scientific Reports 6: 38490

Lin, J.T.; Kitzmiller, T.J.; Cates, J.M.M.; Gorham, J.D. 2005: MHC-independent genetic regulation of liver damage in a mouse model of autoimmune hepatocellular injury. Laboratory Investigation; a Journal of Technical Methods and Pathology 85(4): 550-561

Driscoll, J.; Brown, M.G.; Finley, D.; Monaco, J.J. 1993: MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365(6443): 262-264

O'Farrell, B.; Benzie, J.A.H.; McGinnity, P.; Carlsson, J.; Eyto, E.de.; Dillane, E.; Graham, C.; Coughlan, J.; Cross, T. 2012: MHC-mediated spatial distribution in brown trout (Salmo trutta) fry. Heredity 108(4): 403-409

Stangl, H.; Krammetsvogl, A.; Lesiak, M.; Wolff, C.; Straub, R.H. 2020: MHC/class-II-positive cells inhibit corticosterone of adrenal gland cells in experimental arthritis: a role for IL-1β, IL-18, and the inflammasome. Scientific Reports 10(1): 17071

Swanberg, M.; Lidman, O.; Padyukov, L.; Eriksson, P.; Akesson, E.; Jagodic, M.; Lobell, A.; Khademi, M.; Börjesson, O.; Lindgren, C.M.; Lundman, P.; Brookes, A.J.; Kere, J.; Luthman, H.; Alfredsson, L.; Hillert, J.; Klareskog, L.; Hamsten, A.; Piehl, F.; Olsson, T. 2005: MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nature Genetics 37(5): 486-494

Xie, L.; Xu, Y.; Huang, G.; Ye, M.; Hu, X.; Shu, S.; Lynn, H. 2020: MHCA with SACP versus DHCA in Pediatric Aortic Arch Surgery: A Comparative Study. Scientific Reports 10(1): 4439

Venkatesh, G.; Grover, A.; Srinivasaraghavan, G.; Rao, S. 2020: MHCAttnNet: predicting MHC-peptide bindings for MHC alleles classes i and Ii using an attention-based deep neural model. Bioinformatics 36(Suppl_1): I399-I406

Daley, S.R. 2015: MHCI and CD8 lineage commitment. Prolonged access to thymic epithelial MHCI seals CD8⁺ lineage commitment. Immunology and Cell Biology 93(4): 326-327

Glynn, M.W.; Elmer, B.M.; Garay, P.A.; Liu, X-Bo.; Needleman, L.A.; El-Sabeawy, F.; McAllister, A.Kimberley. 2011: MHCI negatively regulates synapse density during the establishment of cortical connections. Nature Neuroscience 14(4): 442-451

Khan, A.; Khan, D.; Khan, I.; Ali, F.; Karim, F.Ul.; Imran, M. 2018: MHD Flow of Sodium Alginate-Based Casson Type Nanofluid Passing Through A Porous Medium With Newtonian Heating. Scientific Reports 8(1): 8645

Yasin, M.Hafizi.Mat.; Ishak, A.; Pop, I. 2015: MHD Stagnation-Point Flow and Heat Transfer with Effects of Viscous Dissipation, Joule Heating and Partial Velocity Slip. Scientific Reports 5: 17848

Alsabery, A.I.; Sheremet, M.A.; Chamkha, A.J.; Hashim, I. 2018: MHD convective heat transfer in a discretely heated square cavity with conductive inner block using two-phase nanofluid model. Scientific Reports 8(1): 7410

Farooq, U.; Lu, D.; Munir, S.; Ramzan, M.; Suleman, M.; Hussain, S. 2019: MHD flow of Maxwell fluid with nanomaterials due to an exponentially stretching surface. Scientific Reports 9(1): 7312

Alghamdi, W.; Alsubie, A.; Kumam, P.; Saeed, A.; Gul, T. 2021: MHD hybrid nanofluid flow comprising the medication through a blood artery. Scientific Reports 11(1): 11621

Raizah, Z.; Aly, A.M.; Alsedais, N.; Mansour, M.Ahmed. 2021: MHD mixed convection of hybrid nanofluid in a wavy porous cavity employing local thermal non-equilibrium condition. Scientific Reports 11(1): 17151

Jafar, A.B.; Shafie, S.; Ullah, I. 2020: MHD radiative nanofluid flow induced by a nonlinear stretching sheet in a porous medium. Heliyon 6(6): E04201

Baker, E.B.; Nawer, J.; Xiao, X.; Matson, D.M. 2020: MHD surrogate model for convection in electromagnetically levitated molten metal droplets processed using the ISS-EML facility. Npj Microgravity 6: 9

Baker, E.B.; Nawer, J.; Xiao, X.; Matson, D.M. 2020: MHD surrogate model for convection in electromagnetically levitated molten metal droplets processed using the ISS-EML facility. Npj Microgravity 6(1): 9

Thamri, A.; Baccar, H.; Struzzi, C.; Bittencourt, C.; Abdelghani, A.; Llobet, E. 2016: MHDA-Functionalized Multiwall Carbon Nanotubes for detecting non-aromatic VOCs. Scientific Reports 6: 35130

Iacobucci, G. 2021: MHRA to shed a fifth of its workforce in post-Brexit cost cutting drive. Bmj 374: N1918

Woody Ii, E.W. 2020: MHS Genesis Implementation: Strategies in Support of Successful EHR Conversion. Military Medicine 185(9-10): E1520-E1527

Ma, Y.; Zhao, J.; Ma, Y. 2020: MHSNMF: multi-view hessian regularization based symmetric nonnegative matrix factorization for microbiome data analysis. Bmc Bioinformatics 21(Suppl 6): 234

Ma, H.; Zou, Y.; Liu, P.X. 2021: MHSU-Net: a more versatile neural network for medical image segmentation. Computer Methods and Programs in Biomedicine 208: 106230

Wiegratz, I. 2021: MHT: how and how long in healthy women above 65?. Therapeutische Umschau. Revue Therapeutique 78(8): 457-464

Neulen, J. 2021: MHT: who benefits? who does not benefit?. Therapeutische Umschau. Revue Therapeutique 78(8): 465-471

Paiva Ferreira, L.ér.K.D.; Paiva Ferreira, L.A.M.; Bezerra Barros, G.C.; Mozzini Monteiro, T.; de Araújo Silva, L.A.; Pereira, R.d.A.; Figueiredo, P.T.R.; Alves, A.F.; Rodrigues, L.ís.C.; Piuvezam, M.R. 2021: MHTP, a synthetic alkaloid, attenuates combined allergic rhinitis and asthma syndrome through downregulation of the p38/ERK1/2 MAPK signaling pathway in mice. International Immunopharmacology 96: 107590

Grünbein, M.Luise.; Bielecki, J.; Gorel, A.; Stricker, M.; Bean, R.; Cammarata, M.; Dörner, K.; Fröhlich, L.; Hartmann, E.; Hauf, S.; Hilpert, M.; Kim, Y.; Kloos, M.; Letrun, R.; Messerschmidt, M.; Mills, G.; Nass Kovacs, G.; Ramilli, M.; Roome, C.M.; Sato, T.; Scholz, M.; Sliwa, M.; Sztuk-Dambietz, J.; Weik, M.; Weinhausen, B.; Al-Qudami, N.; Boukhelef, D.; Brockhauser, S.; Ehsan, W.; Emons, M.; Esenov, S.; Fangohr, H.; Kaukher, A.; Kluyver, T.; Lederer, M.; Maia, L.; Manetti, M.; Michelat, T.; Münnich, A.; Pallas, F.; Palmer, G 2019: MHz data collection of a microcrystalline mixture of different jack bean proteins. Scientific Data 6(1): 18

Hasse, K.; Kränkel, C. 2020: MHz-repetition rate fs-laser-inscribed crystalline waveguide lasers inscribed at 100 mm/s. Optics Express 28(8): 12011-12019

Nucci, D.; Minelli, L.; Gianfredi, V. 2020: MI NUTRO (MIgrants NUTRition kn Owledge per l'integrazione): un intervento di educazione alimentare tra gli immigrati, Perugia - uno studio pilota. Recenti Progressi in Medicina 111(9): 546-552

Lim, G.B. 2020: MI causes insulin resistance via apoptosis of macrophages in VAT. Nature Reviews. Cardiology 17(10): 613

Huynh, K. 2020: MI drives progression of breast cancer by promoting a protumoural immune landscape. Nature Reviews. Cardiology 17(10): 611

Campion, C. 1998: Mi mortality outpacing growth of chest pain centers. Nursing Spectrum 11(1): 6-8

Gue, Y.X.; Kanji, R.; Gati, S.; Gorog, D.A. 2020: Mi with Non-obstructive Coronary Artery Presenting with STEMI: a Review of Incidence, Aetiology, Assessment and Treatment. European Cardiology 15: E20

Azmi, A.S.; Philip, P.A.; Beck, F.W.J.; Wang, Z.; Banerjee, S.; Wang, S.; Yang, D.; Sarkar, F.H.; Mohammad, R.M. 2011: MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy. Oncogene 30(1): 117-126

Canner, J.A.; Sobo, M.; Ball, S.; Hutzen, B.; DeAngelis, S.; Willis, W.; Studebaker, A.W.; Ding, K.; Wang, S.; Yang, D.; Lin, J. 2009: MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53. British Journal of Cancer 101(5): 774-781

Riyad, M.; Khalil, M.; Adib, A. 2021: MI-EEGNET: a novel convolutional neural network for motor imagery classification. Journal of Neuroscience Methods 353: 109037

Chen, S.; Ghandikota, S.; Gautam, Y.; Mersha, T.B. 2020: MI-MAAP: marker informativeness for multi-ancestry admixed populations. Bmc Bioinformatics 21(1): 131

Yang, Q.; Zhang, X.; Chen, B. 2020: MI3DNet: a Compact CNN for Motor Imagery EEG Classification with Visualizable Dense Layer Parameters. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2020: 510-513

Schoensiegel, F.; Paschen, A.; Sieger, S.; Eskerski, H.; Mier, W.; Rothfels, H.; Kleinschmidt, J.; Schadendorf, D.; Haberkorn, U. 2004: MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma. Cancer Gene Therapy 11(6): 408-418

Gradiz, R.; Silva, H.C.; Carvalho, L.; Botelho, M.Filomena.; Mota-Pinto, A. 2016: MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Scientific Reports 6: 21648

Banci, L.; Bertini, I.; Cefaro, C.; Ciofi-Baffoni, S.; Gallo, A.; Martinelli, M.; Sideris, D.P.; Katrakili, N.; Tokatlidis, K. 2009: MIA40 is an oxidoreductase that catalyzes oxidative protein folding in mitochondria. Nature Structural and Molecular Biology 16(2): 198-206

Jiang, F.; Cao, J.; Kong, R.; Fang, L.; Wang, B.; Zhang, S.; Yang, L.; Cao, X. 2021: MICAL2 regulates myofibroblasts differentiation in epidural fibrosis via SRF/MRTF-A signaling pathway. Life Sciences 269: 119045

Qu, X.; Du, Y.; Shu, Y.; Gao, M.; Sun, F.; Luo, S.; Yang, T.; Zhan, L.; Yuan, Y.; Chu, W.; Pan, Z.; Wang, Z.; Yang, B.; Lu, Y. 2017: MIAT Is a Pro-fibrotic Long Non-coding RNA Governing Cardiac Fibrosis in Post-infarct Myocardium. Scientific Reports 7: 42657

Liu, Y.; Li, X.; Zhang, H.; Huang, Y. 2020: MIAT inhibits proliferation of cervical cancer cells through regulating miR-150-5p. Cancer Cell International 20: 242

Jansen, R.L.; Hupperets, P.S.; Arends, J.W.; Joosten-Achjanie, S.R.; Volovics, A.; Schouten, H.C.; Hillen, H.F. 1998: MIB-1 labelling index is an independent prognostic marker in primary breast cancer. British Journal of Cancer 78(4): 460-465

van der Avoort, I.A.M.; van der Laak, J.A.W.M.; Paffen, A.; Grefte, J.M.M.; Massuger, L.F.A.G.; de Wilde, P.C.M.; de Hullu, J.A.; Bulten, J. 2007: MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 20(7): 770-778

Li, M.; Liu, B.; Yi, J.; Yang, Y.; Wang, J.; Zhu, W-Guo.; Luo, J. 2020: MIB1-mediated degradation of WRN promotes cellular senescence in response to camptothecin treatment. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 34(9): 11488-11497

Rubio, P.M.; Galán, V.; Rodado, S.; Plaza, D.; Martínez, L. 2020: MIBG Therapy for Neuroblastoma: Precision Achieved with Dosimetry, and Concern for False Responders. Frontiers in Medicine 7: 173

Marcassa, C. 2022: MIBG and imaging of cardiac adrenergic system: from heart failure to ventricular arrhythmias and atrial fibrillation, through cardiac asynchrony. what else?. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 29(5): 2232-2234

Arrais, T.ís.R.; Cavalli, G.D.; Dos Santos, B.ár.T.; Pereira, G.B.; Migliavaca, C.B.; Grossman, G.B.; Biolo, A.éi. 2022: MIBG cardiac imaging compared to ejection fraction in evaluation of cardiotoxicity: a systematic review. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 29(5): 2274-2291

Zidaru, A.; Eales, B.M.; Wang, W.; Merlau, P.R.; Lasco, T.M.; Sofjan, A.K.; Tam, V.H. 2020: MIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolates. Journal of Global Antimicrobial Resistance 23: 385-387

Bretonnière, Cédric.; Maitte, A.; Caillon, J.; Potel, G.; Boutoille, D.; Jacqueline, Cédric.; Guitton, C. 2016: MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa. Journal of Antibiotics 69(11): 806-810

Fisher, O.M.; Levert-Mignon, A.J.; Lord, S.J.; Lee-Ng, K.K.M.; Botelho, N.K.; Falkenback, D.; Thomas, M.L.; Bobryshev, Y.V.; Whiteman, D.C.; Brown, D.A.; Breit, S.N.; Lord, R.V. 2015: MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma. British Journal of Cancer 112(8): 1384-1391

Tanaka, Y.; Taniyoshi, K.; Imamura, A.; Mukai, R.; Sukemura, S.; Sakoda, K.; Adachi, S. 2022: MIC-100, a new system for high-throughput phenotyping of instantaneous leaf photosynthetic rate in the field. Functional Plant Biology: Fpb 49(6): 496-504

Tani, R.; Ito, N.; Matsui, K.; Yamasaki, S.; Hamada, A.; Tokumaru, K.; Toratani, S.; Okamoto, T. 2021: MICA A5.1 homozygous genotype is associated with a risk for early-onset oral cancer. Oral Oncology 116: 105256

Ayo, C.M.; Bestetti, R.B.; de Campos Junior, E.; Ronchi, L.S.ér.; Borim, A.A.; Brandão, C.C.ás.; de Matttos, L.C. 2021: MICA and KIR: Immunogenetic Factors Influencing Left Ventricular Systolic Dysfunction and Digestive Clinical Form of Chronic Chagas Disease. Frontiers in Immunology 12: 714766

Fechtenbaum, M.; Desoutter, J.; Delvallez, G.; Brochot, E.; Guillaume, N.; Goëb, V. 2019: MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study. Genes and Immunity 20(7): 599-605

Wu, Y.; Tang, H.; Si, R.; Xia, S.; Wang, R.; Wang, Q. 2020: MICA enhances sensitivity to cisplatin in patients with extensive small cell lung cancer via downregulation of ABCG2. Oncology Letters 20(2): 1143-1152

Shao, W.; Lobashevsky, E.S.; Kaslow, R.A.; Dorak, M.T. 2004: MICA intron 1 sequences of conserved extended HLA haplotypes: implications for sequencing-based typing. Genes and Immunity 5(5): 371-374

Gong, X.; Chen, P.; Ma, P.; Gao, J.; Yang, J.; Guo, H.; Yan, C.; Zhang, B.; He, Y. 2020: MICA polymorphisms associated with antithyroid drug-induced agranulocytosis in the Chinese Han population. Immunity Inflammation and Disease 8(4): 695-703

Ding, W.; Ma, Y.; Zhu, W.; Pu, W.; Zhang, J.; Qian, F.; Zhou, Y.; Deng, Y.; Guo, S.; Wang, J.; Zhou, X. 2020: MICA ∗012:01 Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer. Frontiers in Genetics 11: 511

Zhu, W.; Deng, Y.; Wang, J.; Guo, X.; Ding, W.; Chao, J.; Lin, D.; Wang, Y.; Zhou, X. 2019: MICA*049, not MICA*009, is associated with Behçet's disease in a Chinese population. Scientific Reports 9(1): 10856

Tian, W.; Boggs, D.A.; Uko, G.; Essiet, A.; Inyama, M.; Banjoko, B.; Adewole, T.; Ding, W-Z.; Mohseni, M.; Fritz, R.; Chen, D-F.; Palmer, L.J.; Fraser, P.A. 2003: MICA, HLA-B haplotypic variation in five population groups of sub-Saharan African ancestry. Genes and Immunity 4(7): 500-505

Ding, H.; Buzzard, G.W.; Huang, S.; Sehorn, M.G.; Marcus, R.K.; Wei, Y. 2021: MICA-G129R: a bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells. Plos one 16(6): E0252662

Hu, B.; Yu, Y.; Wang, W.; Cui, G.-B. 2021: MICA: a toolkit for multimodal image coupling analysis. Journal of Neuroscience Methods 347: 108962

Min, P.; Zhang, L.; Wang, Y.; Qi, C.; Song, Y.; Bibi, M.; Zhang, Y.; Ma, Y.; Zhao, X.; Yu, M.; Du, J. 2020: MICAL-L2 Is Essential for c-Myc Deubiquitination and Stability in Non-small Cell Lung Cancer Cells. Frontiers in Cell and Developmental Biology 8: 575903

Xu, C.; Mao, L.; Tian, H.; Lin, S.; Zhao, X.; Lin, J.; Li, D.; Li, X.; Mei, X. 2021: MICAL1 (molecule interacting with CasL 1) protects oligodendrocyte cells from oxidative injury through regulating apoptosis, autophagy in spinal cord injury. Neuroscience Letters 750: 135712

Konstantinidis, K.; Bezzerides, V.J.; Lai, L.; Isbell, H.M.; Wei, A.-C.; Wu, Y.; Viswanathan, M.C.; Blum, I.D.; Granger, J.M.; Heims-Waldron, D.; Zhang, D.; Luczak, E.D.; Murphy, K.R.; Lu, F.; Gratz, D.H.; Manta, B.; Wang, Q.; Wang, Q.; Kolodkin, A.L.; Gladyshev, V.N.; Hund, T.J.; Pu, W.T.; Wu, M.N.; Cammarato, A.; Bianchet, M.A.; Shea, M.A.; Levine, R.L.; Anderson, M.E. 2020: MICAL1 constrains cardiac stress responses and protects against disease by oxidizing CaMKIi. Journal of Clinical Investigation 130(9): 4663-4678

Wang, Y.; Min, P.; Qi, C.; Zhao, S.; Yu, M.; Zhang, Y.; Du, J. 2021: MICAL2 Facilitates Gastric Cancer Cell Migration via MRTF-A-Mediated CDC42 Activation. Frontiers in Molecular Biosciences 8: 568868

Giarratana, N.; Conti, F.; La Rovere, R.; Gijsbers, R.; Carai, P.; Duelen, R.; Vervliet, T.; Bultynck, G.; Ronzoni, F.; Piciotti, R.; Costamagna, D.; Fulle, S.; Barravecchia, I.; Angeloni, D.; Torrente, Y.; Sampaolesi, M. 2020: MICAL2 is essential for myogenic lineage commitment. Cell Death and Disease 11(8): 654

Wang, F.; Chen, X.; Cheng, H.; Song, L.; Liu, J.; Caplan, S.; Zhu, L.; Wu, J.Y. 2021: MICAL2PV suppresses the formation of tunneling nanotubes and modulates mitochondrial trafficking. EMBO reports 22(7): e52006

Kim, Y.; Born, C.; Bléry, M.; Steinle, A. 2020: MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA. Frontiers in Immunology 11: 960

Kramer, J.; Obejero-Paz, C.A.; Myatt, G.; Kuryshev, Y.A.; Bruening-Wright, A.; Verducci, J.S.; Brown, A.M. 2013: MICE models: superior to the HERG model in predicting Torsade de Pointes. Scientific Reports 3: 2100

Swann, W.F. 1931: Michael Faraday. Ii. Science 73(1896): 462-468

Heseltine, M. 1952: MICHAEL Heseltine, C.B. British Medical Journal 1(4760): 716

Stephan, T.; Brüser, C.; Deckers, M.; Steyer, A.M.; Balzarotti, F.; Barbot, M.; Behr, T.S.; Heim, G.; Hübner, W.; Ilgen, P.; Lange, F.; Pacheu-Grau, D.; Pape, J.K.; Stoldt, S.; Huser, T.; Hell, S.W.; Möbius, W.; Rehling, P.; Riedel, D.; Jakobs, S. 2020: MICOS assembly controls mitochondrial inner membrane remodeling and crista junction redistribution to mediate cristae formation. EMBO Journal 39(14): E104105

El-Harasis, M.A.; Schreier, R.E.; Orton, J.M.; Ellis, C.R. 2021: MICRA AV upgrade following MICRA VR: generation "Y-not"?. Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing 61(3): 627-628

Koller, K.; Rudrapatna, U.; Chamberland, M.; Raven, E.P.; Parker, G.D.; Tax, C.M.W.; Drakesmith, M.; Fasano, F.; Owen, D.; Hughes, G.; Charron, C.; Evans, C.J.; Jones, D.K. 2021: MICRA: Microstructural image compilation with repeated acquisitions. Neuroimage 225: 117406

Iverson, W.P. 1985: Microbes Play a Considerable Role in Corrosion. Journal of Research of the National Bureau of Standards 90(4): 327-330

Wee, S.Y.; Edgcomb, V.P.; Beaudoin, D.; Yvon-Lewis, S.; Sylvan, J.B. 2021: Microbial Abundance and Diversity in Subsurface Lower Oceanic Crust at Atlantis Bank, Southwest Indian Ridge. Applied and Environmental Microbiology 87(22): E0151921

Wolfromm, R.; Vermaere, J. 1964: Microbial Allergy in Dermatology. La Presse Thermale et Climatique 101: 136-144

Horzov, L.; Kryvanych, V.; Melnyk, V.; Drobnych, V.; Boyko, N. 2020: Microbial Markers of Chronic Cataral Gingivitis in Treatment of Children with Fixed Orthodontic Apparatus. Georgian Medical News 303: 125-134

Raybould, H.E.; Zumpano, D.L. 2021: Microbial metabolites and the vagal afferent pathway in the control of food intake. Physiology and Behavior 240: 113555

Shishniashvili, T.; Suladze, T.; Makhviladze, M.; Pkhaladze, M. 2018: Microecological Changes in the Intestine and its Effect on the Condition of Hard Tissues of Teeth in Adolescence. Georgian Medical News 2018(274): 38-41

Sher, L.D.; Schwan, H.P. 1965: Microelectrophoresis with Alternating Electric Fields. Science 148(3667): 229-231

Nikolaishvili, N.; Chichua, G.; Muzashvili, T.; Burkadze, G. 2021: Microenvironment Alterations in Conjunctival Neoplastic Leosions with different Proliferation-Apoptotic Characteristics. Georgian Medical News 315: 152-159

Strullu, D.G.; Grellier, B.; Marciniak, D.; Letouzé, R. 1986: Micropropagation of Chestnut and Conditions of Mycorrhizal Syntheses in Vitro. New Phytologist 102(1): 95-101

Katerenchuk, I.P.; Tkachenko, L.A.; Yarmola, T.I.; Talash, V.V. 2021: Microscopic Polyangiitis - a View of the Problem through the Lens of a Nephrologist. Wiadomosci Lekarskie 74(4): 1024-1031

Rutter, C.M.; Ozik, J.; DeYoreo, M.; Collier, N. 2019: Microsimulation Model Calibration using Incremental Mixture Approximate Bayesian Computation. Annals of Applied Statistics 13(4): 2189-2212

Llinas, J.; Mackie, J.T.; Hyndman, T.H. 2021: Microsporidia-Associated Granulomatous Disease in two Australian Collections of Captive Inland Bearded Dragons (Pogona Vitticeps). Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 52(1): 396-400

Mchedlidze, K.; Shalashvili, K.; Aneli, J. 2020: Microstructural Characeristics of Rhododendron Ponticum L. Leaves. Georgian Medical News 308: 98-101

Salmon, P.A.; Assimacopoulos, C.A. 1964: Microsurgery. Minnesota Medicine 47: 679-686

Rajput, N.K.; Kalangi, T.K.V.; Andappan, A.; Swain, A.K. 2021: MICS CABG: a single-center experience of the first 100 cases. Indian Journal of Thoracic and Cardiovascular Surgery 37(1): 16-26

Thiery, M. 1965: Micturition induced by Giggling. British Medical Journal 1(5439): 879-880

Gottschalk, B.; Klec, C.; Leitinger, G.; Bernhart, E.; Rost, Ré.; Bischof, H.; Madreiter-Sokolowski, C.T.; Radulović, Sžana.; Eroglu, E.; Sattler, W.; Waldeck-Weiermair, M.; Malli, R.; Graier, W.F. 2019: MICU1 controls cristae junction and spatially anchors mitochondrial Ca 2+ uniporter complex. Nature Communications 10(1): 3732

Chakraborty, P.K.; Mustafi, S.Banerjee.; Xiong, X.; Dwivedi, S.Kumar.Dhar.; Nesin, V.; Saha, S.; Zhang, M.; Dhanasekaran, D.; Jayaraman, M.; Mannel, R.; Moore, K.; McMeekin, S.; Yang, D.; Zuna, R.; Ding, K.; Tsiokas, L.; Bhattacharya, R.; Mukherjee, P. 2017: MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nature Communications 8: 14634

Perocchi, F.; Gohil, V.M.; Girgis, H.S.; Bao, X.Robert.; McCombs, J.E.; Palmer, A.E.; Mootha, V.K. 2010: MICU1 encodes a mitochondrial EF hand protein required for Ca(2+) uptake. Nature 467(7313): 291-296

Dietsche, F.; Zhang, L.; Elrod, J.W.; Methner, A. 2021: MICU1 opens the gates to cold-induced death. Cell Calcium 98: 102451

Xue, Q.; Pei, H.; Liu, Q.; Zhao, M.; Sun, J.; Gao, E.; Ma, X.; Tao, L. 2017: MICU1 protects against myocardial ischemia/reperfusion injury and its control by the importer receptor Tom70. Cell Death and Disease 8(7): E2923

Antony, A.Noronha.; Paillard, M.; Moffat, C.; Juskeviciute, E.; Correnti, J.; Bolon, B.; Rubin, E.; Csordás, Görgy.; Seifert, E.L.; Hoek, J.B.; Hajnóczky, Görgy. 2016: MICU1 regulation of mitochondrial Ca(2+) uptake dictates survival and tissue regeneration. Nature Communications 7: 10955

Puente, B.N.; Sun, J.; Parks, R.J.; Fergusson, M.M.; Liu, C.; Springer, D.A.; Aponte, A.M.; Liu, J.C.; Murphy, E. 2020: MICU3 Plays an Important Role in Cardiovascular Function. Circulation Research 127(12): 1571-1573

Patron, M.; Granatiero, V.; Espino, J.; Rizzuto, R.; De Stefani, D. 2019: MICU3 is a tissue-specific enhancer of mitochondrial calcium uptake. Cell Death and Differentiation 26(1): 179-195

Qiao, Y.; Zhou, Y.; Song, C.; Zhang, X.; Zou, Y. 2020: MID1 and MID2 regulate cell migration and epithelial-mesenchymal transition via modulating Wnt/β-catenin signaling. Annals of Translational Medicine 8(16): 1021

Trockenbacher, A.; Suckow, V.; Foerster, J.; Winter, J.; Krauss, S.; Ropers, H.H.; Schneider, R.; Schweiger, S. 2001: MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nature Genetics 29(3): 287-294

Gonzalez, J.A.; Ogba, O.Maduka.; Morehouse, G.F.; Rosson, N.; Houk, K.N.; Leach, A.G.; Cheong, P.H-Y.; Burke, M.D.; Lloyd-Jones, G.C. 2016: MIDA boronates are hydrolysed fast and slow by two different mechanisms. Nature Chemistry 8(11): 1067-1075

Repossini, A.; Baudo, M.; D'Alonzo, M.; Petruccelli, R.; Rosati, F. 2020: MIDCAB Tips and tricks for a successful procedure. Multimedia Manual of Cardiothoracic Surgery: Mmcts 2020

Angelescu, R.; Dobrescu, R. 2021: MIDGET:Detecting differential gene expression on microarray data. Computer Methods and Programs in Biomedicine 211: 106418

Luo, X.; Wang, G.; Song, T.; Zhang, J.; Aertsen, M.; Deprest, J.; Ourselin, S.; Vercauteren, T.; Zhang, S. 2021: MIDeepSeg: Minimally interactive segmentation of unseen objects from medical images using deep learning. Medical Image Analysis 72: 102102

Yu, R.; Liu, T.; Jin, S.-B.; Ankarcrona, M.; Lendahl, U.; Nistér, M.; Zhao, J. 2021: MIEF1/2 orchestrate mitochondrial dynamics through direct engagement with both the fission and fusion machineries. Bmc Biology 19(1): 229

Huang, W.; Chen, J.; Liu, X.; Liu, X.; Duan, S.; Chen, L.; Liu, X.; Lan, J.; Zou, Y.; Guo, D.; Zhou, J. 2021: MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail. Experimental Cell Research 406(1): 112722

Peng, M.; Hu, Y.; Song, W.; Duan, S.; Xu, Q.; Ding, Y.; Geng, J.; Zhou, J. 2017: MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition. Scientific Reports 7(1): 11000

Areeshi, M.Y.; Mandal, R.K.; Dar, S.A.; Jawed, A.; Wahid, M.; Lohani, M.; Panda, A.K.; Mishra, B.N.; Akhter, N.; Haque, S. 2017: MIF -173 G > C (rs755622) Gene Polymorphism Modulates Tuberculosis Risk: Evidence from a Meta-analysis and Trial Sequential Analysis. Scientific Reports 7(1): 17003

Kim, B.; Kusibati, R.; Heisler-Taylor, T.; Mantopoulos, D.; Ding, J.; Abdel-Rahman, M.H.; Satoskar, A.R.; Godbout, J.P.; Bhattacharya, S.K.; Cebulla, C.M. 2017: MIF Inhibitor ISO-1 Protects Photoreceptors and Reduces Gliosis in Experimental Retinal Detachment. Scientific Reports 7(1): 14336

El Bounkari, O.; Bernhagen, Jürrgen. 2012: MIF and autophagy: a novel link beyond "eating". Cell Research 22(6): 950-953

Wang, Q.; Zhao, D.; Xian, M.; Wang, Z.; Bi, E.; Su, P.; Qian, J.; Ma, X.; Yang, M.; Liu, L.; Zu, Y.; Pingali, S.R.; Chen, K.; Cai, Z.; Yi, Q. 2020: MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma. Blood 136(22): 2557-2573

Calandra, T.; Bernhagen, J.; Metz, C.N.; Spiegel, L.A.; Bacher, M.; Donnelly, T.; Cerami, A.; Bucala, R. 1995: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377(6544): 68-71

Penticuff, J.C.; Woolbright, B.L.; Sielecki, T.M.; Weir, S.J.; Taylor, J.A. 2019: MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential. Nature Reviews. Urology 16(5): 318-328

Du, G-Li.; Luo, J-Yi.; Wang, D.; Li, Y-Hong.; Fang, B-Bin.; Li, X-Mei.; Gao, X-Ming.; Yang, Y-Ning. 2020: MIF gene rs755622 polymorphism positively associated with acute coronary syndrome in Chinese Han population: case-control study. Scientific Reports 10(1): 140

Leake, I. 2018: MIF in granulomatosis with polyangiitis. Nature Reviews. Rheumatology 14(9): 501

de Azevedo, R.A.; Shoshan, E.; Whang, S.; Markel, G.; Jaiswal, A.R.; Liu, A.; Curran, M.A.; Travassos, L.R.; Bar-Eli, M. 2020: MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma. Oncoimmunology 9(1): 1846915

Perveen, S.; Ayasolla, K.; Zagloul, N.; Patel, H.; Ochani, K.; Orner, D.; Benveniste, H.; Salerno, M.; Vaska, P.; Zuo, Z.; Alabed, Y.; Nasim, M.; Miller, E.J.; Ahmed, M. 2019: MIF inhibition enhances pulmonary angiogenesis and lung development in congenital diaphragmatic hernia. Pediatric Research 85(5): 711-718

Liu, Y.; Liu, Y.; Wang, Q.; Song, Y.; Chen, S.; Cheng, B.; Zhang, Y.; Cui, Z.; Wu, Z.; Zhu, C. 2021: MIF inhibitor ISO-1 alleviates severe acute pancreatitis-associated acute kidney injury by suppressing the NLRP3 inflammasome signaling pathway. International Immunopharmacology 96: 107555

Cheng, B.; Wang, Q.; Song, Y.; Liu, Y.; Liu, Y.; Yang, S.; Li, D.; Zhang, Y.; Zhu, C. 2020: MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo. Scientific Reports 10(1): 6741

Shvil, N.; Banerjee, V.; Zoltsman, G.; Shani, T.; Kahn, J.; Abu-Hamad, S.; Papo, N.; Engel, S.; Bernhagen, J.; Israelson, A. 2018: MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS. Cell Death and Disease 9(2): 107

Wang, Y.; Chen, Y.; Wang, C.; Yang, M.; Wang, Y.; Bao, L.; Wang, J.E.; Kim, B.; Chan, K.Y.; Xu, W.; Capota, E.; Ortega, J.; Nijhawan, D.; Li, G-Min.; Luo, W.; Wang, Y. 2021: MIF is a 3' flap nuclease that facilitates DNA replication and promotes tumor growth. Nature Communications 12(1): 2954

Bernhagen, Jürgen.; Krohn, R.; Lue, H.; Gregory, J.L.; Zernecke, A.; Koenen, R.R.; Dewor, M.; Georgiev, I.; Schober, A.; Leng, L.; Kooistra, T.; Fingerle-Rowson, Günter.; Ghezzi, P.; Kleemann, R.; McColl, S.R.; Bucala, R.; Hickey, M.J.; Weber, C. 2007: MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Medicine 13(5): 587-596

Bernhagen, J.; Calandra, T.; Mitchell, R.A.; Martin, S.B.; Tracey, K.J.; Voelter, W.; Manogue, K.R.; Cerami, A.; Bucala, R. 1993: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365(6448): 756-759

Bell, J.E. 2002: MIF keeps macrophages on guard. Nature Reviews. Immunology 2(2): 70

Talos, F.; Mena, P.; Fingerle-Rowson, G.; Moll, U.; Petrenko, O. 2005: MIF loss impairs Myc-induced lymphomagenesis. Cell Death and Differentiation 12(10): 1319-1328

Martin, T.R. 2000: MIF mediation of sepsis. Nature Medicine 6(2): 140-141

Qin, L.; Qin, J.; Lv, X.; Yin, C.; Zhang, Q.'e.; Zhang, J. 2021: MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma. Oncology Letters 22(1): 549

De la Cruz-Mosso, U.; García-Iglesias, T.; Bucala, R.; Estrada-García, I.; González-López, L.; Cerpa-Cruz, S.; Parra-Rojas, I.; Gámez-Nava, J.Iván.; Pérez-Guerrero, Eúl.Emilio.; Muñoz-Valle, Jé.Francisco. 2018: MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients. Cellular Immunology 324: 42-49

Roger, T.; David, J.; Glauser, M.P.; Calandra, T. 2001: MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414(6866): 920-924

Carrero-Rojas, G.én.; Hernández, R.G.; Blumer, R.; de la Cruz, R.R.; Pastor, A.M. 2021: MIF versus SIF Motoneurons, what Are their Respective Contribution in the Oculomotor Medial Rectus Pool?. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 41(47): 9782-9793

Ghoochani, A.; Schwarz, M.A.; Yakubov, E.; Engelhorn, T.; Doerfler, A.; Buchfelder, M.; Bucala, R.; Savaskan, N.E.; Eyüpoglu, I.Y. 2016: MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis. Oncogene 35(48): 6246-6261

Noe, J.T.; Mitchell, R.A. 2020: MIF-Dependent Control of Tumor Immunity. Frontiers in Immunology 11: 609948

He, Z.; Wang, Y.; Zhuan, L.; Li, Y.; Tang, Z.-O.; Wu, Z.; Ma, Y. 2021: MIF-mediated NF-κB signaling pathway regulates the pathogenesis of polycystic ovary syndrome in rats. Cytokine 146: 155632

Wan, C.; Hou, S.; Ni, R.; Lv, L.; Ding, Z.; Huang, X.; Hang, Q.; He, S.; Wang, Y.; Cheng, C.; Gu, X.X.; Xu, G.; Shen, A. 2015: MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability. Oncogene 34(2): 237-245

Morand, E.F.; Leech, M.; Bernhagen, Jürgen. 2006: MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nature Reviews. Drug Discovery 5(5): 399-410

Li, D.-Y.; Zhang, J.-Y.; Chen, Q.-J.; Liu, F.; Zhao, Q.; Gao, X.-M.; Li, X.-M.; Yang, Y.-N. 2020: MIF -173G/C (rs755622) polymorphism modulates coronary artery disease risk: evidence from a systematic meta-analysis. Bmc Cardiovascular Disorders 20(1): 300

Yoo, J-Y.; Yang, W.S.; Lee, J.H.; Kim, B.G.; Broaddus, R.R.; Lim, J.M.; Kim, T.H.; Jeong, J-W. 2018: MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells. Oncogene 37(2): 255-262

Suyama, Y.; Matsuki, Y. 2015: MIG-seq: an effective PCR-based method for genome-wide single-nucleotide polymorphism genotyping using the next-generation sequencing platform. Scientific Reports 5: 16963

Li, L.; Xia, Y.; Ji, X.; Wang, H.; Zhang, Z.; Lu, P.; Ding, Q.; Wang, D.; Liu, M. 2021: MIG/CXCL9 exacerbates the progression of metabolic-associated fatty liver disease by disrupting Treg/Th17 balance. Experimental Cell Research 407(2): 112801

Nurcholis, M.; Murata, M.; Limtong, S.; Kosaka, T.; Yamada, M. 2019: MIG1 as a positive regulator for the histidine biosynthesis pathway and as a global regulator in thermotolerant yeast Kluyveromyces marxianus. Scientific Reports 9(1): 9926

Izumi, A.; Hiraguchi, H.; Kodaka, M.; Ikeuchi, E.; Narita, J.; Kobayashi, R.; Matsumoto, Y.; Suzuki, T.; Yamamoto, Y.; Sato, R.; Inoue, J. 2021: MIG12 is involved in the LXR activation-mediated induction of the polymerization of mammalian acetyl-CoA carboxylase. Biochemical and Biophysical Research Communications 567: 138-142

Wadia, R. 2021: MIH - stainless steel crown or composite?. British Dental Journal 231(2): 114

Kaur, R.; Singh, H.; Samria, S.; Kumar, N.; Parachuri, N.; Sharma, R.; Bandello, F.; Loewenstein, A.; Bilong, Y.; Hafeez Faridi, M.; Sharma, A. 2020: MII RetCam assisted smartphone-based fundus imaging (MSFI)-A boon for paediatric retinal imaging. Eye 34(8): 1307-1309

Osborne, H.; Lai, Y.M.; Lepperød, M.E.; Sichau, D.; Deutz, L.; de Kamps, M. 2021: MIIND : a Model-Agnostic Simulator of Neural Populations. Frontiers in Neuroinformatics 15: 614881

Yan, G.; Ru, Y.; Yan, F.; Xiong, X.; Hu, W.; Pan, T.; Sun, J.; Zhang, C.; Wang, Q.; Li, X. 2019: MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling. Cell Communication and Signaling: Ccs 17(1): 44

Barclay, L. 1930: Mikulicz's Disease. Canadian Medical Association Journal 22(4): 498-501

Hu, Z.; Zhuang, Q.; Xiao, Y.; Wu, G.; Shi, Z.; Chen, L.; Wang, Y.; Yu, J. 2021: MIL normalization -- prerequisites for accurate MRi radiomics analysis. Computers in Biology and Medicine 133: 104403

Yan, J.; Zhuang, Q.; Li, Z.; Xiong, Y.; He, M.; Kang, C.; Zhang, Q.; Han, L.; Liang, E.; Liu, H.; Ke, P.; Huang, X. 2021: MIL-1, a novel antitumor agent derived from natural product millepachine, acts as tubulin polymerization inhibitor for the treatment of hepatocellular carcinoma. European Journal of Pharmacology 898: 173975

Qin, P.; Han, L.; Zhang, X.; Li, M.; Li, D.; Lu, M.; Cai, Z. 2021: MIL-101(Fe)-derived magnetic porous carbon as sorbent for stir bar sorptive-dispersive microextraction of sulfonamides. Mikrochimica Acta 188(10): 340

Xie, X.; Peng, L.; Yang, H.; Waterhouse, G.I.N.; Shang, L.; Zhang, T. 2021: MIL-101-Derived Mesoporous Carbon Supporting Highly Exposed Fe Single-Atom Sites as Efficient Oxygen Reduction Reaction Catalysts. Advanced Materials 33(23): E2101038

Moinfar, S.; Khodayari, A.; Sohrabnezhad, S.; Aghaei, A.; Jamil, L.A. 2020: MIL-53(Al)/Fe2O3 nanocomposite for solid-phase microextraction of organophosphorus pesticides followed by GC-MS analysis. Mikrochimica Acta 187(12): 647

Schabath, M.B.; Aberle, D.R. 2019: MILD trial, strong confirmation of lung cancer screening efficacy. Nature Reviews. Clinical Oncology 16(9): 529-530

Dinets, A.; Nykytiuk, O.; Gorobeiko, M.; Barabanchyk, O.; Khrol, N. 2021: Milestones and Pitfalls in Strategic Planning of Healthcare in Capital City in Transition. Georgian Medical News 315: 189-195

Golz, A. 2021: Milestones in the History of Orthopedics. Harefuah 160(6): 393-396

Attia, M.M.; Saad, M.F.; Abdel-Salam, A.B. 2017: Milk as a Substitute for Serum in Diagnosis of Toxoplasmosis in Goats. Journal of the Egyptian Society of Parasitology 47(1): 227-234

Strauss, A.; Salomao, T.A. 1965: Milk Intolerance: Clinical and Immuno-Serological Data. Study of 120 Allergic Children. Alergia 12: 87-102

De Iongh, H.; Vles, R.O.; Van Peltj 1964: Milk of Mammals Fed An Aflatoxin-Containing Diet. Nature 202: 466-467

Manwaring, W.H. 1941: Milk-Borne Carcinogenic Virus. California and Western Medicine 54(5): 258-259

Thornton, I.M.; Horowitz, T.S. 2020: MILO Mobile: An iPad App to Measure Search Performance in Multi-Target Sequences. I-Perception 11(3): 2041669520932587

Monk, B.J.; Grisham, R.N.; Banerjee, S.; Kalbacher, E.; Mirza, M.R.; Romero, I.; Vuylsteke, P.; Coleman, R.L.; Hilpert, F.; Oza, A.M.; Westermann, A.; Oehler, M.K.; Pignata, S.; Aghajanian, C.; Colombo, N.; Drill, E.; Cibula, D.; Moore, K.N.; Christy-Bittel, J.; Del Campo, J.M.; Berger, R.; Marth, C.; Sehouli, J.; O'Malley, D.M.; Churruca, C.; Boyd, A.P.; Kristensen, G.; Clamp, A.; Ray-Coquard, I.; Vergote, I. 2020: MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 38(32): 3753-3762

Zhan, T.; Cao, C.; Li, L.; Gu, N.; Civin, C.I.; Zhan, X. 2016: MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4. Leukemia 30(6): 1327-1334

Zhu, J.; Li, N. 2020: MIM waveguide structure consisting of a semicircular resonant cavity coupled with a key-shaped resonant cavity. Optics Express 28(14): 19978-19987

Lee, Y-Goo.; Macoska, J.A.; Korenchuk, S.; Pienta, K.J. 2002: MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4(4): 291-294

Johnson, A.E.W.; Pollard, T.J.; Shen, L.; Lehman, L-Wei.H.; Feng, M.; Ghassemi, M.; Moody, B.; Szolovits, P.; Celi, L.Anthony.; Mark, R.G. 2016: MIMIC-III, a freely accessible critical care database. Scientific Data 3: 160035

Levasseur, A.; Bekliz, M.; Chabrière, E.; Pontarotti, P.; La Scola, B.; Raoult, D. 2016: MIMIVIRE is a defence system in mimivirus that confers resistance to virophage. Nature 531(7593): 249-252

Nguyen, H.; Ly, K.L.; Nguyen, T.; Wang, Y.; Wang, Z. 2021: MIMONet: Structured-light 3D shape reconstruction by a multi-input multi-output network. Applied Optics 60(17): 5134-5144

Wagih, O.; Reimand, Jüri.; Bader, G.D. 2015: MIMP: predicting the impact of mutations on kinase-substrate phosphorylation. Nature Methods 12(6): 531-533

Mallows, J.L. 2007: MIMS is not a stand-alone resource. Medical Journal of Australia 187(10): 596; Author Reply 596-7

Huang, M-Y.; Xuan, F.; Liu, W.; Cui, H-J. 2017: MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation. Oncogene 36(3): 387-396

Ramachandran, S.; Henikoff, S. 2018: MINCE-Seq: Mapping In Vivo Nascent Chromatin with EdU and Sequencing. Methods in Molecular Biology 1832: 159-168

Dhana, K.; James, B.D.; Agarwal, P.; Aggarwal, N.T.; Cherian, L.J.; Leurgans, S.E.; Barnes, L.L.; Bennett, D.A.; Schneider, J.A. 2021: MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. Journal of Alzheimer's Disease: Jad 83(2): 683-692

Kheirouri, S.; Alizadeh, M. 2021: MIND diet and cognitive performance in older adults: a systematic review. Critical Reviews in Food Science and Nutrition 2021: 1-19

Toms, J. 2020: MIND, Anti-Psychiatry, and the Case of the Mental Hygiene Movement's 'Discursive Transformation'. Social History of Medicine: the Journal of the Society for the Social History of Medicine 33(2): 622-640

Lapin, M.; Tjensvoll, K.; Oltedal, S.; Buhl, T.; Gilje, Børnar.; Smaaland, R.; Nordgård, O. 2016: MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment. Scientific Reports 6: 28929

Shegog, R.; Begley, C.; Chong, J.; Sepulveda, R.; Addy, R.; Martin, K.; Rosales, O.; Halavacs, N.; Labiner, D. 2020: MINDSET: Clinic-based decision support demonstrates longitudinal efficacy for increased epilepsy self-management adherence among Spanish speaking patients. Epilepsy and Behavior: E&b 113: 107552

Vandewiele, G.; Steenwinckel, B.; Turck, F.D.; Ongenae, F. 2020: MINDWALC: mining interpretable, discriminative walks for classification of nodes in a knowledge graph. Bmc Medical Informatics and Decision Making 20(Suppl 4): 191

Luo, Y.; Zhou, J.; Tang, J.; Zhou, F.; He, Z.; Liu, T.; Liu, T. 2021: MINDY1 promotes bladder cancer progression by stabilizing YAP. Cancer Cell International 21(1): 395

Tang, J.; Luo, Y.; Long, G.; Zhou, L. 2021: MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α. Cell Death and Disease 12(10): 937

Jacobsen, H.B.; Klungsøyr, O.; Landrø, N.I.; Stiles, T.C.; Roche, B.T. 2020: MINDflex Training for Cognitive Flexibility in Chronic Pain: a Randomized, Controlled Cross-Over Trial. Frontiers in Psychology 11: 604832

Gabritchidze, S.; Karanadze, N.; Charkviani, N.; Chokhonelidze, A. 2021: Mineral Water "dzuguri" and type 2 Diabetes Mellitus: Screening Results. Georgian Medical News 314: 121-124

Kostyrenko, O.P.; Vynnyk, N.I.; Koptev, M.M.; Hasiuk, P.A.; Skrypnyk, M.I.; Bilous, A.M.; Proskurnya, S.A. 2021: Mineralization of Teeth Enamel after Eruption. Wiadomosci Lekarskie 74(6): 1297-1301

Tezuka, Y.; Turcu, A.F. 2020: Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2020

Gawron, P.; Ostaszewski, M.; Satagopam, V.; Gebel, S.; Mazein, A.; Kuzma, M.; Zorzan, S.; McGee, F.; Otjacques, Bît.; Balling, R.; Schneider, R. 2016: MINERVA-a platform for visualization and curation of molecular interaction networks. Npj Systems Biology and Applications 2: 16020

Schmidt, R.; Weihs, T.; Wurm, C.A.; Jansen, I.; Rehman, J.; Sahl, S.J.; Hell, S.W. 2021: MINFLUX nanometer-scale 3D imaging and microsecond-range tracking on a common fluorescence microscope. Nature Communications 12(1): 1478

Gwosch, K.C.; Pape, J.K.; Balzarotti, F.; Hoess, P.; Ellenberg, J.; Ries, J.; Hell, S.W. 2020: MINFLUX nanoscopy delivers 3D multicolor nanometer resolution in cells. Nature Methods 17(2): 217-224

Ilahi, I.; Haq, T.U. 2021: MINi REVIEW: Role of Kisspeptin-GPR54 system in regulation of reproductive functions in human and other mammals. Pakistan Journal of Pharmaceutical Sciences 34(1): 177-184

Chaim, E.Adami.; Ramos, A.Cardoso.; Cazzo, E. 2017: Mini-Gastric Bypass: Description of the Technique and Preliminary Results. Arquivos Brasileiros de Cirurgia Digestiva: Abcd 30(4): 264-266

Tyrer, J. 2020: MINIMISE Moisture™: a local quality improvement initiative raising awareness of moisture-associated skin damage. British Journal of Nursing 29(20): S8

Candreva, A.; Gotschy, A.; Templin, C. 2021: MINOCA and the invasive assessment of the coronary microvascular function. Therapeutische Umschau. Revue Therapeutique 78(1): 36-40

Vranken, N.P.A.; Pustjens, T.F.S.; Kolkman, E.; Hermanides, R.S.; Bekkers, S.C.A.M.; Smulders, M.W.; van Cauteren, Y.J.M.; Heijman, J.; Rasoul, S.; Ottervanger, J.P.; van 't Hof, A.W.J. 2020: MINOCA: the caveat of absence of coronary obstruction in myocardial infarction. International Journal of Cardiology. Heart and Vasculature 29: 100572

Weber, M.; Leutenegger, M.; Stoldt, S.; Jakobs, S.; Mihaila, T.S.; Butkevich, A.N.; Hell, S.W. 2021: MINSTED fluorescence localization and nanoscopy. Nature Photonics 15(5): 361-366

Cmero, M.; Schmidt, B.; Majewski, I.J.; Ekert, P.G.; Oshlack, A.; Davidson, N.M. 2021: MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data. Genome Biology 22(1): 296

Loher, P.; Telonis, A.G.; Rigoutsos, I. 2017: MINTmap: fast and exhaustive profiling of nuclear and mitochondrial tRNA fragments from short RNA-seq data. Scientific Reports 7: 41184

Hallgren, M.B.; Overballe-Petersen, S.ør.; Lund, O.; Hasman, H.; Clausen, P.T.L.C. 2021: MINTyper: an outbreak-detection method for accurate and rapid SNP typing of clonal clusters with noisy long reads. Biology Methods and Protocols 6(1): Bpab 008

Cheston, C.C.; Sox, C.M.; Michelson, C.D.; Fraiman, Y.S. 2020: MINdI: Mindfulness Instruction for new Interns. Mededportal: the Journal of Teaching and Learning Resources 16: 10933

Deng, J.; Pan, Y.; Yao, T.; Zhou, W.; Li, H.; Mei, T. 2021: MINet: Meta-Learning Instance Identifiers for Video Object Detection. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 30: 6879-6891

Furtado, A.I.; Viveiros, R.; Casimiro, T. 2021: MIP Synthesis and Processing Using Supercritical Fluids. Methods in Molecular Biology 2359: 19-42

Wong, L.; You, Z.-H.; Guo, Z.-H.; Yi, H.-C.; Chen, Z.-H.; Cao, M.-Y. 2020: MIPDH: a Novel Computational Model for Predicting microRNA-mRNA Interactions by DeepWalk on a Heterogeneous Network. Acs Omega 5(28): 17022-17032

Van de Wall, B.J.M.; Baumgärtner, R.; Houwert, R.M.; Link, B.ör.C.; Heng, M.; Knobe, M.; Groenwold, R.H.H.; Babst, R.; Beeres, F.J.P. 2022: MIPO versus nailing for humeral shaft fractures: a meta-analysis and systematic review of randomised clinical trials and observational studies. European Journal of Trauma and Emergency Surgery: Official Publication of the European Trauma Society 48(1): 47-59

Doan, R.N.; Miller, M.B.; Kim, S.N.; Rodin, R.E.; Ganz, J.; Bizzotto, S.; Morillo, K.S.; Huang, A.Y.; Digumarthy, R.; Zemmel, Z.; Walsh, C.A. 2021: MIPP-Seq: ultra-sensitive rapid detection and validation of low-frequency mosaic mutations. Bmc Medical Genomics 14(1): 47

Lowdon, J.W.; Diliën, H.; Singla, P.; Peeters, M.; Cleij, T.J.; van Grinsven, B.; Eersels, K. 2020: MIPs for commercial application in low-cost sensors and assays - An overview of the current status quo. Sensors and Actuators. B Chemical 325: 128973

Brendel, R.; Schwolow, S.; Gerhardt, N.; Schwab, J.; Rau, P.; Oest, M.; Rohn, S.; Weller, P. 2021: MIR spectroscopy versus MALDI-ToF-MS for authenticity control of honeys from different botanical origins based on soft independent modelling by class analogy (SIMCA) - a clash of techniques?. Spectrochimica Acta. Part a Molecular and Biomolecular Spectroscopy 263: 120225

Zhao, M.; Tang, Z.; Wang, Y.; Ding, J.; Guo, Y.; Zhang, N.; Gao, T. 2021: MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non-small-cell Lung Cancer. Journal of Cancer 12(22): 6600-6609

Sun, M-Xia.; An, Q.; Chen, L-Mei.; Guo, L. 2020: MIR-520f Regulated Itch Expression and Promoted Cell Proliferation in Human Melanoma Cells. Dose-Response:aPublicationofInternationalHormesisSociety 18(2): 1559325820918450

Zhu, Q.; Zhang, Q.; Gu, M.; Zhang, K.; Xia, T.; Zhang, S.; Chen, W.; Yin, H.; Yao, H.; Fan, Y.; Pan, S.; Xie, H.; Liu, H.; Cheng, T.; Zhang, P.; Zhang, T.; You, B.; You, Y. 2020: MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma. Autophagy 2020: 1-17

Ishige, F.; Hoshino, I.; Iwatate, Y.; Chiba, S.; Arimitsu, H.; Yanagibashi, H.; Nagase, H.; Takayama, W. 2020: MIR1246 in body fluids as a biomarker for pancreatic cancer. Scientific Reports 10(1): 8723

Strazisar, M.; Cammaerts, S.; van der Ven, K.; Forero, D.A.; Lenaerts, A-S.; Nordin, A.; Almeida-Souza, L.; Genovese, G.; Timmerman, V.; Liekens, A.; De Rijk, P.; Adolfsson, R.; Callaerts, P.; Del-Favero, J. 2015: MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets. Molecular Psychiatry 20(4): 472-481

Čelešnik, H.; Büdefeld, T.ž; Čizmarević, B.; Švagan, M.; Potočnik, U.š 2021: MIR137/MIR2682 locus is associated with perineural invasiveness in head and neck cancer. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 50(9): 874-881

Han, J.; Sarkar, A.; Gage, F.H. 2015: MIR137: big impacts from small changes. Nature Neuroscience 18(7): 931-933

Zhong, Y.; Li, L.; Chen, Z.; Diao, S.; He, Y.; Zhang, Z.; Zhang, H.; Yuan, X.; Li, J. 2020: MIR143 Inhibits Steroidogenesis and Induces Apoptosis Repressed by H3K27me3 in Granulosa Cells. Frontiers in Cell and Developmental Biology 8: 565261

Dong, H.; Yan, S.; Jing, Y.; Yang, R.; Zhang, Y.; Zhou, Y.; Zhu, Y.; Sun, J. 2021: MIR156-Targeted SPL9 Is Phosphorylated by SnRK2s and Interacts with ABI5 to Enhance ABA Responses in Arabidopsis. Frontiers in Plant Science 12: 708573

Yang, K.; Zhang, Y.; Mai, X.; Hu, L.; Ma, C.; Wei, J. 2021: MIR17HG genetic variations affect the susceptibility of IgA nephropathy in Chinese Han people. Gene 800: 145838

Yuan, J.; Tan, L.; Yin, Z.; Zhu, W.; Tao, K.; Wang, G.; Shi, W.; Gao, J. 2019: MIR17HG-miR-18a/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt/β-catenin signalling. Cell Death and Disease 10(6): 454

Wang, X.; Yu, X.; Long, X.; Pu, Q. 2021: MIR205 host gene (MIR205HG) drives osteosarcoma metastasis via regulating the microRNA 2114-3p (miR-2114-3p)/twist family bHLH transcription factor 2 (TWIST2) axis. Bioengineered 12(1): 1576-1586

Liu, L.; Li, Y.; Zhang, R.; Li, C.; Xiong, J.; Wei, Y. 2020: MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis. Bmc Pulmonary Medicine 20(1): 163

Deng, S.; Gu, B.; Yu, Z.; Shen, Z.; Ren, H. 2021: MIR210HG Aggravates Sepsis-Induced Inflammatory Response of Proximal Tubular Epithelial Cell via the NF-κB Signaling Pathway. Yonsei Medical Journal 62(5): 461-469

Yu, T.; Li, G.; Wang, C.; Gong, G.; Wang, L.; Li, C.; Chen, Y.; Wang, X. 2021: MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis. Rna Biology 2021: 1-18

Okuma, N.; Soyano, T.; Suzaki, T.; Kawaguchi, M. 2020: MIR2111-5 locus and shoot-accumulated mature miR2111 systemically enhance nodulation depending on HAR1 in Lotus japonicus. Nature Communications 11(1): 5192

Deng, X.; Ye, D.; Hua, K.; Song, H.; Luo, Q.; Munankarmy, A.; Liu, D.; Zhou, B.; Zheng, W.; Zhou, X.; Ji, C.; Wang, X.; Yu, Y.; Fang, L. 2021: MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor. Cell Death and Disease 12(9): 810

Li, Y. 2020: MIR31HG exhibits oncogenic property and acts as a sponge for miR-361-3p in cervical carcinoma. Biochemical and Biophysical Research Communications 529(4): 890-897

Xin, C.; Bi, X.; Xiao, C.; Dong, L. 2021: MIR31HG regulates the proliferation, migration and invasion of breast cancer by regulating the expression of POLDIP2. Journal of Buon: Official Journal of the Balkan Union of Oncology 26(2): 459-465

Han, C.; Li, H.; Ma, Z.; Dong, G.; Wang, Q.; Wang, S.; Fang, P.; Li, X.; Chen, H.; Liu, T.; Xu, L.; Wang, J.; Wang, J.; Yin, R. 2021: MIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma. Cell Death and Disease 12(5): 424

Mills, R.L.; Farrell, J.L.; Reiff, W.M. 1989: MIRAGE or no mirage?. Nature 340(6230): 193-194

Onuma, S.; Wada, T.; Araki, R.; Wada, K.; Tanase-Nakao, K.; Narumi, S.; Fukui, M.; Shoji, Y.; Etani, Y.; Ida, S.; Kawai, M. 2020: MIRAGE syndrome caused by a novel missense variant (p.Ala1479Ser) in the SAMD9 gene. Human Genome Variation 7: 4

Onuma, S.; Wada, T.; Araki, R.; Wada, K.; Tanase-Nakao, K.; Narumi, S.; Fukui, M.; Shoji, Y.; Etani, Y.; Ida, S.; Kawai, M. 2020: MIRAGE syndrome caused by a novel missense variant (p.Ala1479Ser) in the SAMD9 gene. Human Genome Variation 7(1): 4

Zheng, R.F.; Su, Z.; Wang, L.; Zhao, X.; Li, Z.G. 2021: MIRAGE syndrome caused by variation of sterile alpha motif domain-containing protein 9 gene. Zhonghua Er Ke Za Zhi 59(5): 417-419

Roldan-Pallares, M.; LLanes-Estrada, M.; LLanes-Menendez, F. 2016: MIRAgel: the immunohistochemical expression of CD3, CD34, and CD68 in the surrounding capsule. Eye 30(10): 1381-1388

Elizarova, A.; Ozturk, M.; Guler, R.; Medvedeva, Y.A. 2021: MIREyA: a computational approach to detect miRNA-directed gene activation. F1000research 10: 249

Xia, Y.; Zhen, L.; Li, H.; Wang, S.; Chen, S.; Wang, C.; Yang, X. 2021: MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway. Cell Death and Disease 12(4): 326

Martins, P.M.; Navarro, S.; Silva, A.; Pinto, M.F.; Sárkány, Z.; Figueiredo, F.; Pereira, P.J.é B.; Pinheiro, F.; Bednarikova, Z.; Burdukiewicz, M.ł; Galzitskaya, O.V.; Gazova, Z.; Gomes, C.áu.M.; Pastore, A.; Serpell, L.C.; Skrabana, R.; Smirnovas, V.; Ziaunys, M.; Otzen, D.E.; Ventura, S.; Macedo-Ribeiro, S. 2020: MIRRAGGE - Minimum Information Required for Reproducible AGGregation Experiments. Frontiers in Molecular Neuroscience 13: 582488

Antonov, A.V.; Knight, R.A.; Melino, G.; Barlev, N.A.; Tsvetkov, P.O. 2013: MIRUMIR: an online tool to test micro RNAs as biomarkers to predict survival in cancer using multiple clinical data sets. Cell Death and Differentiation 20(2): 367

Bellany, I. 1970: MIRVs and the strategic balance. Nature 226(5244): 412-413

Kaye, G.D.; Lindsey, G.R. 1970: MIRVs and the strategic balance. Nature 227(5259): 696-697

Sartori, L. 1970: MIRVs and the strategic balance. Nature 228(5266): 53; Discussion 53-4

Robinson, A.; Alvarez-Solas, J.; Calov, R.; Ganopolski, A.; Montoya, M. 2017: MIS-11 duration key to disappearance of the Greenland ice sheet. Nature Communications 8: 16008

Clouser, K.; Baer, A.; Bhavsar, S.; Gadhavi, J.; Li, S.; Schnall, J.; Weiss, J.E. 2020: MIS-C After ARDS Associated with SARS-CoV-2. Pediatric Infectious Disease Journal 39(11): E363-E365

Clarke, J. 2020: MIS-C clinical guidance released amid race to define the condition. Nature Reviews. Rheumatology 16(10): 538

İpek, S.; Güllü, U.U.; Yurttutan, S.ık.; Güngör, Şük.ü; Yurttutan, N. 2021: MIS-C with diarrhea complaint and acute kidney injury: a pediatric COVID-19 patient. Progress in Pediatric Cardiology 63: 101436

Mosquera Fernández, P.; García García, S.; Epalza, C.; Blázquez-Gamero, D.; Carrasco, J.; Fernandez-Cook, E.; Prieto-Tato, L.; Torres, D.; Villaverde, S.; Belda, S.; Toral-Vázquez, B.én.; Moraleda, C. 2021: MIS-C, can Latency Interval Help in Diagnosis?. Pediatric Infectious Disease Journal 40(7): E281-E282

Leonova, O.N.; Cherepanov, E.A.; Krutko, A.V. 2021: MIS-TLIF versus O-TLIF for single-level degenerative stenosis: study protocol for randomised controlled trial. Bmj Open 11(3): E041134

Iqbal, S.; Hoksza, D.; Pérez-Palma, E.; May, P.; Jespersen, J.B.; Ahmed, S.S.; Rifat, Z.T.; Heyne, H.O.; Rahman, M.S.; Cottrell, J.R.; Wagner, F.F.; Daly, M.J.; Campbell, A.J.; Lal, D. 2020: MISCAST: MIssense variant to protein StruCture Analysis web SuiTe. Nucleic Acids Research 48(W1): W132-W139

Vodicska, B.; Cerikan, B.; Schiebel, E.; Hoffmann, I. 2018: MISP regulates the IQGAP1/Cdc42 complex to collectively orchestrate spindle orientation and mitotic progression. Scientific Reports 8(1): 6330

Balakrishnan, J.M.; Kunju, S.A.; Wilson, W.; Sujir, S.N.; Bhat, R.; Vandana, K.E. 2020: MIST (Modified Intubating Sequence for Transmissibility) Bundle for Infectious Diseases with Aerosol Hazard. Western Journal of Emergency Medicine 21(5): 1076-1079

Chalfoun, J.; Majurski, M.; Blattner, T.; Bhadriraju, K.; Keyrouz, W.; Bajcsy, P.; Brady, M. 2017: MIST: Accurate and Scalable Microscopy Image Stitching Tool with Stage Modeling and Error Minimization. Scientific Reports 7(1): 4988

Alves, N.Silva.; Astrinidis, S.Adina.; Eisenhardt, N.; Sieverding, C.; Redolfi, J.; Lorenz, M.; Weberruss, M.; Moreno-Andrés, D.; Antonin, W. 2017: MISTIC-fusion proteins as antigens for high quality membrane protein antibodies. Scientific Reports 7: 41519

Chennen, K.; Weber, T.; Lornage, X.èr.; Kress, A.; Böhm, J.; Thompson, J.; Laporte, J.; Poch, O. 2020: MISTIC: a prediction tool to reveal disease-relevant deleterious missense variants. Plos one 15(7): E0236962

Müller, D.; Kramer, F. 2021: MIScnn: a framework for medical image segmentation with convolutional neural networks and deep learning. Bmc Medical Imaging 21(1): 12

Luo, E.M.; Newman, S.; Amat, M.; Charpignon, M.-L.; Duralde, E.R.; Jain, S.; Kaufman, A.R.; Korolev, I.; Lai, Y.; Lam, B.D.; Lipcsey, M.; Martinez, A.; Mechanic, O.J.; Mlabasati, J.; McCoy, L.G.; Nguyen, F.T.; Samuel, M.; Yang, E.; Celi, L.A. 2021: MIT COVID-19 Datathon: data without boundaries. Bmj Innovations 7(1): 231-234

Butler, D. 2002: MIT gets plugged in for global data archive. Nature 419(6910): 869

Tollefson, J. 2018: MIT launches multimillion-dollar collaboration to develop fusion energy. Nature 555(7696): 294-295

Tollefson, J. 2018: MIT launches multimillion-dollar collaboration to develop fusion energy. Nature 555(7696): 294-295

Nadis, S. 1995: MIT links biologists to engineers. Nature 374(6522): 486

Nadis, S. 1999: MIT promises us the sensitive computer... Nature 401(6756): 836

Khamsi, R. 2005: MIT wraps up Dublin lab following funding failure. Nature 433(7024): 345

Li, W.; Feng, Y.; Chen, H.; He, C.; Mei, L.; Liu, X.Z.; Men, M. 2020: MITF Is Mutated in Type 1 Waardenburg Syndrome with Unusual Phenotype. Otology and Neurotology: Official Publication of the American Otological Society American Neurotology Society and European Academy of Otology and Neurotology 41(10): E1250-E1255

Ji, Z.; Erin Chen, Y.; Kumar, R.; Taylor, M.; Jenny Njauw, C-Ni.; Miao, B.; Frederick, D.T.; Wargo, J.A.; Flaherty, K.T.; Jönsson, Göran.; Tsao, H. 2015: MITF Modulates Therapeutic Resistance through EGFR Signaling. Journal of Investigative Dermatology 135(7): 1863-1872

Ballesteros-Álvarez, J.é; Dilshat, R.; Fock, V.; Möller, K.ín.; Karl, L.; Larue, L.; Ögmundsdóttir, M.ét.H.; Steingrímsson, E.ík. 2020: MITF and TFEB cross-regulation in melanoma cells. Plos one 15(9): E0238546

Riesenberg, S.; Groetchen, A.; Siddaway, R.; Bald, T.; Reinhardt, J.; Smorra, D.; Kohlmeyer, J.; Renn, M.; Phung, B.; Aymans, P.; Schmidt, T.; Hornung, V.; Davidson, I.; Goding, C.R.; Jönsson, Göran.; Landsberg, J.; Tüting, T.; Hölzel, M. 2015: MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. Nature Communications 6: 8755

Möller, K.; Sigurbjornsdottir, S.; Arnthorsson, A.O.; Pogenberg, V.; Dilshat, R.; Fock, V.; Brynjolfsdottir, S.H.; Bindesboll, C.; Bessadottir, M.; Ogmundsdottir, H.M.; Simonsen, A.; Larue, L.; Wilmanns, M.; Thorsson, V.; Steingrimsson, E.; Ogmundsdottir, M.H. 2019: MITF has a central role in regulating starvation-induced autophagy in melanoma. Scientific Reports 9(1): 1055

Sánchez-Del-Campo, L.; Martí-Díaz, R.án.; Montenegro, M.ía.F.; González-Guerrero, R.; Hernández-Caselles, T.; Martínez-Barba, E.; Piñero-Madrona, A.; Cabezas-Herrera, J.; Goding, C.R.; Rodríguez-López, J.é N. 2021: MITF induces escape from innate immunity in melanoma. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 117

Yu, R.; Liu, L.; Li, Y.-L.; Fan, L.-L. 2021: MITF p.Arg217Thr Variant Identified in a Han Chinese Family with Tietz/Waardenburg Syndrome. Biomed Research International 2021: 4381272

Thongpradit, S.; Jinawath, N.; Javed, A.; Noojarern, S.; Khongkraparn, A.; Tim-Aroon, T.; Lertsukprasert, K.; Suktitipat, B.; Jensen, L.T.; Wattanasirichaigoon, D. 2020: MITF variants cause nonsyndromic sensorineural hearing loss with autosomal recessive inheritance. Scientific Reports 10(1): 12712

Yi, X.; Zhao, G.; Zhang, H.; Guan, D.; Meng, R.; Zhang, Y.; Yang, Q.; Jia, H.; Dou, K.; Liu, C.; Que, F.; Yin, J.Q. 2011: MITF-siRNA formulation is a safe and effective therapy for human melasma. Molecular Therapy: the Journal of the American Society of Gene Therapy 19(2): 362-371

Swinbanks, D. 1995: MITI drops headlights for gene sequencing. Nature 374(6523): 583

Swinbanks, D. 1991: MITI reveals 1992 budget. Nature 352(6338): 748

Barker, S. 1996: MITI turns up heat on research into thermophile genes. Nature 381(6582): 455

Emmons, D.L.; Mazzuchi, T.A.; Sarkani, S.; Larsen, C.E. 2018: Mitigating Cognitive Biases in Risk Identification: Practitioner Checklist for the Aerospace Sector. Defense Acquisition Research Journal 25(1): 52-93

de Latouliere, L.; Manni, I.; Ferrari, L.; Pisati, F.; Totaro, M.Grazia.; Gurtner, A.; Marra, E.; Pacello, L.; Pozzoli, O.; Aurisicchio, L.; Capogrossi, M.C.; Deflorian, G.; Piaggio, G. 2021: MITO-Luc/GFP zebrafish model to assess spatial and temporal evolution of cell proliferation in vivo. Scientific Reports 11(1): 671

Dona, M.; Neijman, K.; Timmers, H.J.L.M. 2021: MITOCHONDRIA: Succinate dehydrogenase subunit B-associated phaeochromocytoma and paraganglioma. International Journal of Biochemistry and Cell Biology 134: 105949

Strutynska, N.A.; Kotsiuruba, A.V.; Budko, A.Yu.; Mys, L.A.; Sagach, V.F. 2016: Mitochondrial Dysfunction in the Aging Heart Is Accompanied by Constitutive No-Synthases Uncoupling on the Background of Oxidative and Nitrosative Stress. Fiziolohichnyi Zhurnal 62(2): 3-11

Pagliarone, A.C.; Castañeda, E.D.; Santana, J.P.P.; de Oliveira, C.A.B.; Robeldo, T.A.; Teixeira, F.R.; Borra, R.C. 2021: Mitochondrial heat shock protein mortalin as potential target for therapies based on oxidative stress. Photodiagnosis and Photodynamic Therapy 34: 102256

Shiiba, I.; Takeda, K.; Nagashima, S.; Ito, N.; Tokuyama, T.; Yamashita, S.-I.; Kanki, T.; Komatsu, T.; Urano, Y.; Fujikawa, Y.; Inatome, R.; Yanagi, S. 2021: MITOL promotes cell survival by degrading Parkin during mitophagy. Embo Reports 22(3): E49097

Hussain, M.; Mohammed, A.; Saifi, S.; Khan, A.; Kaur, E.; Priya, S.; Agarwal, H.; Sengupta, S. 2021: MITOL-dependent ubiquitylation negatively regulates the entry of PolγA into mitochondria. Plos Biology 19(3): E3001139

Vecchione, A.; Fassan, M.; Anesti, V.; Morrione, A.; Goldoni, S.; Baldassarre, G.; Byrne, D.; D'Arca, D.; Palazzo, J.P.; Lloyd, J.; Scorrano, L.; Gomella, L.G.; Iozzo, R.V.; Baffa, R. 2009: MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer. Oncogene 28(2): 257-269

Freixataxonera, E.; Gonzalexruiz, J.; Tornersoler, M.; Dexeusfont, S. 1964: Mitral Commissurotomy during Pregnancy. Revista Espanola de Cardiologia 17: 544-550

Byass, P. 2020: MITS: an interim step towards improved cause of death data. LANCET. Global Health 8(7): E865-E866

Zhang, P.; Kang, J-Yan.; Gou, L-Tao.; Wang, J.; Xue, Y.; Skogerboe, G.; Dai, P.; Huang, D-Wei.; Chen, R.; Fu, X-Dong.; Liu, M-Fang.; He, S. 2015: MIWI and piRNA-mediated cleavage of messenger RNAs in mouse testes. Cell Research 25(2): 193-207

Wang, J.; Dai, X.; Luo, H.; Yan, C.; Zhang, G.; Luo, J. 2021: MI_DenseNetCAM: a Novel Pan-Cancer Classification and Prediction Method Based on Mutual Information and Deep Learning Model. Frontiers in Genetics 12: 670232

Zaytseva, O.O.; Jansen, B.C.; Hanić, M.; Mrčela, M.; Razdorov, G.; Stojković, R.; Erhardt, J.; Brizić, I.; Jonjić, S.; Pezer, M.; Lauc, G. 2018: MIgGGly (mouse IgG glycosylation analysis) - a high-throughput method for studying Fc-linked IgG N-glycosylation in mice with nanoUPLC-ESI-MS. Scientific Reports 8(1): 13688

Glass, E.M.; Dribinsky, Y.; Yilmaz, P.; Levin, H.; Van Pelt, R.; Wendel, D.; Wilke, A.; Eisen, J.A.; Huse, S.; Shipanova, A.; Sogin, M.; Stajich, J.; Knight, R.; Meyer, F.; Schriml, L.M. 2014: MIxS-BE: a MIxS extension defining a minimum information standard for sequence data from the built environment. Isme Journal 8(1): 1-3

Stec, B.; Yang, H.; Johnson, K.A.; Chen, L.; Roberts, M.F. 2000: MJ0109 is an enzyme that is both an inositol monophosphatase and the 'missing' archaeal fructose-1,6-bisphosphatase. Nature Structural Biology 7(11): 1046-1050

Pocock, I. 2007: MJDF and the modern dental career. British Dental Journal 203(5 Suppl): 5-6

Giles, F.J.; Swords, R.T.; Nagler, A.; Hochhaus, A.; Ottmann, O.G.; Rizzieri, D.A.; Talpaz, M.; Clark, J.; Watson, P.; Xiao, A.; Zhao, B.; Bergstrom, D.; Le Coutre, P.D.; Freedman, S.J.; Cortes, J.E. 2013: MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia. Leukemia 27(1): 113-117

Apgar, J.M.; Wilkening, R.R.; Parker, D.L.; Meng, D.; Wildonger, K.J.; Sperbeck, D.; Greenlee, M.L.; Balkovec, J.M.; Flattery, A.M.; Abruzzo, G.K.; Galgoci, A.M.; Giacobbe, R.A.; Gill, C.J.; Hsu, M.-J.; Liberator, P.; Misura, A.S.; Motyl, M.; Kahn, J.N.; Powles, M.; Racine, F.; Dragovic, J.; Fan, W.; Kirwan, R.; Lee, S.; Liu, H.; Mamai, A.; Nelson, K.; Peel, M. 2020: MK-5204: An orally active β-1,3-glucan synthesis inhibitor. Bioorganic and Medicinal Chemistry Letters 30(17): 127357

Lin, B.; Dietrich, W.D.; Ginsberg, M.D.; Globus, M.Y.; Busto, R. 1993: MK-801 (dizocilpine) protects the brain from repeated normothermic global ischemic insults in the rat. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 13(6): 925-932

Flores-Barrera, E.; Thomases, D.R.; Tseng, K.Y. 2020: MK-801 Exposure during Adolescence Elicits Enduring Disruption of Prefrontal E-i Balance and its Control of Fear Extinction Behavior. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 40(25): 4881-4887

Meyer, F.B.; Anderson, R.E.; Friedrich, P.F. 1990: MK-801 attenuates capillary bed compression and hypoperfusion following incomplete focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 10(6): 895-902

Fleischer, J.E.; Tateishi, A.; Drummond, J.C.; Scheller, M.S.; Grafe, M.R.; Zornow, M.H.; Shearman, G.T.; Shapiro, H.M. 1989: MK-801, an excitatory amino acid antagonist, does not improve neurologic outcome following cardiac arrest in cats. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 9(6): 795-804

Saoud, H.; Kereselidze, E.; Eybrard, S.év.; Louilot, A. 2021: MK-801-induced behavioral and dopaminergic responses in the shell part of the nucleus accumbens in adult male rats are disrupted after neonatal blockade of the ventral subiculum. Neurochemistry International 150: 105195

Wang, X.; Li, W.; Marcus, J.; Pearson, M.; Song, L.; Smith, K.; Terracina, G.; Lee, J.; Hong, K.-L.K.; Lu, S.X.; Hyde, L.; Chen, S.-C.; Kinsley, D.; Melchor, J.P.; Rubins, D.J.; Meng, X.; Hostetler, E.; Sur, C.; Zhang, L.; Schachter, J.B.; Hess, J.F.; Selnick, H.G.; Vocadlo, D.J.; McEachern, E.J.; Uslaner, J.M.; Duffy, J.L.; Smith, S.M. 2020: MK-8719, a Novel and Selective O-GlcNAcase Inhibitor that Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy. Journal of Pharmacology and Experimental Therapeutics 374(2): 252-263

Zhang, F.; Cho, K.I.K.; Tang, Y.; Zhang, T.; Kelly, S.; Biase, M.D.; Xu, L.; Li, H.; Matcheri, K.; Whitfield-Gabrieli, S.; Niznikiewicz, M.; Stone, W.S.; Wang, J.; Shenton, M.E.; Pasternak, O. 2021: MK-Curve improves sensitivity to identify white matter alterations in clinical high risk for psychosis. Neuroimage 226: 117564

Zhang, T.; Jiang, J.; Liu, J.; Xu, L.; Duan, S.; Sun, L.; Zhao, W.; Qian, F. 2020: MK2 Is Required for Neutrophil-Derived ROS Production and Inflammatory Bowel Disease. Frontiers in Medicine 7: 207

Oberst, A. 2017: MK2 balances inflammation and cell death. Nature Cell Biology 19(10): 1150-1152

Chen, Y.; Yang, W.; Zhang, X.; Yang, S.; Peng, G.; Wu, T.; Zhou, Y.; Huang, C.; Reinach, P.S.; Li, W.; Liu, Z. 2016: MK2 inhibitor reduces alkali burn-induced inflammation in rat cornea. Scientific Reports 6: 28145

Dondelinger, Y.; Delanghe, T.; Rojas-Rivera, D.; Priem, D.; Delvaeye, T.; Bruggeman, I.; Van Herreweghe, F.; Vandenabeele, P.; Bertrand, M.J.M. 2017: MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nature Cell Biology 19(10): 1237-1247

Dondelinger, Y.; Delanghe, T.; Bertrand, M.M.J. 2018: MK2 puts an additional brake on RIPK1 cytotoxic potential. Cell Death and Differentiation 25(3): 457-459

Fyhrquist, N.; Matikainen, S.; Lauerma, A. 2010: MK2 signaling: lessons on tissue specificity in modulation of inflammation. Journal of Investigative Dermatology 130(2): 342-344

Ruiz, M.; Khairallah, M.; Dingar, D.; Vaniotis, G.; Khairallah, R.J.; Lauzier, B.; Thibault, S.; Trépanier, J.ël.; Shi, Y.; Douillette, A.; Hussein, B.; Nawaito, S.A.; Sahadevan, P.; Nguyen, A.; Sahmi, F.; Gillis, M.-A.; Sirois, M.G.; Gaestel, M.; Stanley, W.C.; Fiset, C.él.; Tardif, J.-C.; Allen, B.G. 2021: MK2-Deficient Mice Are Bradycardic and Display Delayed Hypertrophic Remodeling in Response to a Chronic Increase in Afterload. Journal of the American Heart Association 10(4): E017791

Guo, G.; Tang, J.; Shi, M.; Yang, C.; Ou, H.; Chen, W. 2021: MK212, a 5-hydroxytryptamine 2C receptor agonist, reverses prepulse inhibition deficits in the medial prefrontal cortex and ventral hippocampus. ProgressinNeuro-PsychopharmacologyandBiologicalPsychiatry 2021: 110441

Sun, D.; Wang, J.; Zhang, H.; Liu, S.; Wei, P.; Wang, H.; Xu, Z.; Fu, Q.; Zhang, K. 2020: MK2206 Enhances Cisplatin-Induced Cytotoxicity and Apoptosis in Testicular Cancer Through Akt Signaling Pathway Inhibition. Translational Oncology 13(7): 100769

Xiang, R-Fang.; Wang, Y.; Zhang, N.; Xu, W-Bin.; Cao, Y.; Tong, J.; Li, J-Min.; Wu, Y-Li.; Yan, H. 2017: MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway. Cell Death and Disease 8(5): E2776

Nishi, K.; Tsunoda, T.; Uchida, Y.; Sueta, T.; Sawatsubashi, M.; Yamano, T.; Hashiguchi, Y.; Swain, A.; Shirasawa, S.; Sakata, T. 2020: MK615 Suppresses Hypoxia Tolerance by Up-regulation of E-cadherin in Colorectal Cancer Cells with Mutant KRAS. Anticancer Research 40(8): 4687-4694

McDougall, S.A.; Apodaca, M.G.; Park, G.I.; Teran, A.; Baum, T.J.; Montejano, N.R. 2020: MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems. Psychopharmacology 237(8): 2469-2483

Wang, C.; Huang, B.; Sun, L.; Wang, X.; Zhou, B.; Tang, H.; Geng, W. 2021: MK8722, an AMPK activator, inhibiting carcinoma proliferation, invasion and migration in human pancreatic cancer cells. Biomedicine and PharmacoTherapy 144: 112325

Kim, A-Young.; Yoon, Y.Na.; Leem, J.; Lee, J-Young.; Jung, K-Young.; Kang, M.; Ahn, J.; Hwang, S-Gu.; Oh, J.Su.; Kim, J-Sung. 2020: MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast Cancer. Frontiers in Oncology 10: 571601

Depeille, P.E.; Ding, Y.; Bromberg-White, J.L.; Duesbery, N.S. 2007: MKK signaling and vascularization. Oncogene 26(9): 1290-1296

Sun, Y.; Zhang, D.; Guo, X.; Li, W.; Li, C.; Luo, J.; Zhou, M.; Xue, L. 2019: MKK3 modulates JNK-dependent cell migration and invasion. Cell Death and Disease 10(3): 149

Fukuda, K.; Tesch, G.H.; Yap, F.Y.; Forbes, J.M.; Flavell, R.A.; Davis, R.J.; Nikolic-Paterson, D.J. 2008: MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin model. Laboratory Investigation; a Journal of Technical Methods and Pathology 88(4): 398-407

Stramucci, L.; Pranteda, A.; Stravato, A.; Amoreo, C.Azzurra.; Pennetti, A.; Diodoro, M.Grazia.; Bartolazzi, A.; Milella, M.; Bossi, G. 2019: MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer. Cell Death and Disease 10(11): 842

Matesanz, N.; Bernardo, E.; Acín-Pérez, R.; Manieri, E.; Pérez-Sieira, S.; Hernández-Cosido, L.; Montalvo-Romeral, V.; Mora, A.; Rodríguez, E.; Leiva-Vega, L.; Lechuga-Vieco, A.Victoria.; Ruiz-Cabello, Jús.; Torres, J.L.; Crespo-Ruiz, M.; Centeno, F.; Álvarez, C.V.; Marcos, M.; Enríquez, J.Antonio.; Nogueiras, R.; Sabio, G. 2017: MKK6 controls T3-mediated browning of white adipose tissue. Nature Communications 8(1): 856

Wada, T.; Joza, N.; Cheng, H-ying.M.; Sasaki, T.; Kozieradzki, I.; Bachmaier, K.; Katada, T.; Schreiber, M.; Wagner, E.F.; Nishina, H.; Penninger, J.M. 2004: MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence. Nature Cell Biology 6(3): 215-226

Xiang, Y.; Wang, J.; Li, J.P.; Guo, W.; Huang, F.; Zhang, H.M.; Li, H.H.; Dai, Z.T.; Zhang, Z.J.; Li, H.; Bao, L.Y.; Gu, C.J.; Chen, K.; Zhang, T.C.; Liao, X.H. 2020: MKL-1 is a coactivator for STAT5b, the regulator of Treg cell development and function. Cell Communication and Signaling: Ccs 18(1): 107

Wani, N.; Raza, K. 2021: MKL-GRNI: a parallel multiple kernel learning approach for supervised inference of large-scale gene regulatory networks. PEERJ. Computer Science 7: E363

Chen, B.; Yuan, Y.; Sun, L.; Chen, J.; Yang, M.; Yin, Y.; Xu, Y. 2020: MKL1 Mediates TGF-β Induced RhoJ Transcription to Promote Breast Cancer Cell Migration and Invasion. Frontiers in Cell and Developmental Biology 8: 832

Gao, P.; Gao, P.; Zhao, J.; Shan, S.; Luo, W.; Slivano, O.J.; Zhang, W.; Tabuchi, A.; LeMaire, S.A.; Maegdefessel, L.; Shen, Y.H.; Miano, J.M.; Singer, H.A.; Long, X. 2021: MKL1 cooperates with p38MAPK to promote vascular senescence, inflammation, and abdominal aortic aneurysm. Redox Biology 41: 101903

Cheng, X.; Yang, Y.; Fan, Z.; Yu, L.; Bai, H.; Zhou, B.; Wu, X.; Xu, H.; Fang, M.; Shen, A.; Chen, Q.; Xu, Y. 2015: MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription. Oncogene 34(44): 5570-5581

Li, Z.; Chen, B.; Dong, W.; Kong, M.; Fan, Z.; Yu, L.; Wu, D.; Lu, J.; Xu, Y. 2019: MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription. Cell Death and Disease 10(12): 899

Fan, H.; Yuan, J.; Li, Y.; Jia, Y.; Li, J.; Wang, X.; Li, X. 2021: MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axis. Cell Death and Disease 12(1): 128

Zhang, H-Min.; Li, H.; Wang, G-Xin.; Wang, J.; Xiang, Y.; Huang, Y.; Shen, C.; Dai, Z-Tong.; Li, J-Peng.; Zhang, T-Cun.; Liao, X-Hua. 2020: MKL1/miR-5100/CAAP1 loop regulates autophagy and apoptosis in gastric cancer cells. Neoplasia 22(5): 220-230

Adriaans, I.E.; Hooikaas, P.J.; Aher, A.; Vromans, M.J.M.; van Es, R.M.; Grigoriev, I.; Akhmanova, A.; Lens, S.M.A. 2020: MKLP2 Is a Motile Kinesin that Transports the Chromosomal Passenger Complex during Anaphase. Current Biology: Cb 30(13): 2628-2637.E9

Astanehe, A.; Finkbeiner, M.R.; Krzywinski, M.; Fotovati, A.; Dhillon, J.; Berquin, I.M.; Mills, G.B.; Marra, M.A.; Dunn, S.E. 2012: MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition. Oncogene 31(41): 4434-4446

Wang, J.; Da, C.; Su, Y.; Song, R.; Bai, Z. 2021: MKNK2 enhances chemoresistance of ovarian cancer by suppressing autophagy via miR-125b. Biochemical and Biophysical Research Communications 556: 31-38

Bauerfeld, C.; Talwar, H.; Zhang, K.; Liu, Y.; Samavati, L. 2020: MKP-1 Modulates Mitochondrial Transcription Factors, Oxidative Phosphorylation, and Glycolysis. Immunohorizons 4(5): 245-258

Hou, X.; Li, L.; Chen, S.; Ge, C.; Shen, M.; Fu, Z. 2021: MKP-1 Overexpression Reduces Postischemic Myocardial Damage through Attenuation of ER Stress and Mitochondrial Damage. Oxidative Medicine and Cellular Longevity 2021: 8905578

Rininger, A.; Dejesus, C.; Totten, A.; Wayland, A.; Halterman, M.W. 2012: MKP-1 antagonizes C/EBPβ activity and lowers the apoptotic threshold after ischemic injury. Cell Death and Differentiation 19(10): 1634-1643

Li, Z.; Zhang, L.; Liu, F.-Y.; Li, P.; He, J.; Kirkwood, C.L.; Sohn, J.; Chan, J.M.; Magner, W.J.; Kirkwood, K.L. 2021: MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension. Oral Oncology 120: 105401

Pan, Y.; Xu, C.; Pan, Z.K. 2017: MKP-1 negative regulates Staphylococcus aureus induced inflammatory responses in Raw264.7 cells: roles of PKA-MKP-1 pathway and enhanced by rolipram. Scientific Reports 7(1): 12366

Lei, S.; Xu, H.; Chen, N.; Pan, H.; Xie, W.; He, Y.; Jin, J. 2020: MKP-1 overexpression is associated with chemoresistance in bladder cancer via the MAPK pathway. Oncology Letters 20(2): 1743-1751

Du, Y.; Du, Y.; Zhang, Y.; Huang, Z.; Fu, M.; Li, J.; Pang, Y.; Lei, P.; Wang, Y.Tian.; Song, W.; He, G.; Dong, Z. 2019: MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer's disease models. Signal Transduction and Targeted Therapy 4: 58

Du, Y.; Du, Y.; Zhang, Y.; Huang, Z.; Fu, M.; Li, J.; Pang, Y.; Lei, P.; Wang, Y.Tian.; Song, W.; He, G.; Dong, Z. 2019: MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer's disease models. Signal Transduction and Targeted Therapy 4(1): 58

Wang, J.; Kho, D.H.; Zhou, J-Y.; Davis, R.J.; Wu, G.S. 2017: MKP-1 suppresses PARP-1 degradation to mediate cisplatin resistance. Oncogene 36(43): 5939-5947

Unenkhuu, B.; Kim, D.Bin.; Kim, H.Seok. 2021: MKP-3 suppresses LPS-induced inflammatory responses in HUVECs via inhibition of p38 MAPK/NF-κB pathway. Animal Cells and Systems 25(4): 235-244

Chattopadhyay, S.; Machado-Pinilla, R.; Manguan-García, C.; Belda-Iniesta, C.; Moratilla, C.; Cejas, P.; Fresno-Vara, J.A.; de Castro-Carpeño, J.; Casado, E.; Nistal, M.; Gonzalez-Barón, M.; Perona, R. 2006: MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. Oncogene 25(23): 3335-3345

Kawakami, Y.; Rodríguez-León, Jín.; Koth, C.M.; Büscher, D.; Itoh, T.; Raya, A.; Ng, J.K.; Esteban, Cón.Rodríguez.; Takahashi, S.; Henrique, D.; Schwarz, M-Fun.; Asahara, H.; Izpisúa Belmonte, J.Carlos. 2003: MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nature Cell Biology 5(6): 513-519

Bai, X.; Yang, H.; Pu, J.; Zhao, Y.; Jin, Y.; Yu, Q. 2021: MKRN1 Ubiquitylates p21 to Protect against Intermittent Hypoxia-Induced Myocardial Apoptosis. Oxidative Medicine and Cellular Longevity 2021: 9360339

Wolf, E.J.; Miles, A.; Lee, E.S.; Nabeel-Shah, S.; Greenblatt, J.F.; Palazzo, A.F.; Tropepe, V.; Emili, A. 2020: MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. Cell Reports 31(8): 107693

Shin, C.; Ito, Y.; Ichikawa, S.; Tokunaga, M.; Sakata-Sogawa, K.; Tanaka, T. 2017: MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses. Scientific Reports 7: 46097

Abreu, A.P.; Toro, C.A.; Song, Y.B.; Navarro, V.M.; Bosch, M.A.; Eren, A.; Liang, J.N.; Carroll, R.S.; Latronico, A.C.; Rønnekleiv, O.K.; Aylwin, C.F.; Lomniczi, A.; Ojeda, S.; Kaiser, U.B. 2020: MKRN3 inhibits the reproductive axis through actions in kisspeptin-expressing neurons. Journal of Clinical Investigation 130(8): 4486-4500

Li, C.; Lu, W.; Yang, L.; Li, Z.; Zhou, X.; Guo, R.; Wang, J.; Wu, Z.; Dong, Z.; Ning, G.; Shi, Y.; Gu, Y.; Chen, P.; Hao, Z.; Han, T.; Yang, M.; Wang, W.; Huang, X.; Li, Y.; Gao, S.; Hu, R. 2020: MKRN3 regulates the epigenetic switch of mammalian puberty via ubiquitination of MBD3. National Science Review 7(3): 671-685

Kyttälä, M.; Tallila, J.; Salonen, R.; Kopra, O.; Kohlschmidt, N.; Paavola-Sakki, P.; Peltonen, L.; Kestilä, M. 2006: MKS1, encoding a component of the flagellar apparatus basal body proteome, is mutated in Meckel syndrome. Nature Genetics 38(2): 155-157

Karabulut, O.C.; Karpuzcu, B.ül.A.; Türk, E.; Ibrahim, A.H.; Süzek, B.ış E. 2021: ML-AdVInfect: a Machine-Learning Based Adenoviral Infection Predictor. Frontiers in Molecular Biosciences 8: 647424

Yang, Z.; Zhong, W.; Zhao, L.; Chen, C.Y.-C. 2021: ML-DTI: Mutual Learning Mechanism for Interpretable Drug-Target Interaction Prediction. Journal of Physical Chemistry Letters 12(17): 4247-4261

Xia, Z.; Ren, Y.; Li, S.; Xu, J.; Wu, Y.; Cao, Z. 2021: ML-SA1 and SN-2 inhibit endocytosed viruses through regulating TRPML channel expression and activity. Antiviral Research 195: 105193

Xia, Z.; Wang, L.; Li, S.; Tang, W.; Sun, F.; Wu, Y.; Miao, L.; Cao, Z. 2020: ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity. Antiviral Research 182: 104922

Christensen, C.N.; Ward, E.N.; Lu, M.; Lio, P.; Kaminski, C.F. 2021: ML-SIM: universal reconstruction of structured illumination microscopy images using transfer learning. Biomedical Optics Express 12(5): 2720-2733

Kocan, M.; Sarwar, M.; Ang, S.Y.; Xiao, J.; Marugan, J.J.; Hossain, M.A.; Wang, C.; Hutchinson, D.S.; Samuel, C.S.; Agoulnik, A.I.; Bathgate, R.A.D.; Summers, R.J. 2017: ML290 is a biased allosteric agonist at the relaxin receptor RXFP1. Scientific Reports 7(1): 2968

Lei, B.; Qian, L.; Zhang, Y.; Chen, Y.; Gao, M.; Shah, W.; Cao, X.; Zhang, P.; Zhao, W.; Liu, J.; Wang, J.; Ma, X.; Yang, Y.; Meng, X.; Cai, F.; Xu, Y.; Luo, J.; Wang, B.; Zhang, Y.; He, A.; Zhang, W. 2020: MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia. Journal of Cancer 11(23): 6768-6781

Zhang, J.; Liang, D.; Liu, A.; Gao, M.; Chen, X.; Zhang, X.; Chen, X. 2021: MLBF-Net: a Multi-Lead-Branch Fusion Network for Multi-Class Arrhythmia Classification Using 12-Lead ECG. IEEE Journal of Translational Engineering in Health and Medicine 9: 1900211

Booth, J.; Caillet, V.; Briggs, A.; Hardcastle, N.; Angelis, G.; Jayamanne, D.; Shepherd, M.; Podreka, A.; Szymura, K.; Nguyen, D.T.; Poulsen, P.; O'Brien, R.; Harris, B.; Haddad, C.; Eade, T.; Keall, P. 2021: MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 155: 131-137

Shimada, S.; Shimojima, K.; Masuda, T.; Nakayama, Y.; Kohji, T.; Tsukamoto, H.; Matsubasa, T.; Oka, A.; Yamamoto, T. 2014: MLC1 mutations in Japanese patients with megalencephalic leukoencephalopathy with subcortical cysts. Human Genome Variation 1: 14019

Wang, X.-R.; Du, H.-B.; Wang, H.-H.; Zhang, L.-M.; Si, Y.-H.; Zhang, H.; Zhao, Z.-G. 2021: Mesenteric Lymph Drainage Improves Cardiac Papillary Contractility and Calcium Sensitivity in Rats with Hemorrhagic Shock. Journal of Surgical Research 266: 245-253

Song, X.; Li, W.; Zhou, D.; Dai, Y.; Fang, J.; Li, H.; Zhang, L. 2021: MLDA-Net: Multi-Level Dual Attention-Based Network for Self-Supervised Monocular Depth Estimation. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 30: 4691-4705

Nikolenko, J.V.; Kurshakova, M.M.; Krasnov, A.N.; Georgieva, S.G. 2021: MLE Helicase Is a new Participant in the Transcription Regulation of the ftz-f1 Gene Encoding Nuclear Receptor in Higher Eukaryotes. DOKLADY. Biochemistry and Biophysics 496(1): 1-4

Scarpa, M.; Ruffolo, C.; Kotsafti, A.; Canal, F.; Erroi, F.; Basato, S.; DallAgnese, L.; Fiorot, A.; Pozza, A.; Brun, P.; Bassi, N.; Dei Tos, A.; Castoro, C.; Castagliuolo, I.; Scarpa, M. 2021: MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer. Frontiers in Molecular Biosciences 8: 624873

Han, Y.; Peng, Y.; Fu, Y.; Cai, C.; Guo, C.; Liu, S.; Li, Y.; Chen, Y.; Shen, E.; Long, K.; Wang, X.; Yu, J.; Shen, H.; Zeng, S. 2020: MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT Signaling. Advanced Science 7(13): 2000112

O'Konek, J.J.; Boucher, P.D.; Iacco, A.A.; Wilson, T.E.; Shewach, D.S. 2009: MLH1 deficiency enhances tumor cell sensitivity to ganciclovir. Cancer Gene Therapy 16(9): 683-692

Rashid, S.; Freitas, M.O.; Cucchi, D.; Bridge, G.; Yao, Z.; Gay, L.; Williams, M.; Wang, J.; Suraweera, N.; Silver, A.; McDonald, S.A.C.; Chelala, C.; Szabadkai, G.; Martin, S.A. 2019: MLH1 deficiency leads to deregulated mitochondrial metabolism. Cell Death and Disease 10(11): 795

Ding, X.; Mohd, A.B.; Huang, Z.; Baba, T.; Bernardini, M.Q.; Lyerly, H.K.; Berchuck, A.; Murphy, S.K.; Buermeyer, A.B.; Devi, G.R. 2009: MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition. British Journal of Cancer 101(2): 269-277

Del Priore, L.ía.; Pigozzi, M.ía.I.és. 2020: MLH1 focus mapping in the guinea fowl (Numida meleagris) give insights into the crossover landscapes in birds. Plos one 15(10): E0240245

McDaid, J.R.; Loughery, J.; Dunne, P.; Boyer, J.C.; Downes, C.S.; Farber, R.A.; Walsh, C.P. 2009: MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea. British Journal of Cancer 101(3): 441-451

Pineda, M.; Mur, P.; Iniesta, Mía.Dolores.; Borràs, E.; Campos, O.; Vargas, G.; Iglesias, Sílvia.; Fernández, A.; Gruber, S.B.; Lázaro, C.; Brunet, J.; Navarro, M.; Blanco, I.; Capellá, G. 2012: MLH1 methylation screening is effective in identifying epimutation carriers. European Journal of Human Genetics: Ejhg 20(12): 1256-1264

Gausachs, M.; Mur, P.; Corral, J.; Pineda, M.; González, S.; Benito, Lúcia.; Menéndez, M.; Espinàs, J.Alfons.; Brunet, J.; Iniesta, Mía.Dolores.; Gruber, S.B.; Lázaro, C.; Blanco, I.; Capellá, G. 2012: MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study. European Journal of Human Genetics: Ejhg 20(7): 762-768

Esteller, M.; Levine, R.; Baylin, S.B.; Ellenson, L.H.; Herman, J.G. 1998: MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 17(18): 2413-2417

Kim, S.Sun.; Eun, J.Woo.; Choi, J-Hye.; Woo, H.Goo.; Cho, H.Jung.; Ahn, H.Ri.; Suh, C.Won.; Baek, G.Ok.; Cho, S.Won.; Cheong, J.Youn. 2020: MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma. Scientific Reports 10(1): 17862

Donís, S.P.ñe.; González, A.P.ér.; Alves, M.G.O.; do Carmo Carvalho, B.F.; Ferreira, C.C.P.; Almeida, J.D.; Iruegas, E.P.ín.; Petronacci, C.M.C.; Peñaranda, J.é M.S.ár.; Sayáns, M.P.ér. 2021: MLH1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma. Applied Immunohistochemistry and Molecular Morphology: Aimm 29(8): 613-618

Fu, Y.; Li, Z.; Gao, F.; Yang, J.; Wu, H.; Zhang, B.; Pu, X.; Fan, X. 2021: MLH1/PMS2 Expression could tell Classical NTRK Fusion in Fluorescence in Situ Hybridization Positive Colorectal Carcinomas. Frontiers in Oncology 11: 669197

Kurpiel, B.; Thomas, M.S.; Mubeen, M.; Ring, K.L.; Modesitt, S.C.; Moskaluk, C.A.; Mills, A.M. 2022: MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 41(1): 1-11

Lipkin, S.M.; Wang, V.; Jacoby, R.; Banerjee-Basu, S.; Baxevanis, A.D.; Lynch, H.T.; Elliott, R.M.; Collins, F.S. 2000: MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nature Genetics 24(1): 27-35

Lopes Abath Neto, O.; Medne, L.; Donkervoort, S.; Rodríguez-García, M.E.; Bolduc, V.ér.; Hu, Y.; Guadagnin, E.; Foley, A.R.; Brandsema, J.F.; Glanzman, A.M.; Tennekoon, G.I.; Santi, M.; Berger, J.H.; Megeney, L.A.; Komaki, H.; Inoue, M.; Cotrina-Vinagre, F.J.; Hernández-Lain, A.; Martin-Hernández, E.; Williams, L.; Borell, S.; Schorling, D.; Lin, K.; Kolokotronis, K.; Lichter-Konecki, U.; Kirschner, J.; Nishino, I.; Banwell, B.; Martínez-Azorín, F.; Burgon, P.G.; Bönnemann, C.G. 2021: MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated  serum creatine kinase. Brain: a Journal of Neurology 144(9): 2722-2731

Canut, Mía.I.; Villa, O.; Kudsieh, B.; Mattlin, H.; Banchs, I.; González, J.R.; Armengol, Lís.; Casaroli-Marano, R.P. 2021: MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension. Scientific Reports 11(1): 1583

Zhu, Y.; Sun, J.-M.; Sun, Z.-C.; Chen, F.-J.; Wu, Y.-P.; Hou, X.-Y. 2020: MLK3 Is Associated with Poor Prognosis in Patients with Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells. Frontiers in Oncology 10: 600762

Chen, J.; Miller, E.M.; Gallo, K.A. 2010: MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells. Oncogene 29(31): 4399-4411

Chadee, D.N.; Kyriakis, J.M. 2004: MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation. Nature Cell Biology 6(8): 770-776

Schroyer, A.L.; Stimes, N.W.; Abi Saab, W.F.; Chadee, D.N. 2018: MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells. Oncogene 37(8): 1031-1040

Rattanasinchai, C.; Llewellyn, B.J.; Conrad, S.E.; Gallo, K.A. 2017: MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells. Oncogenesis 6(6): E345

Seit-Nebi, A.; Cheng, W.; Xu, H.; Han, J. 2012: MLK4 has negative effect on TLR4 signaling. Cellular and Molecular Immunology 9(1): 27-33

Abi Saab, W.F.; Brown, M.S.; Chadee, D.N. 2012: MLK4β functions as a negative regulator of MAPK signaling and cell invasion. Oncogenesis 1: E6

Wu, Q.; He, X.; Wu, L.-M.; Zhang, R.-Y.; Li, L.-M.; Wu, C.-M.; Lu, Y.-B.; Hu, B.; Shi, C.; Lu, Z.-F.; Yang, B.; Zheng, L.; Hu, Y.-W.; Wang, Q. 2020: MLKL Aggravates Ox-LDL-Induced Cell Pyroptosis via Activation of NLRP3 Inflammasome in Human Umbilical Vein Endothelial Cells. Inflammation 43(6): 2222-2231

Xia, B.; Fang, S.; Chen, X.; Hu, H.; Chen, P.; Wang, H.; Gao, Z. 2016: MLKL forms cation channels. Cell Research 26(5): 517-528

Zhao, Q.; Cheng, X.; Guo, J.; Bi, Y.; Kuang, L.; Ren, J.; Zhong, J.; Pan, L.; Zhang, X.; Guo, Y.; Liu, Y.; Jin, S.; Tan, Y.; Yu, X. 2021: MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway. International Journal of Biological Sciences 17(3): 869-881

Galluzzi, L.; Kepp, O.; Kroemer, G. 2014: MLKL regulates necrotic plasma membrane permeabilization. Cell Research 24(2): 139-140

Samson, A.L.; Zhang, Y.; Geoghegan, N.D.; Gavin, X.J.; Davies, K.A.; Mlodzianoski, M.J.; Whitehead, L.W.; Frank, D.; Garnish, S.E.; Fitzgibbon, C.; Hempel, A.; Young, S.N.; Jacobsen, A.V.; Cawthorne, W.; Petrie, E.J.; Faux, M.C.; Shield-Artin, K.; Lalaoui, N.; Hildebrand, J.M.; Silke, J.; Rogers, K.L.; Lessene, G.; Hawkins, E.D.; Murphy, J.M. 2020: MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis. Nature Communications 11(1): 3151

Zhan, C.; Huang, M.; Yang, X.; Hou, J. 2021: MLKL: Functions beyond serving as the Executioner of Necroptosis. Theranostics 11(10): 4759-4769

Macrini, C.M.T.; Pombo-de-Oliveira, M.S.; Ford, A.M.; Alves, G. 2003: MLL AT-hook sequence is strongly conserved in infant acute leukemia with or without MLL gene rearrangement. Leukemia 17(7): 1432-1433

Cuthbert, G.; Thompson, K.; McCullough, S.; Watmore, A.; Dickinson, H.; Telford, N.; Mugneret, F.; Harrison, C.; Griffiths, M.; Bown, N. 2000: MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study. Leukemia 14(11): 1885-1891

Erfurth, F.; Hemenway, C.S.; de Erkenez, A.C.; Domer, P.H. 2004: MLL fusion partners AF4 and AF9 interact at subnuclear foci. Leukemia 18(1): 92-102

Stam, R.W.; Hubeek, I.; den Boer, M.L.; Buijs-Gladdines, J.G.C.A.M.; Creutzig, U.; Kaspers, G.J.L.; Pieters, R. 2006: MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia. Leukemia 20(1): 179-182

Shima, Y.; Yumoto, M.; Katsumoto, T.; Kitabayashi, I. 2017: MLL is essential for NUP98-HOXA9-induced leukemia. Leukemia 31(10): 2200-2210

Bogni, A.; Pui, C-H.; Relling, M.V. 2005: MLL methylation is not likely a common mechanism for therapy-related AML. Leukemia 19(7): 1291-1292

Quentmeier, H.; Reinhardt, J.; Zaborski, M.; Drexler, H.G. 2003: MLL partial tandem duplications in acute leukemia cell lines. Leukemia 17(5): 980-981

Pigazzi, M.; Masetti, R.; Bresolin, S.; Beghin, A.; Di Meglio, A.; Gelain, S.; Trentin, L.; Baron, E.; Giordan, M.; Zangrando, A.; Buldini, B.; Leszl, A.; Putti, M.C.; Rizzari, C.; Locatelli, F.; Pession, A.; Te Kronnie, G.; Basso, G. 2011: MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study. Leukemia 25(3): 560-563

Basecke, J.; Karim, K.; Podleschny, M.; Becker, A.; Glass, B.; Trumper, L.; Griesinger, F. 2006: MLL rearrangements emerge during spontaneous apoptosis of clinical blood samples. Leukemia 20(6): 1193-1194

Matlawska-Wasowska, K.; Kang, H.; Devidas, M.; Wen, J.; Harvey, R.C.; Nickl, C.K.; Ness, S.A.; Rusch, M.; Li, Y.; Onozawa, M.; Martinez, C.; Wood, B.L.; Asselin, B.L.; Chen, I-M.; Roberts, K.G.; Baruchel, A.; Soulier, J.; Dombret, H.; Zhang, J.; Larson, R.S.; Raetz, E.A.; Carroll, W.L.; Winick, N.J.; Aplan, P.D.; Loh, M.L.; Mullighan, C.G.; Hunger, S.P.; Heerema, N.A.; Carroll, A.J.; Dunsmore, K.P.; Winter, S.S. 2016: MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study. Leukemia 30(9): 1909-1912

Armstrong, S.A.; Staunton, J.E.; Silverman, L.B.; Pieters, R.; den Boer, M.L.; Minden, M.D.; Sallan, S.E.; Lander, E.S.; Golub, T.R.; Korsmeyer, S.J. 2002: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nature Genetics 30(1): 41-47

Krivtsov, A.V.; Armstrong, S.A. 2007: MLL translocations, histone modifications and leukaemia stem-cell development. Nature Reviews. Cancer 7(11): 823-833

Stam, R.W. 2012: MLL-AF4 driven leukemogenesis: what are we missing?. Cell Research 22(6): 948-949

Giugliano, E.; Rege-Cambrin, G.; Scaravaglio, P.; Serra, A.; Wlodarska, I.; Emanuel, B.; Saglio, G.; Hagemeijer, A. 2001: MLL-AF6 fusion resulting from a new three-way translocation t(6;11;7) in a patient with acute myeloid leukemia. Leukemia 15(10): 1674-1676

Stubbs, M.C.; Kim, Y.M.; Krivtsov, A.V.; Wright, R.D.; Feng, Z.; Agarwal, J.; Kung, A.L.; Armstrong, S.A. 2008: MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Leukemia 22(1): 66-77

Chen, X.; Burkhardt, D.B.; Hartman, A.A.; Hu, X.; Eastman, A.E.; Sun, C.; Wang, X.; Zhong, M.; Krishnaswamy, S.; Guo, S. 2019: MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors. Nature Communications 10(1): 5767

Pession, A.; Martino, V.; Tonelli, R.; Beltramini, C.; Locatelli, F.; Biserni, G.; Franzoni, M.; Freccero, F.; Montemurro, L.; Pattacini, L.; Paolucci, G. 2003: MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells. Oncogene 22(54): 8671-8676

Horton, S.J.; Jaques, J.; Woolthuis, C.; van Dijk, J.; Mesuraca, M.; Huls, G.; Morrone, G.; Vellenga, E.; Schuringa, J.J. 2013: MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny. Leukemia 27(5): 1116-1126

Ugale, A.; Säwén, P.; Dudenhöffer-Pfeifer, M.; Wahlestedt, M.; Norddahl, G.L.; Bryder, D. 2017: MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment. Oncogene 36(22): 3207-3212

Slater, D.J.; Hilgenfeld, E.; Rappaport, E.F.; Shah, N.; Meek, R.G.; Williams, W.Reed.; Lovett, B.D.; Osheroff, N.; Autar, R.S.; Ried, T.; Felix, C.A. 2002: MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site. Oncogene 21(30): 4706-4714

Kosasih, H.J.; Davidson, N.M.; Bjelosevic, S.; Morrish, E.; Brennan, M.S.; Oshlack, A.; Johnstone, R.W.; Brumatti, G.; Khaw, S.L.; Ekert, P.G. 2020: MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia. Blood Advances 4(19): 4918-4923

Skucha, A.; Ebner, J.; Schmöllerl, J.; Roth, M.; Eder, T.; César-Razquin, Aán.; Stukalov, A.; Vittori, S.; Muhar, M.; Lu, B.; Aichinger, M.; Jude, J.; Müller, Aé.C.; Győrffy, Bázs.; Vakoc, C.R.; Valent, P.; Bennett, K.L.; Zuber, J.; Superti-Furga, G.; Grebien, F. 2018: MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. Nature Communications 9(1): 1983

Schraets, D.; Lehmann, T.; Dingermann, T.; Marschalek, R. 2003: MLL-mediated transcriptional gene regulation investigated by gene expression profiling. Oncogene 22(23): 3655-3668

Perl, A.E. 2020: MLL-menin and FLT3 inhibitors team up for AML. Blood 136(21): 2369-2370

Brightman, D.S.; Grant, R.L.; Ruzycki, P.A.; Suzuki, R.; Hennig, A.K.; Chen, S. 2018: MLL1 is essential for retinal neurogenesis and horizontal inner neuron integrity. Scientific Reports 8(1): 11902

Addicks, G.C.; Brun, C.E.; Sincennes, M-Claude.; Saber, J.; Porter, C.J.; Francis Stewart, A.; Ernst, P.; Rudnicki, M.A. 2019: MLL1 is required for PAX7 expression and satellite cell self-renewal in mice. Nature Communications 10(1): 4256

Hanna, C.W.; Taudt, A.; Huang, J.; Gahurova, L.; Kranz, A.; Andrews, S.; Dean, W.; Stewart, A.Francis.; Colomé-Tatché, M.; Kelsey, G. 2018: MLL2 conveys transcription-independent H3K4 trimethylation in oocytes. Nature Structural and Molecular Biology 25(1): 73-82

Huntsman, D.G.; Chin, S.F.; Muleris, M.; Batley, S.J.; Collins, V.P.; Wiedemann, L.M.; Aparicio, S.; Caldas, C. 1999: MLL2, the second human homolog of the Drosophila trithorax gene, maps to 19q13.1 and is amplified in solid tumor cell lines. Oncogene 18(56): 7975-7984

Zheng, J-Yi.; Wang, C-Yu.; Gao, C.; Xiao, Q.; Huang, C-Wei.; Wu, M.; Li, L-Yun. 2021: MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity. Cell Death and Disease 12(4): 364

Zhao, D-Mei.; Xue, H-Hui. 2017: MLL4 keeps Foxp3 in the loop. Nature Immunology 18(9): 957-958

Placek, K.; Hu, G.; Cui, K.; Zhang, D.; Ding, Y.; Lee, J-Eun.; Jang, Y.; Wang, C.; Konkel, J.Elizabeth.; Song, J.; Liu, C.; Ge, K.; Chen, W.; Zhao, K. 2017: MLL4 prepares the enhancer landscape for Foxp3 induction via chromatin looping. Nature Immunology 18(9): 1035-1045

Fasciani, A.; D'Annunzio, S.; Poli, V.; Fagnocchi, L.; Beyes, S.; Michelatti, D.; Corazza, F.; Antonelli, L.; Gregoretti, F.; Oliva, G.; Belli, R.; Peroni, D.; Domenici, E.; Zambrano, S.; Intartaglia, D.; Settembre, C.; Conte, I.; Testi, C.; Vergyris, P.; Ruocco, G.; Zippo, A. 2020: MLL4-associated condensates counterbalance Polycomb-mediated nuclear mechanical stress in Kabuki syndrome. Nature Genetics 52(12): 1397-1411

Pereira-Martins, D.A.; Weinhäuser, I.; Coelho-Silva, J.Luiz.; França-Neto, P.L.; Almeida, L.Y.; Bianco, T.M.; Silva, C.L.; França, R.F.; Traina, F.; Rego, E.M.; Schuringa, J.Jacob.; Lucena-Araujo, A.R. 2021: MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model. Cell Death and Disease 12(4): 371

Zhou, P.; Ding, X.; Wan, X.; Liu, L.; Yuan, X.; Zhang, W.; Hui, X.; Meng, G.; Xiao, H.; Li, B.; Zhong, J.; Hou, F.; Deng, L.; Zhang, Y. 2018: MLL5 suppresses antiviral innate immune response by facilitating STUB1-mediated RIG-I degradation. Nature Communications 9(1): 1243

Emerling, B.M.; Bonifas, J.; Kratz, C.P.; Donovan, S.; Taylor, B.R.; Green, E.D.; Le Beau, M.M.; Shannon, K.M. 2002: MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene 21(31): 4849-4854

Quan, Y.; Cui, Y.; Wahafu, W.; Liu, Y.; Ping, H.; Zhang, X. 2020: MLL5α activates AR/NDRG1 signaling to suppress prostate cancer progression. American Journal of Cancer Research 10(5): 1608-1629

Perlman, E.J.; Gadd, S.; Arold, S.T.; Radhakrishnan, A.; Gerhard, D.S.; Jennings, L.; Huff, V.; Guidry Auvil, J.M.; Davidsen, T.M.; Dome, J.S.; Meerzaman, D.; Hsu, C.Hao.; Nguyen, C.; Anderson, J.; Ma, Y.; Mungall, A.J.; Moore, R.A.; Marra, M.A.; Mullighan, C.G.; Ma, J.; Wheeler, D.A.; Hampton, O.A.; Gastier-Foster, J.M.; Ross, N.; Smith, M.A. 2015: MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours. Nature Communications 6: 10013

Deutsch, J.L.; Heath, J.L. 2020: MLLT10 in benign and malignant hematopoiesis. Experimental Hematology 87: 1-12

Calvanese, V.; Nguyen, A.T.; Bolan, T.J.; Vavilina, A.; Su, T.; Lee, L.K.; Wang, Y.; Lay, F.D.; Magnusson, M.; Crooks, G.M.; Kurdistani, S.K.; Mikkola, H.K.A. 2019: MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment. Nature 576(7786): 281-286

Sreevalsan, S.; Döring, M.; Paszkowski-Rogacz, M.; Brux, M.; Blanck, C.; Meyer, M.; Momburg, F.; Buchholz, F.; Theis, M. 2020: MLLT6 maintains PD-L1 expression and mediates tumor immune resistance. Embo Reports 21(12): E50155

Tong, S.; Si, Y.; Yu, H.; Zhang, L.; Xie, P.; Jiang, W. 2017: MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma. Scientific Reports 7(1): 5599

Ho, I-Lin.; Kuo, K-Lin.; Liu, S-Hwa-.; Chang, H-Chiang.; Hsieh, J-Ton.; Wu, J-Tai.; Chiang, C-Kang.; Lin, W-Chou.; Tsai, Y-Chieh.; Chou, C-Tso.; Hsu, C-Hsun.; Pu, Y-Shiau.; Shi, C-Sheng.; Huang, K-How. 2015: MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma. Scientific Reports 5: 16948

Knorr, K.L.B.; Schneider, P.A.; Meng, X.W.; Dai, H.; Smith, B.D.; Hess, A.D.; Karp, J.E.; Kaufmann, S.H. 2015: MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors. Cell Death and Differentiation 22(12): 2133-2142

Liu, H.; Bei, Q.; Luo, X. 2021: MLN4924 inhibits cell proliferation by targeting the activated neddylation pathway in endometrial carcinoma. Journal of International Medical Research 49(6): 3000605211018592

Xie, L.; Ji, X.; Tu, Y.; Wang, K.; Zhu, L.; Zeng, X.; Wang, X.; Zhang, J.; Zhu, M. 2020: MLN4924 inhibits hedgehog signaling pathway and activates autophagy to alleviate mouse laser-induced choroidal neovascularization lesion. Biomedicine and PharmacoTherapy 130: 110654

Lange, S.; Gehmlich, K.; Lun, A.S.; Blondelle, J.; Hooper, C.; Dalton, N.D.; Alvarez, E.A.; Zhang, X.; Bang, M-Louise.; Abassi, Y.A.; Dos Remedios, C.G.; Peterson, K.L.; Chen, J.; Ehler, E. 2016: MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy. Nature Communications 7: 12120

Li, X.; Lu, W-Jing.; Li, Y'nan.; Wu, F.; Bai, R.; Ma, S.; Dong, T.; Zhang, H.; Lee, A.S.; Wang, Y.; Lan, F. 2019: MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling. Cell Death and Disease 10(8): 610

Yu, C-Hsiang.; Lin, T-Kang.; Jou, S-Tarng.; Lin, C-Yu.; Lin, K-Hsin.; Lu, M-Yao.; Chen, S-Huey.; Cheng, C-Neng.; Wu, K-Hsi.; Wang, S-Chung.; Chang, H-Hao.; Li, M-Ju.; Ni, Y-Ling.; Su, Y-Ning.; Lin, D-Tsamn.; Chen, H-Yu.; Harrison, C.J.; Hung, C-Cheng.; Lin, S-Wha.; Yang, Y-Li. 2020: MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia. Scientific Reports 10(1): 11501

Guevara-Fujita, M.ía.L.; Huaman-Dianderas, F.; Obispo, D.; Sánchez, R.; Barrenechea, V.; Rojas-Málaga, D.; Estrada-Cuzcano, A.; Trubnykova, M.; Cornejo-Olivas, M.; Marca, V.; Gallardo, B.; Dueñas-Roque, M.; Protzel, A.; Castañeda, C.; Abarca, H.; Celis, L.; La Serna-Infantes, J.; Fujita, R. 2021: MLPA followed by target-NGS to detect mutations in the dystrophin gene of Peruvian patients suspected of DMD/DMB. Molecular Genetics and Genomic Medicine 9(9): E1759

Kalantary, S.; Jahani, A.; Jahani, R. 2020: MLR and ANN Approaches for Prediction of Synthetic/Natural Nanofibers Diameter in the Environmental and Medical Applications. Scientific Reports 10(1): 8117

Jacob, J.J.; Rachel, T.; Shankar, B.A.; Gunasekaran, K.; Iyadurai, R.; Anandan, S.; Veeraraghavan, B. 2020: MLST based serotype prediction for the accurate identification of non typhoidal Salmonella serovars. Molecular Biology Reports 47(10): 7797-7803

Maiden, M.C.J.; Jansen van Rensburg, M.J.; Bray, J.E.; Earle, S.G.; Ford, S.A.; Jolley, K.A.; McCarthy, N.D. 2013: MLST revisited: the gene-by-gene approach to bacterial genomics. Nature Reviews. Microbiology 11(10): 728-736

Guo, C.; Yang, X.; Wu, Y.; Yang, H.; Han, Y.; Yang, R.; Hu, L.; Cui, Y.; Zhou, D. 2015: MLST-based inference of genetic diversity and population structure of clinical Klebsiella pneumoniae, China. Scientific Reports 5: 7612

Lim, H.; Jung, Y. 2021: MLSolvA: solvation free energy prediction from pairwise atomistic interactions by machine learning. Journal of Cheminformatics 13(1): 56

Kumari, G.; Doimari, S.; Suman Kumar, M.; Singh, M.; Singh, D.Kumar. 2021: MLVA typing of Brucella melitensis and B. abortus isolates of animal and human origin from India. Animal Biotechnology 2021: 1-9

Dral, P.O.; Ge, F.; Xue, B.-X.; Hou, Y.-F.; Pinheiro, M.; Huang, J.; Barbatti, M. 2021: MLatom 2: An Integrative Platform for Atomistic Machine Learning. Topics in Current Chemistry 379(4): 27

Yang, C.; Wang, W.; Zhang, Y.; Zhang, Z.; Shen, L.; Li, Y.; See, J. 2021: MLife: a lite framework for machine learning lifecycle initialization. Machine Learning 110(11-12): 2993-3013

Hamaguchi, T.; Sanjo, N.; Ae, R.; Nakamura, Y.; Sakai, K.; Takao, M.; Murayama, S.; Iwasaki, Y.; Satoh, K.; Murai, H.; Harada, M.; Tsukamoto, T.; Mizusawa, H.; Yamada, M. 2020: MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type. Journal of Neurology Neurosurgery and Psychiatry 91(11): 1158-1165

Tanaka, M.; Koul, D.; Davies, M.A.; Liebert, M.; Steck, P.A.; Grossman, H.B. 2000: MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells. Oncogene 19(47): 5406-5412

Bennett, G.; Brown, A.; Mudd, G.; Huxley, P.; Van Rietschoten, K.; Pavan, S.; Chen, L.; Watcham, S.; Lahdenranta, J.; Keen, N. 2020: MMAE Delivery Using the Bicycle Toxin Conjugate BT5528. Molecular Cancer Therapeutics 19(7): 1385-1394

Branigan, T.B.; Kozono, D.; Schade, A.E.; Deraska, P.; Rivas, H.G.; Sambel, L.; Reavis, H.D.; Shapiro, G.I.; D'Andrea, A.D.; DeCaprio, J.A. 2021: MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity. Cell Reports 34(9): 108808

Mandape, S.N.; Smart, U.; King, J.L.; Muenzler, M.; Kapema, K.B.; Budowle, B.; Woerner, A.E. 2021: MMDIT: a tool for the deconvolution and interpretation of mitochondrial DNA mixtures. Forensic Science International. Genetics 55: 102568

Sakuma, T.; Nakade, S.; Sakane, Y.; Suzuki, K-Ichi.T.; Yamamoto, T. 2016: MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems. Nature Protocols 11(1): 118-133

Onuora, S. 2020: MMF comparable to cyclophosphamide in AAV. Nature Reviews. Rheumatology 16(7): 350

Warde, N. 2010: MMF for juvenile derMatoMyositis. Nature Reviews. Rheumatology 6(10): 555

Halgren, T.A. 1999: MMFF VI. MMFF94s option for energy minimization studies. Journal of Computational Chemistry 20(7): 720-729

Halgren, T.A. 1999: MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometries. Journal of Computational Chemistry 20(7): 730-748

Smith, A.; Metz, J.; Pagliara, S. 2019: MMHelper: An automated framework for the analysis of microscopy images acquired with the mother machine. Scientific Reports 9(1): 10123

Kiuru, O.; Sinervo, J.; Vähänikkilä, H.; Anttonen, V.; Tjäderhane, L. 2021: MMP Inhibitors and Dentin Bonding: Systematic Review and Meta-Analysis. International Journal of Dentistry 2021: 9949699

Kiehstaller, S.; Ottmann, C.; Hennig, S. 2020: MMP activation-associated aminopeptidase N reveals a bivalent 14-3-3 binding motif. Journal of Biological Chemistry 295(52): 18266-18275

Kazantseva, M.G.; Hung, N.A.; Highton, J.; Hessian, P.A. 2013: MMP expression in rheumatoid inflammation: the rs11568818 polymorphism is associated with MMP-7 expression at an extra-articular site. Genes and Immunity 14(3): 162-169

Cho, N.Hoon.; Hong, K.Pyo.; Hong, S.Hui.; Kang, S.; Chung, K.Young.; Cho, S.Ho. 2004: MMP expression profiling in recurred stage IB lung cancer. Oncogene 23(3): 845-851

Dove, A. 2002: MMP inhibitors: glimmers of hope amidst clinical failures. Nature Medicine 8(2): 95

Das, A.; Monteiro, M.; Barai, A.; Kumar, S.; Sen, S. 2017: MMP proteolytic activity regulates cancer invasiveness by modulating integrins. Scientific Reports 7(1): 14219

Vierkötter, A.; Schikowski, T.; Sugiri, D.; Matsui, M.S.; Krämer, U.; Krutmann, J. 2015: MMP-1 and -3 promoter variants are indicative of a common susceptibility for skin and lung aging: results from a cohort of elderly women (SALIA). Journal of Investigative Dermatology 135(5): 1268-1274

Al-Muhtasib, N.; Forcelli, P.A.; Conant, K.E.; Vicini, S. 2018: MMP-1 overexpression selectively alters inhibition in D1 spiny projection neurons in the mouse nucleus accumbens core. Scientific Reports 8(1): 16230

Wu, Y.; Tang, Y.; Zhang, X.; Chu, Z.; Liu, Y.; Tang, C. 2020: MMP-1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via the JNK and ERK pathway. International Journal of Biochemistry and Cell Biology 129: 105880

Rohani, M.G.; McMahan, R.S.; Razumova, M.V.; Hertz, A.L.; Cieslewicz, M.; Pun, S.H.; Regnier, M.; Wang, Y.; Birkland, T.P.; Parks, W.C. 2015: MMP-10 Regulates Collagenolytic Activity of Alternatively Activated Resident Macrophages. Journal of Investigative Dermatology 135(10): 2377-2384

Mora-Gutiérrez, Jé.María.; Rodríguez, Jé.Antonio.; Fernández-Seara, Mía.A.; Orbe, J.; Escalada, F.Javier.; Soler, Mía.José.; Slon Roblero, Mía.Fernanda.; Riera, M.; Páramo, Jé.Antonio.; Garcia-Fernandez, N. 2020: MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade. Scientific Reports 10(1): 26

Wu, L.-N.; Wang, W.-F.; Wang, X.-W.; Li, W.-L.; Luo, S.; Ni, H.; Zheng, H.-B.; Hong, W.-J.; Jiang, Y.-Q.; Zhu, F. 2021: MMP-10 rs17435959 Polymorphism is Associated with the Formation and Stability of Carotid Atherosclerosis Plaque: a Case-Control Study. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 30(10): 106045

Song, M.; Zhang, S.; Tao, Z.; Li, J.; Shi, Y.; Xiong, Y.; Zhang, W.; Liu, C.; Chen, S. 2021: MMP-12 siRNA improves the homeostasis of the small intestine and metabolic dysfunction in high-fat diet feeding-induced obese mice. Biomaterials 278: 121183

Lan, Q.; Lu, R.; Chen, H.; Pang, Y.; Xiong, F.; Shen, C.; Qin, Z.; Zheng, L.; Xu, G.; Zhao, J. 2020: MMP-13 enzyme and pH responsive theranostic nanoplatform for osteoarthritis. Journal of Nanobiotechnology 18(1): 117

Ren, Y.; Hyakusoku, H.; Sagers, J.E.; Landegger, L.D.; Welling, D.B.; Stankovic, K.M. 2020: MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients with Vestibular Schwannomas. Frontiers in Cellular Neuroscience 14: 191

Wang, W.; Liu, Y.; Yang, Y.; Huang, X.; Hou, Y. 2021: MMP-16 as a new Biomarker for Predicting Prognosis and Chemosensitivity of Serous Ovarian Cancer: a Study Based on Bioinformatics Analysis. Critical Reviews in Eukaryotic Gene Expression 31(4): 1-8

Brauer, R.; Tureckova, J.; Kanchev, I.; Khoylou, M.; Skarda, J.; Prochazka, J.; Spoutil, F.; Beck, I.M.; Zbodakova, O.; Kasparek, P.; Korinek, V.; Chalupsky, K.; Karhu, T.; Herzig, K-H.; Hajduch, M.; Gregor, M.; Sedlacek, R. 2016: MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function. Mucosal Immunology 9(4): 974-985

Langers, A.M.J.; Verspaget, H.W.; Hawinkels, L.J.A.C.; Kubben, F.J.G.M.; van Duijn, W.; van der Reijden, J.J.; Hardwick, J.C.H.; Hommes, D.W.; Sier, C.F.M. 2012: MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients. British Journal of Cancer 106(9): 1495-1498

D Avila-Mesquita, C.; Couto, A.E.S.; Campos, L.C.B.; Vasconcelos, T.F.; Michelon-Barbosa, J.; Corsi, C.A.C.; Mestriner, F.; Petroski-Moraes, B.C.; Garbellini-Diab, M.J.; Couto, D.M.S.; Jordani, M.C.; Ferro, D.; Sbragia, L.ço.; Joviliano, E.E.; Evora, P.R.; Carvalho Santana, R.d.; Martins-Filho, O.A.; Polonis, K.; Menegueti, M.G.; Ribeiro, M.S.; Auxiliadora-Martins, M.; Becari, C. 2021: MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients. Biomedicine and PharmacoTherapy 142: 112067

Medeiros, N.I.; Gomes, J.A.S.; Fiuza, J.A.; Sousa, G.R.; Almeida, E.F.; Novaes, R.O.; Rocha, Vínia.L.S.; Chaves, A.T.; Dutra, W.O.; Rocha, M.O.C.; Correa-Oliveira, R. 2019: MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease. Scientific Reports 9(1): 14170

Liu, Q.; Yang, Z.; Ma, N.; Wang, W.; Li, Y. 2020: MMP-2 and TIMP-2 expression, quantitative analysis and biomechanical changes in scar hypertrophy after autologous free transplantation of rabbit oral mucosa and scrotal skin. Saudi Journal of Biological Sciences 27(11): 3046-3059

Rezaeian, A.A.; Yaghobi, R.; Geramizadeh, B. 2018: MMP-2 gene expression at mRNA level in HBV and HCV infected patients. Tropical Biomedicine 35(3): 839-848

Langers, A.M.J.; Sier, C.F.M.; Hawinkels, L.J.A.C.; Kubben, F.J.G.M.; van Duijn, W.; van der Reijden, J.J.; Lamers, C.B.H.W.; Hommes, D.W.; Verspaget, H.W. 2008: MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not. British Journal of Cancer 98(11): 1820-1823

Rice, J.C.; Weekley, B.H.; Kanholm, T.; Chen, Z.; Lee, S.; Fernandez, D.J.; Abrahamson, R.; Castaldi, A.; Borok, Z.; Dynlacht, B.D.; An, W. 2021: MMP-2 is a novel histone H3 N-terminal protease necessary for myogenic gene activation. Epigenetics and Chromatin 14(1): 23

Bhoopathi, P.; Chetty, C.; Gogineni, V.R.; Gujrati, M.; Dinh, D.H.; Rao, J.S.; Lakka, S.S. 2011: MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors. Gene Therapy 18(7): 692-701

Boyd, R.S.; Balkwill, F.R. 1999: MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. British Journal of Cancer 80(3-4): 315-321

Qiao, Y.; Zhan, C.; Wang, C.; Shi, X.; Yang, J.; He, X.; Ji, E.; Yu, Z.; Yan, C.; Wu, H. 2020: MMP-2 sensitive poly(malic acid) micelles stabilized by π-π stacking enable high drug loading capacity. Journal of Materials Chemistry. B 8(37): 8527-8535

Chetty, C.; Bhoopathi, P.; Lakka, S.S.; Rao, J.S. 2007: MMP-2 siRNA induced Fas/CD95-mediated extrinsic II apoptotic pathway in the A549 lung adenocarcinoma cell line. Oncogene 26(55): 7675-7683

Marshall 1999: MMP-2 structure solved. Nature Biotechnology 17(7): 625

Barton, A.K.; Richter, I.-G.; Ahrens, T.; Merle, R.; Alalwani, A.; Lilge, S.; Purschke, K.; Barnewitz, D.; Gehlen, H. 2021: MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic. Mediators of Inflammation 2021: 9501478

Yin, P.; Su, Y.; Chen, S.; Wen, J.; Gao, F.; Wu, Y.; Zhang, X. 2021: MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway. Analytical Cellular Pathology 2021: 6683391

Alves-Filho, J.é C.; Marcel Silva Melo, B.; Ryffel, B. 2021: MMP-9 Mediates Cross-Talk between Neutrophils and Endothelial Cells in Psoriasis. Journal of Investigative Dermatology 141(4): 716-718

Zoumboulakis, D.; Cirella, K.R.; Gougeon, P.-Y.; Lourenssen, S.R.; Blennerhassett, M.G. 2020: MMP-9 Processing of Intestinal Smooth Muscle-derived GDNF is Required for Neurotrophic Action on Enteric Neurons. Neuroscience 443: 8-18

Aguilera-Montilla, Ní.; Bailón, E.; Uceda-Castro, R.; Ugarte-Berzal, Eía.; Santos, A.; Gutiérrez-González, A.; Pérez-Sánchez, C.; Van den Steen, P.E.; Opdenakker, G.; García-Marco, Jé.A.; García-Pardo, A. 2019: MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest. Oncogene 38(23): 4605-4619

Lu, J.; Wang, J.; Lin, Z.; Shi, G.; Wang, R.; Zhao, Y.; Zhao, Y.; Zhao, J. 2021: MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease. Frontiers in Neurology 12: 721118

Chou, C.H.; Teng, C-M.; Tzen, K-Y.; Chang, Y-C.; Chen, J-H.; Cheng, J.C-H. 2012: MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis. Oncogene 31(4): 458-468

Shan, Y-Q.; Ying, R-C.; Zhou, C-H.; Zhu, A-K.; Ye, J.; Zhu, W.; Ju, T-F.; Jin, H-C. 2015: MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2. Cancer Gene Therapy 22(3): 101-107

Zhao, L.; Song, C.; Huang, Y.; Lei, W.; Sun, J. 2020: MMP-9 regulates CX3CL1/CX3CR1 in the early phase of neuropathic pain in chronic sciatic nerve constriction injury (CCI) rats. Annals of Palliative Medicine 9(4): 2020-2027

Zhang, H.L.; Peng, Y.F.; Zhang, D.P.; Li, D.; Liu, F.X.; Zhao, M.; Yin, S.; Liang, J.X.; Wei, T.T. 2020: MMP-9, Vertebrobasilar Ectasia and Vertebral Artery Dominance in Vertigo or Dizziness Patients with Vascular Risk Factors. Frontiers in Neurology 11: 931

Zhao, R.; Zhou, H.; Zhu, J. 2020: MMP-9-C1562T polymorphism and susceptibility to chronic obstructive pulmonary disease: a meta-analysis. Medicine 99(31): E21479

Dong, Y.; Zhao, H.; Man, J.; Fu, S.; Yang, L. 2021: MMP-9-mediated regulation of hypoxia-reperfusion injury-related neutrophil inflammation in an in vitro proximal tubular cell model. Renal Failure 43(1): 900-910

Wang, T.; Zhang, Y.; Bai, J.; Xue, Y.; Peng, Q. 2021: MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma. Bmc Cancer 21(1): 1068

Jiang, S.; Liu, H.; Zhang, J.; Zhang, F.; Fan, J.; Liu, Y. 2021: MMP1 regulated by NEAT1/miR-361-5p axis facilitates the proliferation and migration of cutaneous squamous cell carcinoma via the activation of Wnt pathway. Cancer Biology and Therapy 2021: 1-11

Wolf, M.; Clay, S.M.; Zheng, S.; Pan, P.; Chan, M.F. 2019: MMP12 Inhibits Corneal Neovascularization and Inflammation through Regulation of CCL2. Scientific Reports 9(1): 11579

Li, M.; Zhou, L.; Li, S.; Fang, L.; Yang, L.; Wu, X.; Yang, C.; Bao, Y.; Lan, S.; Tong, Z.; Zheng, S.; Tang, B.; Zeng, E.; Xie, S.; Chen, C.; Hong, T. 2021: MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and in vitro experiments. Oncology Letters 22(1): 536

Collison, J. 2018: MMP12 makes the cut. Nature Reviews. Rheumatology 14(9): 501

Sánchez, K.; Maguire-Zeiss, K. 2020: MMP13 Expression Is Increased Following Mutant α-Synuclein Exposure and Promotes Inflammatory Responses in Microglia. Frontiers in Neuroscience 14: 585544

Salerno, A.; Brady, K.; Rikkers, M.; Li, C.; Caamaño-Gutierrez, E.; Falciani, F.; Blom, A.W.; Whitehouse, M.R.; Hollander, A.P. 2020: MMP13 and TIMP1 are functional markers for two different potential modes of action by mesenchymal stem/stromal cells when treating osteoarthritis. Stem Cells 38(11): 1438-1453

Müller, M.; Beck, I.M.; Gadesmann, J.; Karschuk, N.; Paschen, A.; Proksch, E.; Djonov, V.; Reiss, K.; Sedlacek, R. 2010: MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 23(4): 511-521

Hoffmann, C.; Vacher, S.; Sirven, Pémon.; Lecerf, C.; Massenet, L.; Moreira, Aélie.; Surun, A.; Schnitzler, A.; Klijanienko, J.; Mariani, O.; Jeannot, E.; Badois, N.; Lesnik, M.; Choussy, O.; Le Tourneau, C.; Guillot-Delost, M.; Kamal, M.; Bieche, I.; Soumelis, V. 2020: MMP2 as an independent prognostic stratifier in oral cavity cancers. Oncoimmunology 9(1): 1754094

Li, C.; Zhang, K.; Liu, A.; Yue, T.; Wei, Y.; Zheng, H.; Piao, J.-G.; Li, F. 2021: MMP2-responsive dual-targeting drug delivery system for valence-controlled arsenic trioxide prodrug delivery against hepatic carcinoma. International Journal of Pharmaceutics 609: 121209

An, F.; Du, J.; Wang, J.; Zhao, L.; Ma, C.; Zhao, J.; Wang, J. 2019: MMP20 Single-Nucleotide Polymorphisms Correlate with Susceptibility to Alcohol-Induced Osteonecrosis of the Femoral Head in Chinese Males. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 25(2): 3750-3761

Guimier, A.; Gabriel, G.C.; Bajolle, F.; Tsang, M.; Liu, H.; Noll, A.; Schwartz, M.; El Malti, R.; Smith, L.D.; Klena, N.T.; Jimenez, G.; Miller, N.A.; Oufadem, M.; Moreau de Bellaing, A.; Yagi, H.; Saunders, C.J.; Baker, C.N.; Di Filippo, S.; Peterson, K.A.; Thiffault, I.; Bole-Feysot, C.; Cooley, L.D.; Farrow, E.G.; Masson, Cécile.; Schoen, P.; Deleuze, J-François.; Nitschké, P.; Lyonnet, S.; de Pontual, L.; Murray, S.A.; Bonnet, D.; Kingsmore, S.F.; Amiel, J.; Bouvagnet, P.; Lo, C.W.; Gordon, C.T. 2015: MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebrates. Nature Genetics 47(11): 1260-1263

Liang, Y.; Guan, C.; Li, K.; Zheng, G.; Wang, T.; Zhang, S.; Liao, G. 2020: MMP25 Regulates Immune Infiltration Level and Survival Outcome in Head and Neck Cancer Patients. Frontiers in Oncology 10: 1088

Tan, P.; Chen, H.; Huang, Z.; Huang, M.; Du, Y.; Li, T.; Chen, Z.; Liu, Y.; Fu, W. 2021: MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC. Molecular Therapy Oncolytics 22: 307-325

Chen, L.; Ke, X. 2021: MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis. Medicine 100(9): E24953

Hu, Q.; Lan, J.; Liang, W.; Chen, Y.; Chen, B.; Liu, Z.; Xiong, Y.; Zhong, Z.; Wang, Y.; Ye, Q. 2020: MMP7 damages the integrity of the renal tubule epithelium by activating MMP2/9 during ischemia-reperfusion injury. Journal of Molecular Histology 51(6): 685-700

Hsu, T-I.; Lin, S-C.; Lu, P-S.; Chang, W-C.; Hung, C-Y.; Yeh, Y-M.; Su, W-C.; Liao, P-C.; Hung, J-J. 2015: MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy. Oncogene 34(7): 826-837

Hsu, T-I.; Lin, S-C.; Lu, P-S.; Chang, W-C.; Hung, C-Y.; Yeh, Y-M.; Su, W-C.; Liao, P-C.; Hung, J-J. 2017: MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy. Oncogene 36(6): 875-876

Wang, K.; Zhou, Y.; Li, G.; Wen, X.; Kou, Y.; Yu, J.; He, H.; Zhao, Q.; Xue, F.; Wang, J.; Zhao, X. 2018: MMP8 and MMP9 gene polymorphisms were associated with breast cancer risk in a Chinese Han population. Scientific Reports 8(1): 13422

Juurikka, K.; Dufour, A.; Pehkonen, K.; Mainoli, B.; Campioni Rodrigues, P.; Solis, N.; Klein, T.; Nyberg, P.; Overall, C.M.; Salo, T.; Åström, P. 2021: MMP8 increases tongue carcinoma cell-cell adhesion and diminishes migration via cleavage of anti-adhesive FXYD5. Oncogenesis 10(5): 44

Xu, T.; Gao, S.; Liu, J.; Huang, Y.; Chen, K.; Zhang, X. 2021: MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma. Journal of Cancer 12(8): 2243-2257

Nandi, S.S.; Katsurada, K.; Sharma, N.M.; Anderson, D.R.; Mahata, S.K.; Patel, K.P. 2020: MMP9 inhibition increases autophagic flux in chronic heart failure. American Journal of Physiology. Heart and Circulatory Physiology 319(6): H1414-H1437

Lavini-Ramos, C.; Silva, H.Moura.; Soares-Schanoski, A.; Monteiro, S.Maria.; Ferreira, L.Rodrigues.Pinto.; Pacanaro, A.Paula.; Gomes, S.; Batista, Jína.; Faé, K.; Kalil, J.; Coelho, Vônica. 2017: MMP9 integrates multiple immunoregulatory pathways that discriminate high suppressive activity of human mesenchymal stem cells. Scientific Reports 7(1): 874

Chevalier, C.él.M.; Krampert, L.; Schreckenbach, M.; Schubert, C.F.; Reich, J.; Novak, B.; Schmidt, M.V.; Rutten, B.P.F.; Schmidt, U. 2021: MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 51: 20-32

Yadav, S.K.; Kambis, T.N.; Kar, S.; Park, S.Y.; Mishra, P.K. 2020: MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro. Cell Death and Disease 11(3): 186

Ringland, C.; Schweig, J.E.; Eisenbaum, M.; Paris, D.; Ait-Ghezala, G.; Mullan, M.; Crawford, F.; Abdullah, L.; Bachmeier, C. 2021: MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease. Bmc Neuroscience 22(1): 39

Feng, X.; Yu, F.; Zhou, X.; Liu, Z.; Liao, D.; Huang, Q.; Li, X.; Jin, X.; Xia, J. 2021: MMP9 rs17576 Is Simultaneously Correlated with Symptomatic Intracranial Atherosclerotic Stenosis and White Matter Hyperintensities in Chinese Population. Cerebrovascular Diseases 50(1): 4-11

Rahn, N.H. 1977: MMPi scales in relatives of schizophrenics. Alabama Journal of Medical Sciences 14(4): 437-438

Lachar, D. 1968: MMPi two-point code-type correlates in a state hospital population. Journal of Clinical Psychology 24(4): 424-427

Kremyar, A.J.; Lee, T.T.C. 2022: MMPI-3 Predictors of Anxiety Sensitivity and Distress Intolerance. Assessment 29(6): 1103-1116

Wang, F.; Xiong, Y.; Xiao, Y.; Han, J.; Deng, X.; Lin, L. 2020: MMPphg from the thermophilic Meiothermus bacteriophage MMP17 as a potential antimicrobial agent against both Gram-negative and Gram-positive bacteria. Virology Journal 17(1): 130

Ita, M.E.; Ghimire, P.; Granquist, E.J.; Winkelstein, B.A. 2022: MMPs in tissues retrieved during surgery from patients with TMJ disorders relate to pain more than to radiological damage score. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 40(2): 338-347

Stokke, J.L.; Szymanski, L.J.; Bankamp, B.; Pratt, F.; Martines, R.; Dien-Bard, J.; Mohandas, S. 2021: MMR Vaccine-Associated Disseminated Measles in an Immunocompromised Adolescent. New England Journal of Medicine 385(13): 1246-1248

Porret, R.ël.; Ishii, A.; Petignat, C.; Crisinel, P.A. 2020: MMR vaccination at UNIL and EPFL : Lausanne medical students get involved. Revue Medicale Suisse 16(710): 1938-1940

García-Hernandez, A.; Pérez, T.; Pardo, M.ía.D.C.; Rizopoulos, D. 2020: MMRM vs joint modeling of longitudinal responses and time to study drug discontinuation in clinical trials using a "de jure" estimand. Pharmaceutical Statistics 19(6): 909-927

Liu, H.; Zong, Q-G.; Zhang, H.; Xiao, C.J.; Shi, Q.Q.; Yao, S.T.; He, J.S.; Zhou, X-Z.; Pollock, C.; Sun, W.J.; Le, G.; Burch, J.L.; Rankin, R. 2019: MMS observations of electron scale magnetic cavity embedded in proton scale magnetic cavity. Nature Communications 10(1): 1040

Luo, Q.; He, W.; Mao, T.; Leng, X.; Wu, H.; Li, W.; Deng, X.; Zhao, T.; Shi, M.; Xu, C.; Han, Y. 2021: MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma. Frontiers in Oncology 11: 711642

Ming, L.; Zou, Y.; Zhao, Y.; Zhang, L.; He, N.; Chen, Z.; Li, S.S.-C.; Li, L. 2020: MMS2plot: An R Package for Visualizing Multiple MS/MS Spectra for Groups of Modified and Non-Modified Peptides. Proteomics 2020: E2000061

Choe, Y.M.; Lee, B.C.; Choi, I.-G.; Suh, G.-H.; Lee, D.Y.; Kim, J.W. 2020: MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment. Neuropsychiatric Disease and Treatment 16: 1767-1775

Xie, Z.; Chooi, J.Yuan.; Toh, S.Hui.Min.; Yang, D.; Basri, N.Binte.; Ho, Y.Swan.; Chng, W.Joo. 2019: MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells. Leukemia 33(3): 739-748

Mirabella, F.; Wu, P.; Wardell, C.P.; Kaiser, M.F.; Walker, B.A.; Johnson, D.C.; Morgan, G.J. 2013: MMSET is the key molecular target in t(4;14) myeloma. Blood Cancer Journal 3: E114

Xie, Z.; Bi, C.; Chooi, J.Y.; Chan, Z.L.; Mustafa, N.; Chng, W.J. 2015: MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib. Leukemia 29(12): 2347-2354

Pei, H.; Zhang, L.; Luo, K.; Qin, Y.; Chesi, M.; Fei, F.; Bergsagel, P.Leif.; Wang, L.; You, Z.; Lou, Z. 2011: MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature 470(7332): 124-128

Min, D-J.; Ezponda, T.; Kim, M.K.; Will, C.M.; Martinez-Garcia, E.; Popovic, R.; Basrur, V.; Elenitoba-Johnson, K.S.; Licht, J.D. 2013: MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC. Leukemia 27(3): 686-694

Shah, M.Y.; Martinez-Garcia, E.; Phillip, J.M.; Chambliss, A.B.; Popovic, R.; Ezponda, T.; Small, E.C.; Will, C.; Phillip, M.P.; Neri, P.; Bahlis, N.J.; Wirtz, D.; Licht, J.D. 2016: MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents. Oncogene 35(45): 5905-5915

Li, K.K.; Lee, K.A. 1998: MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription. Oncogene 16(10): 1325-1331

Liao, X.; Qian, Y.; Chen, Y.; Xiong, X.; Wang, Q.; Heng, P.-A. 2020: MMTLNet: Multi-Modality Transfer Learning Network with adversarial training for 3D whole heart segmentation. Computerized Medical Imaging and Graphics: the Official Journal of the Computerized Medical Imaging Society 85: 101785

Theodorou, V.; Kimm, M.A.; Boer, M.; Wessels, L.; Theelen, W.; Jonkers, J.; Hilkens, J. 2007: MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nature Genetics 39(6): 759-769

Zhou, H.; Chen, W.D.; Qin, X.; Lee, K.; Liu, L.; Markowitz, S.D.; Gerson, S.L. 2001: MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Oncogene 20(42): 6009-6017

Mukherjee, M.; Ge, G.; Zhang, N.; Edwards, D.G.; Sumazin, P.; Sharan, S.K.; Rao, P.H.; Medina, D.; Pati, D. 2014: MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERα)-positive mammary adenocarcinomas. Oncogene 33(48): 5511-5522

Daphna-Iken, D.; Shankar, D.B.; Lawshé, A.; Ornitz, D.M.; Shackleford, G.M.; MacArthur, C.A. 1998: MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene 17(21): 2711-2717

Khalid, H.F.; Ali, A.; Fawad, N.; Rafique, S.; Ullah, I.; Rehman, G.; Shams, M.U.; Idrees, M. 2021: MMTV-LIKE virus and c-myc over-expression are associated with invasive breast cancer. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 91: 104827

Martin, E.E.; Huang, W.; Anwar, T.; Arellano-Garcia, C.; Burman, B.; Guan, J-L.; Gonzalez, M.E.; Kleer, C.G. 2017: MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas. Oncogene 36(16): 2275-2285

Khan, T.; Khan, A.; Wei, D.-Q. 2021: MMV-db: vaccinomics and RNA-based therapeutics database for infectious hemorrhagic fever-causing mammarenaviruses. Database: the Journal of Biological Databases and Curation 2021

Steinegger, M.; Söding, J. 2017: MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nature Biotechnology 35(11): 1026-1028

Uemura, H.; Nakagawa, Y.; Yoshida, K.; Saga, S.; Yoshikawa, K.; Hirao, Y.; Oosterwijk, E. 1999: MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. British Journal of Cancer 81(4): 741-746

Shu, L.; He, D.; Wu, D.; Peng, Y.; Xi, H.; Mao, X.; Wang, H. 2021: MN1 gene loss-of-function mutation causes cleft palate in a pedigree. Brain: a Journal of Neurology 144(2): E18

Carella, C.; Bonten, J.; Sirma, S.; Kranenburg, T.A.; Terranova, S.; Klein-Geltink, R.; Shurtleff, S.; Downing, J.R.; Zwarthoff, E.C.; Liu, P.P.; Grosveld, G.C. 2007: MN1 overexpression is an important step in the development of inv(16) AML. Leukemia 21(8): 1679-1690

Larmonie, N.S.D.; Arentsen-Peters, T.C.J.M.; Obulkasim, A.; Valerio, D.; Sonneveld, E.; Danen-van Oorschot, A.A.; de Haas, V.; Reinhardt, D.; Zimmermann, M.; Trka, J.; Baruchel, A.; Pieters, R.; van den Heuvel-Eibrink, M.M.; Zwaan, C.M.; Fornerod, M. 2018: MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML. Oncogene 37(1): 107-115

Wenge, D.V.; Felipe-Fumero, E.; Angenendt, L.; Schliemann, C.; Schmidt, E.; Schmidt, L.H.; Thiede, C.; Ehninger, G.; Berdel, W.E.; Arteaga, M-F.; Mikesch, J-H. 2015: MN1-Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells. Oncogenesis 4: E179

Carella, C.; Bonten, J.; Rehg, J.; Grosveld, G.C. 2006: MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice. Leukemia 20(9): 1582-1592

Qiu, C.; Su, W.; Shen, N.; Qi, X.; Wu, X.; Wang, K.; Li, L.; Guo, Z.; Tao, H.; Wang, G.; Chen, B.; Xiang, H. 2020: MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway. Bmc Cancer 20(1): 1187

Wang, R.; Wang, S.; Xu, X.; Jiang, W.; Zhang, N. 2021: MNAzyme probes mediated DNA logic platform for micro RNAs logic detection and cancer cell identification. Analytica Chimica Acta 1149: 338213

Bottardi, S.; Guieze, R.; Bourgoin, V.; Fotouhi-Ardakani, N.; Dougé, A.; Darracq, A.ïs.; Lakehal, Y.A.; Berger, M.G.; Mollica, L.; Bay, J.-O.; Omichinski, J.G.; Milot, E. 2020: MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells. Experimental Hematology 88: 68-82.E5

Liu, S.Y.H.; Napier, E.; Runfola, A.; Cavusgil, S.T. 2020: MNE-NGO partnerships for sustainability and social responsibility in the global fast-fashion industry: a loose-coupling perspective. International Business Review 29(5): 101736

Dadar, M.; Manera, A.L.; Fonov, V.S.; Ducharme, S.; Collins, D.Louis. 2021: MNI-FTD templates, unbiased average templates of frontotemporal dementia variants. Scientific Data 8(1): 222

Gao, J.; Teng, L.; Yang, S.; Huang, S.; Li, L.; Zhou, L.; Liu, G.; Tang, H. 2021: MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice. Biochemical Pharmacology 186: 114499

Shi, Y.; Frost, P.; Hoang, B.; Yang, Y.; Fukunaga, R.; Gera, J.; Lichtenstein, A. 2013: MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells. Oncogene 32(2): 190-197

Phillips, A.; Blaydes, J.P. 2008: MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA. Oncogene 27(11): 1645-1649

Moore, C.E.J.; Pickford, J.; Cagampang, F.R.; Stead, R.L.; Tian, S.; Zhao, X.; Tang, X.; Byrne, C.D.; Proud, C.G. 2016: MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways. Scientific Reports 6: 23476

Huang, X-Bo.; Yang, C-Mei.; Han, Q-Mei.; Ye, X-Jin.; Lei, W.; Qian, W-Bin. 2018: MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells. Acta Pharmacologica Sinica 39(12): 1894-1901

Yang, W.; Khoury, E.; Guo, Q.; Prabhu, S.A.; Emond, A.; Huang, F.; Gonçalves, C.; Zhan, Y.; Plourde, D.; Nichol, J.N.; Dahabieh, M.S.; Miller, W.H.; Del Rincón, S.Victoria. 2020: MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression. Oncogene 39(18): 3650-3665

Bartish, M.; Tong, D.; Pan, Y.; Wallerius, M.; Liu, H.; Ristau, J.; de Souza Ferreira, S.; Wallmann, T.; van Hoef, V.; Masvidal, L.; Kerzel, T.; Joly, A.-L.; Goncalves, C.; Preston, S.E.J.; Ebrahimian, T.; Seitz, C.; Bergh, J.; Pietras, K.; Lehoux, S.; Naldini, L.; Andersson, J.; Squadrito, M.L.; Del Rincón, S.V.; Larsson, O.; Rolny, C. 2020: MNK2 governs the macrophage antiinflammatory phenotype. Proceedings of the National Academy of Sciences of the United States of America 117(44): 27556-27565

Zhang, G.; Yang, L.; Li, B.; Lu, Y.; Liu, Q.; Zhao, W.; Ren, T.; Zhou, J.; Wang, S.-H.; Che, W. 2020: MNL-Network: a Multi-Scale Non-local Network for Epilepsy Detection from EEG Signals. Frontiers in Neuroscience 14: 870

Yi, Y.; Yu, M.-C.; Fu, P.-Y.; Liu, G.; Zhou, P.-Y.; Guan, R.-Y.; Zhou, C.; Sun, B.-Y.; Qiu, S.-J. 2021: MNS1 promotes hepatocarcinogenesis and metastasis via activating PI3K/AKT by translocating β-catenin and predicts poor prognosis. Liver International: Official Journal of the International Association for the Study of the Liver 41(6): 1409-1420

Leslie, J.S.; Rawlins, L.E.; Chioza, B.A.; Olubodun, O.R.; Salter, C.G.; Fasham, J.; Jones, H.F.; Cross, H.E.; Lam, S.; Harlalka, G.V.; Muggenthaler, M.M.A.; Crosby, A.H.; Baple, E.L. 2020: MNS1 variant associated with situs inversus and male infertility. European Journal of Human Genetics: Ejhg 28(1): 50-55

Huda, N.; Yasmin, T.; Nabi, A.H.M.N. 2021: MNS16A VNTR polymorphism of human telomerase gene: Elucidation of a gender specific potential allele associated with type 2 diabetes in Bangladeshi population. Journal of Diabetes and its Complications 35(10): 108018

Wang, N.; Yang, Q.; Gu, Y.; Zhen, X.; Shi, Y.; Gu, W.; Wang, J.; He, Y.; Wang, J. 2021: MNSFβ Promotes the Proliferation and Migration of Human Extravillous Trophoblast Cells and the Villus Expression Level of MNSFβ Is Decreased in Recurrent Miscarriage Patients. Gynecologic and Obstetric Investigation 86(1-2): 27-39

Yang, Q.; Ma, Y.; Liu, Y.; Shao, X.; Jia, W.; Yu, X.; Li, Y.-X.; Yang, L.; Gu, W.; Wang, H.; Wang, J.; Wang, Y.-L. 2021: MNSFβ regulates placental development by conjugating IGF2BP2 to enhance trophoblast cell invasiveness. Cell Proliferation 54(12): E13145

Betz, M. 2021: MNT in a Virtual World: a Renal Dietitian's Perspective. Journal of Renal Nutrition: the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation 31(5): 541-542

Zhu, B.; Wu, Y.; Luo, J.; Zhang, Q.; Huang, J.; Li, Q.; Xu, L.; Lu, E.; Ren, B. 2020: MNX1 Promotes Malignant Progression of Cervical Cancer via Repressing the Transcription of p21cip1. Frontiers in Oncology 10: 1307

Cole, L.; Dennis, J. 2020: MNase Profiling of Promoter Chromatin in Salmonella typhimurium-Stimulated GM12878 Cells Reveals Dynamic and Response-Specific Nucleosome Architecture. G3 10(7): 2171-2178

Mieczkowski, J.; Cook, A.; Bowman, S.K.; Mueller, B.; Alver, B.H.; Kundu, S.; Deaton, A.M.; Urban, J.A.; Larschan, E.; Park, P.J.; Kingston, R.E.; Tolstorukov, M.Y. 2016: MNase titration reveals differences between nucleosome occupancy and chromatin accessibility. Nature Communications 7: 11485

Filippi, B.M.; de los Heros, P.; Mehellou, Y.; Navratilova, I.; Gourlay, R.; Deak, M.; Plater, L.; Toth, R.; Zeqiraj, E.; Alessi, D.R. 2011: MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases. EMBO Journal 30(9): 1730-1741

Tan, C.T.; Chang, H.-C.; Zhou, Q.; Yu, C.; Fu, N.Y.; Sabapathy, K.; Yu, V.C. 2021: MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling. Embo Reports 22(1): E50854

Belinsky, M.G.; Kruh, G.D. 1999: MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver. British Journal of Cancer 80(9): 1342-1349

Otsubo, K.; Goto, H.; Nishio, M.; Kawamura, K.; Yanagi, S.; Nishie, W.; Sasaki, T.; Maehama, T.; Nishina, H.; Mimori, K.; Nakano, T.; Shimizu, H.; Mak, T.W.; Nakao, K.; Nakanishi, Y.; Suzuki, A. 2017: MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation. Oncogene 36(29): 4201-4211

Yang, B.; Li, Y.; Zhang, R.; Liu, L.; Miao, H.; Li, Y.; Shao, Z.; Ren, T.; Zhang, Y.; Zhang, Q.; Liu, Y.; Shi, H. 2020: MOB1A regulates glucose deprivation-induced autophagy via IL6-STAT3 pathway in gallbladder carcinoma. American Journal of Cancer Research 10(11): 3896-3910

Jiang, K.; Yao, G.; Hu, L.; Yan, Y.; Liu, J.; Shi, J.; Chang, Y.; Zhang, Y.; Liang, D.; Shen, D.; Zhang, G.; Meng, S.; Piao, H. 2020: MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling. Cell Death and Disease 11(4): 230

Jirout, J. 1964: Mobility of the Thoracic Spinal Cord in Normal Subjects. Review of Czechoslovak Medicine 10: 247-253

Sahu, S.; Sharma, S.; Gupta, P.; Dey, P. 2021: MOC31 Immunostaining in the Diagnosis of Metastatic Adenocarcinoma in Serous Fluid: Special Emphasis on Atypical Cytological Cases. Acta Cytologica 65(3): 242-249

Eisele, S.; Grieshammer, S. 2020: MOCASSIN: Metropolis and kinetic Monte Carlo for solid electrolytes. Journal of Computational Chemistry 41(31): 2663-2677

Bredesen, B.ør.A.é; Rehmsmeier, M. 2021: MOCCA: a flexible suite for modelling DNA sequence motif occurrence combinatorics. Bmc Bioinformatics 22(1): 234

Slaff, B.; Radens, C.M.; Jewell, P.; Jha, A.; Lahens, N.F.; Grant, G.R.; Thomas-Tikhonenko, A.; Lynch, K.W.; Barash, Y. 2021: MOCCASIN: a method for correcting for known and unknown confounders in RNA splicing analysis. Nature Communications 12(1): 3353

Doménech-Betoret, F.; Gómez-Artiga, A.; Abellán-Roselló, L.; Rocabert-Beút, E. 2020: MOCSE Centered on Students: Validation of Learning Demands and Teacher Support Scales. Frontiers in Psychology 11: 582926

Ranganathan, R.; Cannon, S.C.; Horvitz, H.R. 2000: MOD-1 is a serotonin-gated chloride channel that modulates locomotory behaviour in C. elegans. Nature 408(6811): 470-475

Qu, J.; Xu, Y.; Cui, Y.; Wu, S.; Wang, L.; Liu, X.; Xing, Z.; Guo, X.; Wang, S.; Li, R.; Sun, X.; Li, X.; Wang, X.; Liu, T.; Wang, X. 2021: MODB: a comprehensive mitochondrial genome database for Mollusca. Database: the Journal of Biological Databases and Curation 2021

Aggarwal, H.K.; Mani, M.P.; Jacob, M. 2018: Model Based Image Reconstruction using Deep Learned Priors (Modl). PROCEEDINGS. IEEE International Symposium on Biomedical Imaging 2018: 671-674

Usychenko, K.; Usychenko, O. 2020: Model for Predicting the Progression of Liver Fibrosis Based on Biochemical and Genetic Criteria in Patients with Chronic Hepatitis C. Georgian Medical News 308: 63-67

Yang, J.; Liu, Y.; Liu, Y.; Sun, W. 2021: Model Free Estimation of Graphical Model using Gene Expression Data. Annals of Applied Statistics 15(1): 194-207

Biswas, S.; Aggarwal, H.K.; Poddar, S.; Jacob, M. 2018: Model-Based Free-Breathing Cardiac Mri Reconstruction using Deep Learned and Storm Priors: Modl-Storm. Proceedings of the . IEEE International Conference on Acoustics Speech and Signal Processing. Icassp 2018: 6533-6537

Zhou, T.; Zhu, L.; Xu, C.; Li, R. 2020: Model-Free Forward Screening Via Cumulative Divergence. Journal of the American Statistical Association 115(531): 1393-1405

Martin, B.D.; Witten, D.; Willis, A.D. 2020: Modeling Microbial Abundances and Dysbiosis with Beta-Binomial Regression. Annals of Applied Statistics 14(1): 94-115

Watzek, J.; Hauber, M.E.; Jack, K.M.; Murrell, J.R.; Tecot, S.R.; Brosnan, S.F. 2021: Modelling collective decision-making: Insights into collective anti-predator behaviors from an agent-based approach. Behavioural Processes 193: 104530

Nezgoda, I.; Moroz, L.; Singh, S.; Singh, O. 2020: Modern Approaches in Management of Children with Chronic Hepatitis B in Remission of Acute Lymphoblastic Leukemia. Georgian Medical News 308: 71-79

Solopova, A.; Makatsaryia, A.; Yakovleva, O.; Moskvicheva, V. 2017: Modern Approaches to Diagnosis and Treatment of Tumors of Female Genitals of Children and Adolescents (Review). Georgian Medical News 2017(272): 25-33

Ubohov, S.H.; Soloviov, S.O.; Yurkovska, L.H.; Todorova, V.I. 2021: Modern Approaches to the Formation of Professional Competencies of Pharmacists on Issues of Medicines Quality Assurance. Wiadomosci Lekarskie 74(2): 334-340

Serheta, I.V.; Bratkova, O.Y.; Dyakova, O.V.; Dudarenko, O.B.; Drezhenkova, I.L.; Vakolyuk, L.M.; Lobastova, T.V. 2021: Modern Approaches to the Screening Assessment of the Degree of the Risk of Prenosological Disorders in the State of Mental Health of School-Age Pupils in the Context of Analysis of Behavioral Aspects of Public Health. Wiadomosci Lekarskie 74(5): 1169-1173

Chochia, A.; Gogberashvili, K.; Khachapuridze, N.; Bakhtadze, S.; Kapanadze, N.; Khundadze, M. 2019: Modern Aspects of the Effect of Xenobio-Tics on Children and Adolescents (Review). Georgian Medical News 2019(295): 71-76

Gadzhula, N.G.; Horlenko, I.M.; Goray, M.A.; Kvirikashvili, A.M. 2021: Modern Aspects of Traumatic Pulpitis Treatment with the use of Bioceramics. Wiadomosci Lekarskie 74(6): 1341-1345

Dzhuska, A.V.; Kaminska, N.іa.V.; Makarukha, Z.M. 2021: Modern Concept of Understanding the Human right to Life. Wiadomosci Lekarskie 74(2): 341-350

Kosireva, T.; Abakelia, K. 2020: Modern Concepts of Food Liquid effects on Dental-Jaw System (Review). Georgian Medical News 306: 52-57

Piegza, M.; Paterak, M.; Błachut, M.ł; Piegza, J. 2020: Modern Endovascular Treatment Methods for Erectile Dysfunction: a Critical Analysis. Wiadomosci Lekarskie 73(9 Part 2): 2049-2055

Haliienko, L.I.; Zamkevych, V.B.; Zholobko, O.V.; Mykytenko, N.M.; Velikaia, N.V. 2021: Modern Epidemiological Aspects of the Problem of Urogenital Mycoplasmis among the Female Population of Ukraine. Wiadomosci Lekarskie 74(3 Cz 2: 665-668

Chochia, A.; Geladze, N.; Gogberashvili, K.; Khachapuridze, N.; Bakhtadze, S. 2020: Modern Insues of Essential Trace Elements Level Influence on Children and Adulth Health (Review). Georgian Medical News 302: 105-108

Cholokava, N.; Khachapuridze, N.; Bakhtadze, S.; Kapanadze, N.; Jachvadze, M.; Khundadze, M. 2020: Modern Issues of D-Vitamin Significance in Development of Fulerum-Move Devices of Infants, Children and Adolescents ( Review). Georgian Medical News 2020(299): 43-47

Cholokava, N.; Uberi, N.; Bakhtadze, S.; Geladze, N.; Khachapuridze, N.; Kapanadze, N. 2021: Modern Issues of Kalcipherol Influence on Children and Adults' Health (Review). Georgian Medical News 312: 82-87

Schwab, M. 1965: Modern Kidney Function tests. Internistische Praxis 5: 95-103

Beridze, B.; Gogniashvili, G. 2020: Modern Methods in Otorhinolaryngology: Powered-Shaver Adenoidectomy. Georgian Medical News 309: 28-31

Ozhohan, R.; Rozhko, M.M.; Ozhogan, Z.R.; Khopta, R.M.; Miziuk, L. 2020: Modern Methods of Patients Treatment with Dentition Defects Combined with Functional Disorders of the Temporomandibular Joint. Wiadomosci Lekarskie 73(10): 2241-2245

Snisarevskyi, P.P. 2021: Modern Morphological Diagnostics of Ulcerative Colitis and Irritable Bowel Syndrome: Histological, Histochemical and Immunohistochemical Criteria. Wiadomosci Lekarskie 74(3 Cz 1: 381-387

Stetsyk, M.O.; Stetsyk, A.O.; Zhero, N.I.; Kostenko, E.Y.; Kostenko, S.B.; Pirchak, I.D. 2020: Modern Submission of Formation, Composition and Role of Oral (Dental) Biofilm in Development of Periodontal Diseases. Wiadomosci Lekarskie 73(8): 1761-1764

Moeschlin, S. 1965: Modern Treatment of Leukemia. Schweizerische Medizinische Wochenschrift 95: 221-225 Contd

Makharin, O.A.; Zhenilo, V.M.; Patyuchenko, O.Yu. 2017: Modern Views on the Pharmacogenetics of Pain. Anesteziologiia i Reanimatologiia 61: 219-223

Mikhailov, I.V.; Shmeleva, S.V.; Khalilov, M.A.; Bonkalo, T.I.; Tuzov, I.N.; Lakhtin, A.Y. 2020: Modernization of Social Protection in the Russian Federation: Problems and Prospects of Telemedicine in the Practice of Medical-Social Expertise. Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 28(Special Issue): 1123-1130

Tsukamura, M. 1963: Modification of Ultraviolet-Induced Mutation Frequency and Survival in Mycobacterium Avium by Pre-Irradiation Incubation in Phosphorus-Deficient Medium. Japanese Journal of Microbiology 7: 97-104

Labo, G.; Gasbarrini, G.; Faggioli, F. 1964: Modifications of the Exocrine Pancreas after Lipid Diet. Electron Microscope Study. Archivio Italiano Delle Malattie Dell'apparato Digerente 31: 609-610

Shekhanov, S.M. 1964: Modified Composition of the Cerebrospinal Fluid and its Dynamics in Spinal Cord Neoplasms in Children. Voprosy Neirokhirurgii 28: 57-59

Woodroffe, R. 2021: Modified Live Distemper Vaccines Carry Low Mortality Risk for Captive African Wild Dogs, Lycaon Pictus. Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 52(1): 176-184

Slyvka, N.; Rusnak, I.; Zub, L.; Kulachek, Y.; Kulachek, V.; Al Salama, M.; Rovinskyi, O. 2021: Modified Treatment of Hepatorenal Syndrome type i Depending on the Stage of Acute Kidney Injury. Georgian Medical News 314: 125-128

Marchant, B.; Platnick, S.; Meyer, K.; Arnold, G.T.; Riedi, J.ér.ôm. 2016: MODIS Collection 6 shortwave-derived cloud phase classification algorithm and comparisons with CALIOP. Atmospheric Measurement Techniques 9(4): 1587-1599

Borgmann, B.ör.; Schatz, V.; Hammer, M.; Hebel, M.; Arens, M.; Stilla, U. 2021: MODISSA: a multipurpose platform for the prototypical realization of vehicle-related applications using optical sensors. Applied Optics 60(22): F50-F65

Boccaletto, P.; Bagiński, Błażej. 2021: MODOMICS: An Operational Guide to the Use of the RNA Modification Pathways Database. Methods in Molecular Biology 2284: 481-505

Vereshchaka, I.V.; Bulgakova, N.V.; Kornieiev, V.V.; Chaikovskii, K.A.; Maznychenko, A.V. 2016: Modulation of the Monosynaptic Reflex Potentialsin the Decerebrated Rats Under the Influence of Hydroxytryptophan. Fiziolohichnyi Zhurnal 62(2): 41-46

Keskinler, M.V.; Erbakan, A.N.; Oguz, A. 2020: MODY Probability Ratios in Patients Diagnosed with Type 2 Diabetes Mellitus at a Young Age. Medeniyet Medical Journal 35(4): 290-294

Urbanová, J.; Brunerová, L.; Nunes, M.A.; Brož, J. 2020: MODY diabetes and screening of gestational diabetes. Ceska Gynekologie 85(2): 124-130

Millan, A.L.; Trobo, S.ía.I.; de Dios, A.; Cerrato García, M.; Pérez, M.ía.S.; Cerrone, G.E.; Frechtel, G.D.; López, A.P. 2021: MODY patients exhibit shorter telomere length than non-diabetic subjects. Diabetes/Metabolism Research and Reviews 37(2): E3374

Caironi, V.; Schwitzgebel, Vérie.M.; Jornayvaz, Fçois.R.; Gariani, K. 2021: MODY type diabetes: an often-misunderstood entity. Revue Medicale Suisse 17(741): 1062-1066

Yan, J.; MacDonald, J.C.; Maag, A.R.; Coudert, Fçois-Xavier.; Burdette, S.C. 2019: MOF Decomposition and Introduction of Repairable Defects Using a Photodegradable Strut. Chemistry 25(35): 8393-8400

Serina Secanechia, Y.; Lancrin, C. 2020: MOF Histone Acetyltransferase in Blood Cell Development. Trends in Genetics: Tig 36(9): 632-634

Li, Q.; Zhao, Y.; Li, X.; Wang, L.; Li, X.; Zhang, J.; Che, R. 2020: MOF Induces 2D GO to Assemble into 3D Accordion-Like Composites for Tunable and Optimized Microwave Absorption Performance. Small 16(42): E2003905

Bi, X.; Zhang, Y.'a.; Zhang, F.; Zhang, S.; Wang, Z.; Jin, J. 2020: MOF Nanosheet-Based Mixed Matrix Membranes with Metal-Organic Coordination Interfacial Interaction for Gas Separation. Acs Applied Materials and Interfaces 12(43): 49101-49110

Li, D.; Yang, Y.; Chen, B.; Guo, X.; Gao, S.; Wang, M.; Duan, M.; Li, X. 2020: MOF Regulates TNK2 Transcription Expression to Promote Cell Proliferation in Thyroid Cancer. Frontiers in Pharmacology 11: 607605

Liu, X.; Wei, W.; Liu, Y.; Yang, X.; Wu, J.; Zhang, Y.; Zhang, Q.; Shi, T.; Du, J.X.; Zhao, Y.; Lei, M.; Zhou, J-Qiu.; Li, J.; Wong, J. 2017: MOF as an evolutionarily conserved histone crotonyltransferase and transcriptional activation by histone acetyltransferase-deficient and crotonyltransferase-competent CBP/p300. Cell Discovery 3: 17016

Rego, R.M.; Kuriya, G.; Kurkuri, M.D.; Kigga, M. 2021: MOF based engineered materials in water remediation: Recent trends. Journal of Hazardous Materials 403: 123605

Leelasree, T.; Selamneni, V.; Akshaya, T.; Sahatiya, P.; Aggarwal, H. 2020: MOF based flexible, low-cost chemiresistive device as a respiration sensor for sleep apnea diagnosis. Journal of Materials Chemistry. B 8(44): 10182-10189

Zhang, X.; Chen, Y.; Chen, M.; Yu, B.; Wang, B.; Wang, X.; Zhang, W.; Yang, D. 2021: MOF derived multi-metal oxides anchored N, P-doped carbon matrix as efficient and durable electrocatalyst for oxygen evolution reaction. Journal of Colloid and Interface Science 581(Part B): 608-618

Xie, S.; Qin, Q.; Liu, H.; Jin, L.; Wei, X.; Liu, J.; Liu, X.; Yao, Y.; Dong, L.; Li, B. 2020: MOF-74-M (M = Mn, Co, Ni, Zn, MnCo, MnNi, and MnZn) for Low-Temperature NH3-SCR and in Situ DRIFTS Study Reaction Mechanism. Acs Applied Materials and Interfaces 12(43): 48476-48485

Shi, Y.; Huang, J.; Chen, L.; Wang, S.; Xu, J.; Zhu, F.; Cui, S.; Zheng, J.; Ouyang, G. 2022: MOF-74/polystyrene-derived Ni-doped hierarchical porous carbon for structure-oriented extraction of polycyclic aromatic hydrocarbons and their metabolites from human biofluids. Journal of Hazardous Materials 424(Part B): 127465

Yan, Y.; Bo, X.; Guo, L. 2020: MOF-818 metal-organic framework-reduced graphene oxide/multiwalled carbon nanotubes composite for electrochemical sensitive detection of phenolic acids. Talanta 218: 121123

Chen, F.; Shen, K.; Yang, Y.; Huang, H.; Li, Y. 2020: MOF-Assisted Synthesis of Highly Mesoporous Cr2O3/SiO2 Nanohybrids for Efficient Lewis-Acid-Catalyzed Reactions. Acs Applied Materials and Interfaces 12(43): 48691-48699

Li, Q.; Guo, H.; Yang, J.; Zhao, W.; Zhu, Y.; Sui, X.; Xu, T.; Zhang, J.; Zhang, L. 2020: MOF-Based Antibiofouling Hemoadsorbent for Highly Efficient Removal of Protein-Bound Bilirubin. Langmuir: the Acs Journal of Surfaces and Colloids 36(30): 8753-8763

Bim-Júnior, O.; Gaglieri, C.; Bedran-Russo, A.K.; Bueno-Silva, B.; Bannach, G.; Frem, R.; Ximenes, V.F.; Lisboa-Filho, P.N. 2020: MOF-Based Erodible System for On-Demand Release of Bioactive Flavonoid at the Polymer-Tissue Interface. Acs Biomaterials Science and Engineering 6(8): 4539-4550

Qian, Q.; Asinger, P.A.; Lee, M.J.; Han, G.; Mizrahi Rodriguez, K.; Lin, S.; Benedetti, F.M.; Wu, A.X.; Chi, W.S.; Smith, Z.P. 2020: MOF-Based Membranes for Gas Separations. Chemical Reviews 120(16): 8161-8266

Gandara-Loe, J.; Souza, B.E.; Missyul, A.; Giraldo, G.; Tan, J.-C.; Silvestre-Albero, J. 2020: MOF-Based Polymeric Nanocomposite Films as Potential Materials for Drug Delivery Devices in Ocular Therapeutics. Acs Applied Materials and Interfaces 12(27): 30189-30197

Gao, J.; Zhang, F.; Gan, W.; Gui, Y.; Qiu, H.; Li, H.; Yuan, Q. 2020: MOF-Derived 2D/3D Hierarchical N-Doped Graphene as Support for Advanced Pt Utilization in Ethanol Fuel Cell. Acs Applied Materials and Interfaces 12(42): 47667-47676

Chen, C.; Xiong, D.; Gu, M.; Lu, C.; Yi, F.-Y.; Ma, X. 2020: MOF-Derived Bimetallic CoFe-PBA Composites as Highly Selective and Sensitive Electrochemical Sensors for Hydrogen Peroxide and Nonenzymatic Glucose in Human Serum. Acs Applied Materials and Interfaces 12(31): 35365-35374

Zhao, A.; Xu, G.; Li, Y.; Jiang, J.; Wang, C.; Zhang, X.; Zhang, S.; Zhang, L. 2020: MOF-Derived Hierarchical CoSe2 with Sheetlike Nanoarchitectures as an Efficient Bifunctional Electrocatalyst. Inorganic Chemistry 59(17): 12778-12787

Ao, K.; Wei, Q.; Daoud, W.A. 2020: MOF-Derived Sulfide-Based Electrocatalyst and Scaffold for Boosted Hydrogen Production. Acs Applied Materials and Interfaces 12(30): 33595-33602

Cao, B.; Liu, H.; Zhang, X.; Zhang, P.; Zhu, Q.; Du, H.; Wang, L.; Zhang, R.; Xu, B. 2021: MOF-Derived ZnS Nanodots/Ti 3 C 2 T x MXene Hybrids Boosting Superior Lithium Storage Performance. Nano-MicroLetters 13(1): 202

Chen, X.; Li, Q.; Zhang, M.; Li, J.; Cai, S.; Chen, J.; Jia, H. 2020: MOF-Templated Preparation of Highly Dispersed Co/Al2O3 Composite as the Photothermal Catalyst with High Solar-to-Fuel Efficiency for CO2 Methanation. Acs Applied Materials and Interfaces 12(35): 39304-39317

Macedo Andrade, A.; Liu, Z.; Grewal, S.; Nelson, A.J.; Nasef, Z.; Diaz, G.; Lee, M.H. 2021: MOF-derived Co/Cu-embedded N-doped carbon for trifunctional ORR/OER/HER catalysis in alkaline media. Dalton Transactions 50(16): 5473-5482

Lin, B.; Li, S.; Peng, Y.; Chen, Z.; Wang, X. 2021: MOF-derived core/shell C-TiO2/CoTiO3 type Ii heterojunction for efficient photocatalytic removal of antibiotics. Journal of Hazardous Materials 406: 124675

Guo, L.; Bai, X.; Xue, H.; Sun, J.; Song, T.; Zhang, S.; Qin, L.; Huang, K.; He, F.; Wang, Q. 2020: MOF-derived hierarchical 3D bi-doped CoP nanoflower eletrocatalyst for hydrogen evolution reaction in both acidic and alkaline media. Chemical Communications 56(56): 7702-7705

Shi, M.; Wang, Q.; Hao, J.; Min, H.; You, H.; Liu, X.; Yang, H. 2020: MOF-derived hollow Co4S3/C nanosheet arrays grown on carbon cloth as the anode for high-performance Li-ion batteries. Dalton Transactions 49(40): 14115-14122

Niu, X.; Bo, X.; Guo, L. 2021: MOF-derived hollow NiCo2O4/C composite for simultaneous electrochemical determination of furazolidone and chloramphenicol in milk and honey. Food Chemistry 364: 130368

Chu, K.; Li, Z.; Xu, S.; Yao, G.; Xu, Y.; Niu, P.; Zheng, F. 2020: MOF-derived hollow NiCo2O4 nanowires as stable Li-ion battery anodes. Dalton Transactions 49(31): 10808-10815

Li, A.; Tong, Y.; Cao, B.; Song, H.; Li, Z.; Chen, X.; Zhou, J.; Chen, G.; Luo, H. 2017: MOF-derived multifractal porous carbon with ultrahigh lithium-ion storage performance. Scientific Reports 7: 40574

Tan, J.; Yu, M.; Cai, Z.; Lou, X.; Wang, J.; Li, Z. 2021: MOF-derived synthesis of MnS/In2S3p-n heterojunctions with hierarchical structures for efficient photocatalytic CO2 reduction. Journal of Colloid and Interface Science 588: 547-556

Yu, D.; Ma, M.; Liu, Z.; Pi, Z.; Du, X.; Ren, J.; Qu, X. 2020: MOF-encapsulated nanozyme enhanced siRNA combo: Control neural stem cell differentiation and ameliorate cognitive impairments in Alzheimer's disease model. Biomaterials 255: 120160

Wu, H.; Li, T.; Bao, Y.; Zhang, X.; Wang, C.; Wei, C.; Xu, Z.; Tong, W.; Chen, D.; Huang, X. 2021: MOF-enzyme hybrid nanosystem decorated 3D hollow fiber membranes for in-situ blood separation and biosensing array. Biosensors and Bioelectronics 190: 113413

Fan, H.; Peng, M.; Strauss, I.; Mundstock, A.; Meng, H.; Caro, Jürgen. 2021: MOF-in-COF molecular sieving membrane for selective hydrogen separation. Nature Communications 12(1): 38

Chen, X.; Xiao, S.; Wang, H.; Wang, W.; Cai, Y.; Li, G.; Qiao, M.; Zhu, J.; Li, H.; Zhang, D.; Lu, Y. 2020: MOFs Conferred with Transient Metal Centers for Enhanced Photocatalytic Activity. Angewandte Chemie 59(39): 17182-17186

Shen, M.; Zhang, Y.; Xu, H.; Ma, H. 2021: MOFs based on the application and challenges of perovskite solar cells. Iscience 24(9): 103069

Haldar, D.; Duarah, P.; Purkait, M.K. 2020: MOFs for the treatment of arsenic, fluoride and iron contaminated drinking water: a review. Chemosphere 251: 126388

Faust, T. 2016: MOFs move to market. Nature Chemistry 8(11): 990-991

Chen, J.; Sheng, D.; Ying, T.; Zhao, H.; Zhang, J.; Li, Y.; Xu, H.; Chen, S. 2020: MOFs-Based Nitric Oxide Therapy for Tendon Regeneration. Nano-MicroLetters 13(1): 23

Wang, T.; Cao, X.; Jiao, L. 2021: MOFs-Derived Carbon-Based Metal Catalysts for Energy-Related Electrocatalysis. Small 17(22): E2004398

Liu, R.; Chi, L.; Feng, J.; Wang, X. 2020: MOFs-derived conductive structure for high-performance removal/release of phosphate as electrode material. Water Research 184: 116198

Li, W.; Chen, J.; Gao, P. 2022: MOFs-derived hollow Copper-based sulfides for optimized electromagnetic behaviors. Journal of Colloid and Interface Science 606(Part 1): 719-727

Li, B.; Chen, D.; Wang, J.; Yan, Z.; Jiang, L.; Deliang Duan; He, J.; Luo, Z.; Zhang, J.; Yuan, F. 2014: MOFzyme: Intrinsic protease-like activity of Cu-MOF. Scientific Reports 4: 6759

Vibha, D.; Singh, R.K.; Salunkhe, M.; Dash, D.; Tripathi, M. 2021: MOG antibody syndrome presenting as aseptic meningitis: an evolving spectrum. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 42(1): 321-323

Narongkhananukul, C.; Padungkiatsagul, T.; Jindahra, P.; Khongkhatithum, C.; Thampratankul, L.; Vanikieti, K. 2020: MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison. Clinical Ophthalmology 14: 4079-4088

Caroline Breis, L.; Antônio Machado Schlindwein, M.; Pastor Bandeira, I.; Machiavelli Fontana, T.ís.; Fiuza Parolin, L.; Weingrill, P.; Kleinpaul Vieira, R.G.ça.; Vinícius Magno Gonçalves, M. 2021: MOG-IgG-associated disorder and systemic lupus erythematosus disease: Systematic review. Lupus 30(3): 385-392

Kunchok, A.; Flanagan, E.P.; Krecke, K.N.; Chen, J.J.; Caceres, J.A.; Dominick, J.; Ferguson, I.; Kinkel, R.; Probasco, J.C.; Ruvalcaba, M.; Santoro, J.D.; Sieloff, K.; Timothy, J.; Weinshenker, B.G.; McKeon, A.; Pittock, S.J. 2021: MOG-IgG1 and co-existence of neuronal autoantibodies. Multiple Sclerosis 27(8): 1175-1186

Peters, J.; Alhasan, S.; Vogels, C.B.F.; Grubaugh, N.D.; Farhadian, S.; Longbrake, E.E. 2021: MOG-associated encephalitis following SARS-COV-2 infection. Multiple Sclerosis and Related Disorders 50: 102857

Arbustini, E.; Narula, N.; Dec, G.William.; Reddy, K.Srinath.; Greenberg, B.; Kushwaha, S.; Marwick, T.; Pinney, S.; Bellazzi, R.; Favalli, V.; Kramer, C.; Roberts, R.; Zoghbi, W.A.; Bonow, R.; Tavazzi, L.; Fuster, V.; Narula, J. 2014: MOGE(S) nosology in low-to-middle-income countries. Nature Reviews. Cardiology 11(5): 307

Wang, T.; Shao, W.; Huang, Z.; Tang, H.; Zhang, J.; Ding, Z.; Huang, K. 2021: MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. Nature Communications 12(1): 3445

Meng, C.; Basunia, A.; Peters, B.; Gholami, A.Moghaddas.; Kuster, B.; Culhane, Aín.C. 2019: MOGSA: Integrative Single Sample Gene-set Analysis of Multiple Omics Data. Molecular and Cellular Proteomics: Mcp 18(8s1): S153-S168

Winder, G.; Haik, J.; Harats, M.; Avinoam-Dar, G. 2020: Mohs Micrographic Surgery for Cutaneous Malignant Lesions Excision: Experience of a Single Tertiary Medical Center in Israel. Harefuah 159(8): 554-559

Hrdy, J.; Vasickova, P.; Nesvadbova, M.; Novotny, J.; Mati, T.; Kralik, P. 2021: MOL-PCR and xMAP Technology: a Multiplex System for Fast Detection of Food- and Waterborne Viruses. Journal of Molecular Diagnostics: Jmd 23(6): 765-776

Kuklik, H.H.; Cruz, I.T.S.A.; Celli, A.; Fraiz, F.C.; AssunÇÃo, L.R.d.S. 2020: Molar Incisor Hypomineralization and Celiac Disease. Arquivos de Gastroenterologia 57(2): 167-171

Kajaia, D.; Kochiashvili, D.; Muzashvili, T.; Gachechiladze, M.; Burkadze, G. 2021: Molecular Characteristics of the Heterogeneity of Non-Invasive Papillary Urothelial Carcinomas and the Markers of their Recurrence. Georgian Medical News 2021: 316-317

Vale, A.P.; Cousins, C.; Tzora, A.; McCarron, M-Therese.; Green, A.; Molloy, S.; Bainbridge, J.; Leonard, F. 2020: Molecular Characterization of Fecal Escherichia Coli Isolated from Zoo Animals. Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 50(4): 813-821

Benzing, T. 2020: Molecular Design of the Kidney Filtration Barrier. Transactions of the American Clinical and Climatological Association 131: 125-139

Dolynska, M.G.; Dolynskyi, G.A.; Duhlii, T.V.; Petrenko, V.I. 2021: Molecular Epidemiology Approach to Tackle Treatment Failure in Drug Resistant Tuberculosis (Dr-Tb). Wiadomosci Lekarskie 74(3 Cz 2: 669-673

Poluben, L.O.; Neumerzhytska, L.V.; Klymenko, S.V.; Fraenkel, P.; Balk, C.; Shumeiko, O.O. 2020: Molecular Genetic Abnormalities in the Genome of Patients with Ph-Negative Myeloproliferative Neoplasia affected by Ionizing Radiation as a Result of the Chornobyl Nuclear Accident. Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii 25: 362-373

Stepanova, Y.I.; Kolpakov, I.Ye.; Vdovenko, V.Yu.; Zigalo, V.M.; Kondrashova, V.H.; Leonovich, O.S. 2020: Molecular Genetic Aspects of Bronchial Hyperreactivity in Children - Residents of Radioactively Contaminated Areas. Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii 25: 531-542

Zharmakhanova, G.; Syrlybayeva, L.; Nurbaulina, E.; Batyrova, T.; Baikadamova, L. 2019: Molecular Genetic Aspects of the Development of the Mucopolysaccharidoses (Review). Georgian Medical News 2019(295): 152-159

Oboli, G.O.; Chukwuma, D.I.; Fagbule, O.F.; Abe, E.O.; Adisa, A.O. 2020: Molecular Genetics of Cleft Lip and Palate: a Review. Annals of Ibadan Postgraduate Medicine 18(1): S16-S21

Koch, R.W.; Shannon, R.P.; Detwiler, J.T.; Bolek, M.G. 2021: Molecular Identification of Juvenile Neoechinorhynchus Spp. (Phylum: Acanthocephala) Infecting Ostracod and Snail Hosts Provides Insight into Acanthocephalan Host use. Journal of Parasitology 107(5): 739-761

Ghauri, H.N.; Ijaz, M.; Ahmed, A.; Muhammad Naveed, M.U.A.; Nawab, Y.; Javed, M.U.; Ghaffar, A. 2021: Molecular Investigation and Phylogenetic Analysis of Anaplasmosis in Dogs. Journal of Parasitology 107(2): 295-303

Torres-Poveda, K.; Piña-Sánchez, P.; Vallejo-Ruiz, V.ón.; Lizano, M.; Cruz-Valdez, A.; Juárez-Sánchez, P.; Garza-Salazar, J.d.l.; Manzo-Merino, J.ín. 2020: Molecular Markers for the Diagnosis of High-Risk Human Papillomavirus Infection and Triage of Human Papillomavirus-Positive Women. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 72(4): 198-212

Musser, J.M. 2020: Molecular Mechanisms Contributing to Fuzzy Epidemics Caused by Group a Streptococcus, a Flesh-Eating Human Bacterial Pathogen. Transactions of the American Clinical and Climatological Association 131: 356-368

Virgolini, M.B.; Aschner, M. 2021: Molecular Mechanisms of Lead Neurotoxicity. Advances in Neurotoxicology 5: 159-213

Tyrrell, J.D.; Qurollo, B.A.; Mowat, F.M.; Kennedy-Stoskopf, S. 2020: Molecular Prevalence of Selected Vector-Borne Organisms in Captive Red Wolves (Canis Rufus). Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 51(3): 663-667

Choudhuri, S.; Klaassen, C.D. 2022: Molecular Regulation of Bile Acid Homeostasis. Drug Metabolism and Disposition: the Biological Fate of Chemicals 50(4): 425-455

Mizukami, M.; Sato, S.; Nabeshima, K.; Kabeya, H.; Ueda, D.; Suzuki, K.; Maruyama, S. 2020: Molecular Survey of Bartonella Rochalimae in Japanese Raccoon Dogs ( Nyctereutes Procyonoides Viverrinus ). Journal of Wildlife Diseases 56(3): 560-567

Zharmakhanova, G.; Syrlybayeva, L.; Kononets, V.; Nurbaulina, E.; Baikadamova, L. 2021: Molecular-Genetic Aspects of Methylmalonic Aciduria Development (Review). Georgian Medical News 313: 118-124

Yokthongwattana, C.; Bucher, E.; Caikovski, M.; Vaillant, I.; Nicolet, Jël.; Mittelsten Scheid, O.; Paszkowski, J. 2010: MOM1 and Pol-IV/V interactions regulate the intensity and specificity of transcriptional gene silencing. EMBO Journal 29(2): 340-351

Vaillant, I.; Schubert, I.; Tourmente, S.; Mathieu, O. 2006: MOM1 mediates DNA-methylation-independent silencing of repetitive sequences in Arabidopsis. Embo Reports 7(12): 1273-1278

Gupta, P.; Bhowmick, B.; Pal, A. 2020: MOMBAT: Heart rate monitoring from face video using pulse modeling and Bayesian tracking. Computers in Biology and Medicine 121: 103813

Camera, S.; Deleporte, A.él.; Bregni, G.; Trevisi, E.; Pretta, A.; Telli, T.A.; Polastro, L.; Gombos, A.; Kayumba, A.; Ameye, L.; Piccart-Gebhart, M.; Awada, A.; Sclafani, F.; Hendlisz, A. 2020: MOMENTUM: a Phase i Trial Investigating 2 Schedules of Capecitabine with Aflibercept in Patients with Gastrointestinal and Breast Cancer. Clinical Colorectal Cancer 19(4): 311-318.E1

Kalkavan, H.; Green, D.R. 2018: MOMP, cell suicide as a BCL-2 family business. Cell Death and Differentiation 25(1): 46-55

Kalkavan, H.; Green, D.R. 2018: MOMP, cell suicide as a BCL-2 family business. Cell Death and Differentiation 25(1): 46-55

Abunahla, H.; Mohammad, B.; Alazzam, A.; Jaoude, M.Abi.; Al-Qutayri, M.; Abdul Hadi, S.; Al-Sarawi, S.F. 2019: MOMSense: Metal-Oxide-Metal Elementary Glucose Sensor. Scientific Reports 9(1): 5524

Zhao, S.-B.; Dean, N.; Gao, X.-D.; Fujita, M. 2020: MON2 Guides Wntless Transport to the Golgi through Recycling Endosomes. Cell Structure and Function 45(1): 77-92

Siu, H.W.D.; Tebbutt, N.; Chantrill, L.; Karapetis, C.; Steer, C.; Wilson, K.; Espinoza, D.; Bailey, L.; Yip, S.; Cuff, J.; Pavlakis, N.; Thavaneswaran, S.; Briscoe, K.; Srivastav, R.; Shannon, J.; Segelov, E.; Tie, J.; Caird, S.; Francesconi, A.; Price, T.; Wuttke, M.; Ladwa, R.; Sjoquist, K.; Burge, M. 2021: MONARCC: a randomised phase Ii study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG). Bmc Cancer 21(1): 932

Neven, P.; Johnston, S.R.D.; Toi, M.; Sohn, J.; Inoue, K.; Pivot, X.; Burdaeva, O.; Okera, M.; Masuda, N.; Kaufman, P.A.; Koh, H.; Grischke, E.-M.; Conte, P.; Lu, Y.; Haddad, N.; Hurt, K.C.; Llombart-Cussac, A.; Sledge, G.W. 2021: MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2--Advanced Breast Cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 27(21): 5801-5809

Johnston, S.; Martin, M.; Di Leo, A.; Im, S-Ah.; Awada, A.; Forrester, T.; Frenzel, M.; Hardebeck, M.C.; Cox, J.; Barriga, S.; Toi, M.; Iwata, H.; Goetz, M.P. 2019: MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer. Npj Breast Cancer 5: 5

Nudel, S.I. 1964: Mondor's Disease. Sovetskaia Meditsina 27: 132-135

Odinokova, V.A.; Zdor, L.S. 1964: Mondor's Disease. Arkhiv Patologii 26: 63-66

Fabris, F.; Grapulin, G.; Dallantonia, F.; Morea, M. 1964: Mondor's Disease. Chirurgia Italiana 16: 392-396

Weinstein, E.C. 1965: Mondor's Disease. Western Medicine; the Medical Journal of the West 6: 107-108

Martins, C.; Machado da Silva, J.é; Guimarães, D.; Martins, L.ís.; Vaz da Silva, M. 2021: MONITORIA: the start of a new era of ambulatory heart failure monitoring? Part i - Theoretical Rationale. Revista Portuguesa de Cardiologia 40(5): 329-337

Martins, C.; Machado da Silva, J.é; Guimarães, D.; Martins, L.ís.; Vaz da Silva, M. 2021: MONITORIA: the start of a new era of ambulatory heart failure monitoring? Part i - Theoretical Rationale. Revista Portuguesa de Cardiologia 40(5): 329-337

Martins, C.; Machado da Silva, J.é; Guimarães, D.; Martins, L.ís.; Vaz Da Silva, M. 2021: MONITORIA: the start of a new era of ambulatory heart failure monitoring? Part Ii - Design. Revista Portuguesa de Cardiologia 40(5): 343-351

Martins, C.; Machado da Silva, J.é; Guimarães, D.; Martins, L.ís.; Vaz Da Silva, M. 2021: MONITORIA: the start of a new era of ambulatory heart failure monitoring? Part Ii - Design. Revista Portuguesa de Cardiologia 40(5): 343-351

Bureau, J. 1964: Monitoring. Techniques Hospitalieres Medico-Sociales et Sanitaires 19: 51-53

Matejczyk, M.; Swislocka, R.; Kalinowska, M.; Swidersk, G.; Lewandowsk, W.; Jablonska-Trypuo, A. 2017: Monitoring of Synergistic Enhancement of Caffeic Acid on Escherichia Coli K-12 Reca::gfp Strain Treated with Dacarbazine. Acta Poloniae Pharmaceutica 74(3): 809-816

Garmany, G. 1964: Monoamine-Oxidase Inhibitors. Lancet 1(7339): 932

Jericha, E.; Gösselsberger, C.; Abele, H.; Baumgartner, S.; Berger, B.Maximilian.; Geltenbort, P.; Hino, M.; Oda, T.; Raab, R.; Badurek, G. 2020: MONOPOL - A traveling-wave magnetic neutron spin resonator for tailoring polarized neutron beams. Scientific Reports 10(1): 5815

Schlereth, A.; Möller, B.; Liu, W.; Kientz, M.; Flipse, J.; Rademacher, E.H.; Schmid, M.; Jürgens, G.; Weijers, D. 2010: MONOPTEROS controls embryonic root initiation by regulating a mobile transcription factor. Nature 464(7290): 913-916

Glessner, J.T.; Chang, X.; Liu, Y.; Li, J.; Khan, M.; Wei, Z.; Sleiman, P.M.A.; Hakonarson, H. 2021: MONTAGE: a new tool for high-throughput detection of mosaic copy number variation. Bmc Genomics 22(1): 133

Jung, I.; Kim, M.; Rhee, S.; Lim, S.; Kim, S. 2021: MONTI: a Multi-Omics Non-negative Tensor Decomposition Framework for Gene-Level Integrative Analysis. Frontiers in Genetics 12: 682841

Kim, M-Chan.; Kim, C-Sup.; Chung, T-Heum.; Jeong, J.; Lee, S-Ho.; Kim, S-Ryul.; Jung, S-Won.; Park, N-Hwa.; Yoo, C-In. 2012: MONW phenotype is associated with advanced colorectal adenoma in Korean men. Obesity 20(9): 1876-1881

Olivares Olivares, S.L.; Hernández, R.ón.I.E.ón.; Corolla, M.L.T.; Alvarez, J.P.N.; Sánchez-Mendiola, M. 2021: MOOC Learning Assessment in Clinical Settings: Analysis from Quality Dimensions. Medical Science Educator 31(2): 447-455

Alhazzani, N. 2020: MOOC's impact on higher education. Social Sciences and Humanities Open 2(1): 100030

Li, L.; Xie, Z.; Xu, X. 2020: MOPED25: a multimodal dataset of full-body pose and motion in occupational tasks. Journal of Biomechanics 113: 110086

Fujita, W. 2021: MOPr-DOPr heteromer: the meaning and possibility as novel therapeutic target for pain control. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 156(3): 134-138

Nervina, J.M.; Khoo, E.; Alikhani, M.; Teixeira, C.C. 2020: MOPs and accelerated tooth movement: a biased conclusion?. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 158(2): 157-159

Whittington, A.T.; Vugrek, O.; Wei, K.J.; Hasenbein, N.G.; Sugimoto, K.; Rashbrooke, M.C.; Wasteneys, G.O. 2001: MOR1 is essential for organizing cortical microtubules in plants. Nature 411(6837): 610-613

Twell, D.; Park, S.Ki.; Hawkins, T.J.; Schubert, D.; Schmidt, R.; Smertenko, A.; Hussey, P.J. 2002: MOR1/GEM1 has an essential role in the plant-specific cytokinetic phragmoplast. Nature Cell Biology 4(9): 711-714

Mundorf, A.; Schmitz, J.; Hünten, K.; Fraenz, C.; Schlüter, C.; Genç, E.; Ocklenburg, S.; Freund, N. 2021: MORC1 methylation and Bdi are associated with microstructural features of the hippocampus and medial prefrontal cortex. Journal of Affective Disorders 282: 91-97

Pastor, W.A.; Stroud, H.; Nee, K.; Liu, W.; Pezic, D.; Manakov, S.; Lee, S.A.; Moissiard, G.; Zamudio, N.; Bourc'his, Déborah.; Aravin, A.A.; Clark, A.T.; Jacobsen, S.E. 2014: MORC1 represses transposable elements in the mouse male germline. Nature Communications 5: 5795

Guddeti, R.K.; Chutani, N.; Pakala, S.B. 2021: MORC2 Interactome: its Involvement in Metabolism and Cancer. Biophysical Reviews 13(4): 507-514

Liu, J.; Zhang, Q.; Ruan, B.; Chen, W.; Zheng, J.; Xu, B.; Jiang, P.; Miao, Z.; Li, F.; Guo, J.Yanxiang.; Cao, L.; Wang, G. 2019: MORC2 regulates C/EBPα-mediated cell differentiation via sumoylation. Cell Death and Differentiation 26(10): 1905-1917

Luo, J.; Zeng, S.; Tian, C. 2020: MORC4 Promotes Chemoresistance of Luminal A/B Breast Cancer via STAT3-Mediated MID2 Upregulation. Oncotargets and Therapy 13: 6795-6803

Kanan, C.; Ohrenberger, K.; Bayham, M.; Raskin, S.E.; Tranby, E.P.; Boynes, S. 2020: MORE Care: an evaluation of an interprofessional oral health quality improvement initiative. References 80 Suppl. 2: S58-S70

Ren, D.; Rao, Y.; Yu, H.; Xu, Q.; Cui, Y.; Xia, S.; Yu, X.; Liu, H.; Hu, H.; Xue, D.; Zeng, D.; Hu, J.; Zhang, G.; Gao, Z.; Zhu, L.; Zhang, Q.; Shen, L.; Guo, L.; Qian, Q. 2020: MORE FLORET1 Encodes a MYB Transcription Factor That Regulates Spikelet Development in Rice. Plant Physiology 184(1): 251-265

Harris, A.A.; Kabadi, U.M. 2020: More than Meets the Eye in a Patient with Pcos: Androgen-Secreting Granulosa cell Ovarian Tumor in a Virilized Woman with Polycystic Ovarian Syndrome (Pcos). Aace Clinical Case Reports 6(4): E170-E173

Lloyd, D.H. 1994: More Things in Heaven and Earth. Veterinary Dermatology 5(4): Iii

Yan, J.; Zhang, Q.; Guan, Z.; Wang, Q.; Li, L.; Ruan, F.; Lin, R.; Zou, T.; Yin, P. 2017: MORF9 increases the RNA-binding activity of PLS-type pentatricopeptide repeat protein in plastid RNA editing. Nature Plants 3: 17037

Hampshire, D.J.; Ayub, M.; Springell, K.; Roberts, E.; Jafri, H.; Rashid, Y.; Bond, J.; Riley, J.H.; Woods, C.Geoffrey. 2006: MORM syndrome (mental retardation, truncal obesity, retinal dystrophy and micropenis), a new autosomal recessive disorder, links to 9q34. European Journal of Human Genetics: Ejhg 14(5): 543-548

Ma, H.; Lou, Y.; Lin, W.Hui.; Xue, H.Wei. 2006: MORN motifs in plant PIPKs are involved in the regulation of subcellular localization and phospholipid binding. Cell Research 16(5): 466-478

Bergler-Czop, B.; Brzezińska-Wcisło, L. 2020: Morphea and Lichen Sclerosus in a Patient with Hyporthyroidism. Acta Clinica Croatica 59(4): 765-770

Ruffinatti, F.A.; Genova, T.; Mussano, F.; Munaron, L. 2020: MORPHEUS: An automated tool for unbiased and reproducible cell morphometry. Journal of Cellular Physiology 235(12): 10110-10115

Lytvynenko, M.; Narbutova, T.; Vasylyev, V.; Bondarenko, A.; Gargin, V. 2021: Morpho-Functional Changes in Endometrium under the Influence of Chronic Alcoholism. Georgian Medical News 315: 160-164

Godlewski, H. 1963: Morphochemical Principles of Connective Tissue Reactivity. Przeglad Dermatologiczny 50: 197-213 Contd

Jupp, A.P.; Newman, E.I. 1987: Morphological and Anatomical Effects of Severe Drought on the Roots of Lolium Perenne L. References 105(3): 393-402

Dombrovska, N.S.; Nastina, O.M.; Voloshko, V.I.; Pleskach, O.Ya. 2018: Morphological and Functional Myocardial Abnormalities in the Chornobyl Npp Accident Clean-Up Workers of «iodine» Period Having Got Type 2 Diabetes Mellitus. Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii 23: 302-330

Usenko, O.Yu.; Salyutin, R.V.; Zapolskaya, K.M.; Palyanitsya, S.S.; Panchenko, L.A. 2016: Morphological and Immunophenotype of Description of Lipoaspirate Cells. Klinichna Khirurhiia 2016(7): 67-69

Mohammadi, S.; Lutermann, H.; Hoffmann, S.; Emami-Khoyi, A.; Webster, H.J.; Fagir, D.; Bennett, N.C.; van Vuuren, B.J. 2021: Morphological and Molecular Characterization of the Plague Vector Xenopsylla Brasiliensis. Journal of Parasitology 107(2): 289-294

Lipakova, E.Y.; Bilchenko, O.V.; Rudenko, T.A.; Holianishchev, M.O.; Vysotska, O.V.; Rysovana, L.M. 2020: Morphological and Structural Changes in Myocardium, Lipid and Сarbohydrate Metabolism during different Outcomes of Chronic Heart Failure in Patients with Ischemic Heart Disease and Diabetes Mellitus type Ii. Wiadomosci Lekarskie 73(10): 2165-2169

Kutara, K.; Une, Y.; Fujita, Y. 2019: Morphological Assessment of Horseshoe Crabs (Tachypleus Tridentatus) by using Magnetic Resonance Imaging. Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 50(3): 742-748

Kvaratskhelia, S.; Nemsadze, T.; Puturidze, S.; Gogiberidze, M.; Jorbenadze, T. 2021: Morphological Changes in Periodontal Tissue during Periodontitis. Georgian Medical News 311: 50-54

Yaremchuk, O.; Lisnychuk, N.; Nebesna, Z.; Kramar, S.; Kulitska, M.; Shanaida, М; Delibashvili, D. 2021: Morphological Changes in the Liver of Mice with Antiphospholipid Syndrome and Administration of Nitric Oxide Synthesis Modulators. Georgian Medical News 315: 177-180

Kitsyuk, N.; Zvyagintseva, T.; Myronchenko, S. 2021: Morphological Changes in the Skin of Guinea Pigs after the Impact of Local Uva Exposure. Georgian Medical News 314: 162-166

Vereshchahina, T.V.; Boychuk, A.V.; Yakymchuk, Y.B.; Nikitina, I.M.; Datsko, T.V. 2021: Morphological Changes of the Endometrium in Hyperplastic Process in Women of Reproductive Age. Wiadomosci Lekarskie 74(3 Cz 1: 388-394

Yankovetska, A.G.; Vernyhorodskyi, S.V.; Paliy, I.G.; Zaika, S.V. 2021: Morphological Changes of the Gastric Mucosa While using Antiaggregants and Pantoprazole (An Experimental Study). Wiadomosci Lekarskie 74(2): 228-235

Pylypko, I.; Halytska-Kharkhalis, O.; Henyk, T.; Flekey, N.; Panchyshyn, N. 2018: Morphological Changes of the Urogenital System Internal Structure at Modeling of Portal Hypertension in Rats. Georgian Medical News 2018(279): 117-122

Fedoniuk, L.Y.; Kulyanda, I.S.; Dovgalyuk, A.I.; Lomakina, Y.V.; Kramar, S.B.; Kulianda, O.O.; Valko, O.O. 2021: Morphological Characteristics of Acellular Dermal Matrix Manufacturing. Wiadomosci Lekarskie 74(3 Cz 1: 418-422

Berezenko, V.; Bogdanova, T.; Krotevich, M.; Savenko, Y.; Vankhanova, T. 2018: Morphological Characteristics of Chronic Gastroduodenitis in Adolescents with Food Hypersensitivity. Georgian Medical News 2018(284): 93-97

Brodetskyi, I.S.; Dyadyk, O.O.; Myroshnychenko, M.S.; Zaritska, V.I. 2020: Morphological Characteristics of Pleomorphic Adenomas of Salivary Glands (Analysis of the Surgical Material). Wiadomosci Lekarskie 73(11): 2339-2344

Briukhin, G.V.; Abdil'din, R.K. 2016: Morphological Characteristics of the Allantoic Placenta in Rats with Experimental Liver Damage. Morfologiia 150(4): 76-79

Rykova, Y.; Shuper, S.; Shcherbakovsky, M.; Kikinchuk, V.; Peshenko, A. 2019: Morphological Characteristics of the Thyroid Gland of Mature Rats in Moderate Degree Chronic Hyperthermia. Georgian Medical News 2019(292-293): 75-81

Erbes, L.Ariadna.; Zeitoune, Ángel.Alberto.; Torres, H.Maximiliano.; Casco, Víctor.Hugo.; Adur, J. 2019: Morphological Characterization of Colorectal Pits Using Autofluorescence Microscopy Images. Arquivos de Gastroenterologia 56(2): 191-196